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ABSTRACT OF THE DISSERTATION
The Role of eNAMPT-mediated Systemic NAD+ Biosynthesis in Aging and Lifespan.
by
Mitsukuni Yoshida
Doctor of Philosophy in Biology and Biomedical Sciences
Neuroscience
Washington University in St. Louis, 2021
Professor Shin-ichiro Imai, Chairperson
Aging is a systemic decline in tissue functions that occurs during the course of our life, leading
to the development of age-associated health deteriorations and ultimately to the expiration of life.
Over the past few decades, population aging has become increasingly evident in many parts of
the world, leading to an increased prevalence of age-related disabilities and diseases. Because
age is a major risk factor for many chronic diseases, extensive research effort has been spent to
identify common age-associated molecular changes contributing to the pathogenesis and
progression of these health issues. One such molecule identified to play a central role in the
regulation of aging is nicotinamide adenine dinucleotide (NAD+). NAD+ is a universal energy
currency utilized as an essential coenzyme and cosubstrate in a wide variety of biological
processes. Many studies over the past decades have demonstrated that NAD+ availability is one
of the important factors influencing the health and lifespan of many organisms. Studies from
others and ours have demonstrated the enhancement of NAD+ homeostasis and increased activity
of NAD-dependent enzymes has beneficial effects against stress, disease, and aging in nearly
every single tissue type in the body. In support of the role of NAD+ in aging, NAD+ availability
significantly declines with age. Nicotinamide phosphoribosyltransferase (NAMPT) is the ratex

limiting enzyme in the most utilized NAD+ biosynthetic pathway in mammals. Interestingly,
NAMPT has been identified to be secreted out to extracellular space and known to be abundantly
present in the blood. Given the importance of NAD+ homeostasis in tissue functions and health,
we are interested in understanding the role of eNAMPT in aging by characterizing its impact on
NAD+ biosynthesis, tissue function, behavior, and lifespan. We identified that the modulation of
adipose tissue-specific expression of NAMPT alters plasma eNAMPT levels. Increasing or
decreasing eNAMPT levels enhance or suppress NAD+ biosynthesis in remote tissue such as
hypothalamus. Adaptive response to fasting induces secretion of eNAMPT through its
deacetylation by SIRT1, thereby enhancing hypothalamic NAD+ availability. Hypothalamic
NAD+ levels regulated by eNAMPT modulate the SIRT1 activity, neural activity, and behavior
in mice. Furthermore, we identified that adipose-specific NAMPT overexpression offset the ageinduced decline in plasma eNAMPT levels, maintaining higher NAD+ availability in
hypothalamus, hippocampus, pancreas, and retina. Additionally, we find that eNAMPT levels
significantly decline in humans in a linear fashion and are strongly correlated with lifespans in
mice. Mice with increased eNAMPT levels maintain higher tissue NAD+ levels and functions,
show delay in age-related phenotypes, and significant lifespan extension. Lastly, we
characterized that eNAMPT circulating in the blood is encapsulated within exosome. eNAMPT
in the isolated exosome from plasma and adipocyte is internalized by target cells such as
hypothalamic neurons and enhances its NAD+ biosynthesis. Finally, administrations of exosomes
isolated from young mice improve wheel-running activity of aged mice and significantly extend
their lifespan. Our findings revealed exosome as a new mode of regulation for systemic NAD+
biosynthesis and eNAMPT as a key regulatory factor in aging.

xi

Chapter 1:
The Role of Systemic NAD+ Biosynthesis
in Aging and Diseases
This chapter is adapted from a book chapter published in Introductory review on sirtuins in
biology, aging, and disease:

Yoshida, M and Imai, S (2018) Regulation of Sirtuins by systemic NAD+ biosynthesis.
Introductory review on sirtuins in biology, aging, and disease (pp. 7-26). Academic
Press. DOI: https://doi.org/10.1016/B978-0-12-813499-3.00001-0

M.Y.and S.I. wrote the manuscript.
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1.1 SUMMARY
In recent years, NAD+ biology has been increasingly drawing significant attention within
the scientific community and providing its vast implication for various age-associated
pathophysiologies and disease conditions. Particularly, the role of NAD+ in the regulation of
sirtuins, an evolutionary conserved family of NAD+-dependent deacetylases/deacylases, has been
extensively studied.

Systemic NAD+ biosynthesis mediated by intra- and extracellular

nicotinamide phosphoribosyltransferase (NAMPT) and sirtuins cooperate to regulate many
fundamental biological processes in different tissues and organs and promote physiological
resilience in response to nutritional and environmental perturbations. Accumulating lines of
evidence suggest that systemic decline in NAD+ availability is a critical trigger for ageassociated functional decline and disease conditions through the reduction in sirtuin activities in
different subcellular compartments. In this chapter, we will discuss the current understanding of
the intimate connection between systemic NAD+ biosynthesis and sirtuin functions and its
implications in aging and longevity control.

2

1.2

INTRODUCTION
Nicotinamide adenine dinucleotide (NAD+) is a universal energy currency necessary for
various cellular processes mediating metabolic homeostasis, damage response, immune
reaction, and many others. 1-3 While NAD+ has been well recognized for its importance as
a coenzyme in redox reactions, its role as a co-substrate has attracted significant
attentions over the past two decades. NAD+ was originally discovered by Harden and
Young as a low molecular weight substance extracted from yeast that promotes alcohol
fermentation.

4

Since its discovery, NAD+ and its reduced form NADH, as well as

NADP+ and NADPH, have been well studied as coenzymes for many redox reactions.

5

NAD+ has also been identified as a co-substrate for DNA ligase, poly-ADP-ribose
polymerases (PARPs), and CD38/157 ADP-ribosyl cyclases.

6-8

In 2000, NAD+ was

identified as an essential co-substrate for an evolutionarily conserved silent information
regulator 2 (SIR2) family of protein deacetylaeses, also called sirtuins.

9

Yeast SIR2

protein and its mouse homolog, now called SIRT1, were demonstrated to deacetylate
lysines 9 and 14 of histone H3 and lysine 16 of H4 in an NAD+-dependent manner. This
unprecedented enzymatic activity immediately suggested that sirtuins function as sensors
of the cellular energy status represented by NAD+, connecting between cellular
metabolism and epigenetic regulation.
Since then, the biology of sirtuins has been rapidly evolving, demonstrating pleiotropic
NAD+-dependent functions of sirtuins in many critical biological processes, particularly
in the regulation of aging and longevity, in diverse model organisms.

10-12

Although a

challenge was raised for the importance of sirtuins in aging and longevity control, many
studies have now firmly confirmed that sirtuins control the process of aging and promote

3

longevity in yeast, worms, flies, and mice.

13-22

For example, in mammals, the brain-

specific SIRT1-overexpressing (BRASTO) transgenic mice exhibit significant delay in
aging and lifespan extension in both male and female mice.

18

Additionally, whole-body

SIRT6 transgenic mice show lifespan extension, although only males exhibit the
phenotype. 19 Such an evolutionarily conserved function of sirtuins in aging and longevity
control is mainly due to their importance in the regulation of physiological resilience in
each organism. A good example of this case is dietary restriction. Dietary restriction is a
well-studied dietary regimen that delays aging and extends lifespan in many diverse
species including yeast, worms, flies, rodents, and primates.

23-27

Interestingly, sirtuins

are critical in mediating physiological responses to dietary restriction, activating
transcriptional programs that promote metabolic efficiency and stimulating mitochondrial
oxidative metabolism, all of which augment physiological resilience throughout the body.
16,23,28-30

Therefore, it is conceivable that sirtuins have been evolved to maximize

physiological resilience, particularly in life-threatening conditions, and promote survival.
Unfortunately, it seems that sirtuins cannot maintain their critical functions throughout
the life course of an organism. It has now become clear that NAD+ availability declines
systemically in diverse organisms so that sirtuins cannot maintain their full activities,
contributing to age-associated pathophysiologies in each organism.

31-34

For this reason,

more studies have recently started focusing on the functional connection between NAD+
biosynthesis and consumption and sirtuin functions. In this chapter, we will discuss how
NAD+ biosynthesis is regulated, how NAD+ is consumed, and how sirtuin functions are
regulated by NAD+ availability, mainly in mammals. We will also discuss how this tight

4

connection between NAD+ and sirtuins impact the regulation of aging and longevity and
how sirtuin activities can be maintained to mitigate physiological functional decline.
1.3

NAD+ biosynthesis, consumption, and degradation
Given that NAD+ is an essential co-substrate for sirtuin activities, NAD+ availability has
been suggested to directly regulate sirtuin activities and impact their downstream
signaling pathways. Several kinetic studies have demonstrated that Km values of SIRT13 for NAD+ are consistent with the range of NAD+ changes in each subcellular
compartment (Table 1.1). Indeed, another recent study with a newly developed NAD+
biosensor has reported that in cultured cells, free NAD+ concentrations are 106 µM, 109
µM, and 230 µM in the cytoplasm, nucleus, and mitochondria, respectively (Table 1.1).
35

Interestingly, NAD+ appears to be quickly equilibrated between the nucleus and

cytoplasm, whereas mitochondrial NAD+ levels are maintained separately. Therefore,
any changes in NAD+ availability due to the alteration in biosynthesis, consumption, or
degradation likely have significant impacts on sirtuin activities in different subcellular
compartments.
NAD+ biosynthetic pathways: NAD+ can be synthesized from five different substrates:
tryptophan (Trp), nicotinamide (NAM), nicotinic acid (NA), nicotinamide ribose (NR),
and nicotinamide mononucleotide (NMN).

2,36

Trp, NAM, and NA are precursors,

whereas NR and NMN are intermediates. All these five compounds are contained in
different natural food sources.

37,38

The de novo pathway starts from Trp, which is

converted to nicotinic acid mononucleotide (NaMN) through five enzymatic steps and
one nonenzymatic reaction (Figure 1.1). NaMN is also synthesized from NA in the
Preiss-Handler pathway (Figure 1.1).

NaMN is converted to deamido-NAD by
5

nicotinamide/nicotinic acid mononucleotide adenylyltransferase (NMNAT) and then to
NAD+ by NAD+ synthetase (Figure 1.1). In invertebrates and many bacterial species,
NAM needs to be converted to NA by nicotinamidase. In mammals, however, NAM is
the major substrate for NAD+ biosynthesis, and nicotinamide phosphoribosyltransferase
(NAMPT) converts NAM and 5’-phosphoribosyl-pyrophophate to NMN (Figure 1.1).
NMN is then converted to NAD+ by three different NMNATs, NMNAT1-3. NAMPT is
the rate-limiting enzyme in this NAD+ biosynthetic pathway and regulates the NAD+
biosynthetic capacity of cells. 39 NAMPT is expressed ubiquitously, but liver, kidney and
brown adipose tissue express high levels of NAMPT, heart expresses an intermediate
level, white adipose tissue, lung, spleen, testis, and skeletal muscle express low levels,
and brain and pancreas express barely detectable levels.

40

It has been demonstrated that

NAMPT plays a critical role in regulating sirtuin activities in different cell types and
tissues. 39,41,42
Interestingly, mRNA and protein expression of Nampt is regulated in a circadian
oscillation-dependent manner in peripheral tissues, such as liver and white adipose tissue.
43,44

The core circadian machinery mediated by BMAL1 and CLOCK promotes the

transcription of Nampt through their binding to an E box on its promoter. Increased
NAMPT expression leads to higher NAD+ levels, stimulating SIRT1 activity.
Reciprocally, increased SIRT1 activity suppresses the transcriptional activity of BMAL1
and CLOCK, creating a negative feedback loop. This dynamic interaction between
BMAL/CLOCK and NAMPT/SIRT1 generates the circadian oscillation of NAD+ in
peripheral tissues, mediating the rhythmic regulation of many NAD+-dependent enzymes
including sirtuins. However, NAMPT expression and NAD+ levels in peripheral tissues

6

are reduced by high-fat diet (HFD) and aging, impacting sirtuin activities.

32

Although

the molecular mechanism underlying HFD- and aging-induced NAMPT suppression is
yet to be elucidated, TNF-α, one of the major inflammatory cytokines, and oxidative
stress have been found to suppress Nampt expression and NAD+ levels in primary
hepatocytes. Additionally, the activity of the circadian machinery also declines with age,
particularly in the suprachiasmatic nucleus, likely resulting in reduced NAMPT and
NAD+ levels.

45

Contrarily, exercise training and dietary restriction increase Nampt

expression and NAD+ levels in skeletal muscle and adipose tissue, respectively,
stimulating sirtuin activities.
AMPK.

46

This upregulation of Nampt appears to be mediated by

Thus, while the BMAL1/CLOCK/SIRT1-dependent circadian-regulatory

feedback explains the regulation of basal, daily Nampt expression, other mechanisms
appear to be required to induce Nampt in response to environmental and nutritional inputs.
NAD+ consumption and degradation: PARP1 and CD38 knockout mice have revealed
elevated levels of tissue NAD+ and SIRT1 activity, indicating that PARPs, CD38, and the
nuclear sirtuins all share the same pool of NAD+ and that their activities are significantly
influenced by each other.

47-49

Given that PARP activity and CD38 levels have been

reported to significantly increase with age, it is quite likely that increased consumption
and degradation also contributes to the systemic decline in tissue NAD+ availability and
sirtuin activities.

33,50

However, in contrast, it has been reported that PARP1 activity is

inhibited by Deleted in breast cancer 1 (DBC1) in the aged liver.

51

DBC1 possesses a

Nudix homology domain that binds to NAD+. Binding of DBC1 to NAD+ prevents it
from binding to and inhibiting PARP1. With age, as NAD levels decline, DBC1 is freed

7

to inhibit PARP1, promoting the accumulation of DNA damage. Therefore, the effect of
PARP1 on NAD+ availability might vary in a tissue-dependent manner.
Most recently, a new type of NAD+-degrading enzyme, Sterile alpha and TIR
motif-containing protein 1 (SARM1), has been identified.

52

Upon activation of SARM1

in response to axonal damage, the catalytic domain within its Toll/Interleukin-1 receptor
domain shows a very potent NADase activity. Whereas the role of SARM1 has so far
been implicated only in axonal degeneration, it would be interesting to see if SARM1
also contributes to the NAD+ decline during aging and in other disease conditions.
1.4

The role of NAD+ biosynthesis and sirtuins in tissue homeostasis and disease
conditions
Liver. Liver is one of the tissues with the highest NAD+ content (approximately 600-900
pmole/mg tissue), and intrahepatic NAD+ levels oscillate in a circadian manner.

32

This

NAD+ oscillation drives activities of SIRT1, SIRT3, and SIRT6, coordinating robust
metabolic outputs (Figure 1.2).

53,54

For example, SIRT1 regulates glucose metabolism,

fatty acid oxidation, cholesterol transport, and peptide and cofactor biosynthesis in the
liver. SIRT1 upregulates hepatic gluconeogenic genes and downregulates glycolytic
genes through the deacetylation of peroxisome proliferator-activated receptor-gamma
coactivator 1 α (PGC1α).

55

SIRT1 also promotes fatty acid oxidation and cholesterol

transport through the activation of peroxisome proliferator-activated receptor α (PPARα)
and the liver X receptor α (LXRα).

56,57

Under nutritional deprivation, hepatic SIRT1

activity is enhanced likely due to the increase in NAD+ biosynthesis, whereas during
HFD feeding, hepatic NAMPT and NAD+ levels are significantly reduced, likely due to

8

elevated levels of an inflammatory cytokine, TNF-α, and a Nampt-targeting microRNA,
mir-34a, so that SIRT1 activity decreases.

32,55,58

In response to the NAD+ oscillation,

SIRT3 generates circadian oscillation of the acetylation and activity of mitochondrial
oxidative enzymes and respiration.

54

SIRT6 regulates a different subset of circadian

genes in the liver through the oscillatory chromatin recruitment of sterol regulatory
element-binding protein 1 (SREBP-1), producing the rhythmic regulation of genes related
to fatty acid and cholesterol metabolism. 53
Uniquely, liver is an organ with a high regenerative capacity. SIRT1 plays a
critical role in the regenerative capacity of the liver in response to hepatectomy. 59 During
the early stage of regeneration following hepatectomy, NAD+ levels transiently decrease.
60

NAD+ repletion by systemic administration of NR or hepatic NAMPT overexpression

promotes liver regeneration and suppresses steatosis associated with regeneration.

60

In

contrast, liver-specific deletion of Sirt1 reveals delay in cell cycle progression and
hepatic lipid accumulation during regeneration.

59

Thus, NAD+ biosynthesis and sirtuin

functions are tightly connected to coordinate metabolic homeostasis in the liver.
Skeletal Muscle. Skeletal muscle also shows high NAD+ content (400-600 pmole/mg
tissue).
1.2).

32

Skeletal muscle plays a major role in determining insulin sensitivity (Figure

Skeletal SIRT1 directly suppresses the transcription of the protein tyrosine

phophatase-1B (PTP1B) gene.

61

PTP1B is a negative regulator of insulin signaling by

suppressing insulin sensitivity through dephosphorylation of insulin receptor.

62

HFD

feeding decreases SIRT1 protein levels, subsequently increasing PTP1B levels and
insulin resistance in skeletal muscle. Contrarily, fasting increases SIRT1 levels and
decrease PTP1B expression, thereby promoting insulin sensitivity and glucose uptake.
9

SIRT1 is also important to regulate mitochondrial biogenesis, oxidative metabolism, and
anti-oxidant defense pathways through HIF-1α, PGC-1α, and FOXO1 (Figure 1.2).

34,63

SIRT1 and SIRT3 activities are also involved in the mitochondrial unfolded protein
response (UPRmt) pathway and mitophagy.

33,64

These sirtuin functions are known to be

controlled by NAD+ availability. Indeed, administration of NMN significantly improves
mitochondrial oxidative metabolism in skeletal muscle.

38

However, whether this is a

direct effect of NAD+ enhancement in skeletal muscle requires further investigation
because it has been reported that skeletal muscle-specific overexpression of NAMPT
increases NAD+ levels but not mitochondrial functions in skeletal muscle. 65
Adipose Tissue. Unlike the liver and skeletal muscle, the NAD+ content in adipose tissue
is relatively low (20-40 pmole/mg tissue).

32

However, a recent study has clearly

demonstrated that NAMPT-mediated NAD+ biosynthesis is critical for adipose tissue to
control insulin sensitivity at the systemic level (Figure 1.2).

66

Adipose tissue-specific

Nampt knockout mice exhibit severe insulin resistance in adipose tissue, liver, and
skeletal muscle and adipose tissue dysfunction including increased plasma free fatty acid
levels, decreased plasma adiponectin levels, and increased adipose tissue inflammation. 66
Major downstream mediators appear to be SIRT1 and SIRT6. 67,68 Adipose tissue-specific
knockout mice of each sirtuin show mild insulin resistance, decreased adiponectin levels,
and increased inflammation under standard chow or low-fat diet conditions. Therefore, it
is likely that their functions in adipose tissue are redundant or synergistic.

SIRT1

deacetylates and activates FOXO1, thereby enhancing the expression of adiponectin.

69

On the other hand, both SIRT1 and SIRT6 affect NF-κB function and suppress pro-

10

inflammatory genes including IL-6, TNF-α, and monocyte chemoatractant protein1
(MCP1). 67,70
In adipose tissue, there is another interesting connection between sirtuin function
and NAD+ biosynthesis.

SIRT1 promotes the secretion of extracellular NAMPT

(eNAMPT). SIRT1 physically interacts with and deacetylates NAMPT specifically at
lysine 53, enhancing its secretion and enzyme activity. 71 Remarkably, eNAMPT secreted
from adipose tissue remotely regulates NAD+ biosynthesis, SIRT1 activity, and neural
activity in the hypothalamus.

71

Genetic modulation of plasma eNAMPT levels affects

hypothalamic function, particularly physical activity levels during the dark time, in mice.
71

Another study has also reported the contribution of eNAMPT to cardiac NAD+

biosynthesis. 72 Inhibition of monocyte-derived eNAMPT reduces cardiac SIRT1 activity,
inducing cardiomyocyte apoptosis and dysfunction, consistent with the previously
demonstrated role of cardiac SIRT1. These findings strongly suggest that the connection
between NAMPT-mediated NAD+ biosynthesis and sirtuin functions in adipose tissue
plays a critical role in regulating insulin sensitivity and modulating other tissue functions
at a systemic level.
Pancreatic β cells. In pancreatic β cells, SIRT1 enhances glucose-stimulated insulin
secretion (Figure 1.2). SIRT1 represses the transcription of uncoupling protein 2 (Ucp2)
gene, which encodes a mitochondrial inner-membrane protein that uncouples respiration
from ATP production. The suppression of Ucp2 expression by SIRT1 enhances the
coupling of glycolysis to ATP synthesis, resulting in the enhancement of glucosestimulated insulin secretion.

73,74

SIRT1 also appears to control some unidentified step

downstream of membrane depolarization.
11

74

Furthermore, SIRT1 provides the protection

of pancreatic β cells against metabolic stress, such as glucolipotoxicity caused by high-fat
diet, or inflammatory reactions caused by IL-1β and IFNγ through the suppression of
iNOS expression and NF-κB activity.

75,76

SIRT1 also deacetylates FOXO1, enhancing

the expression of NeuroD and MafA, which in turn offers β cell protection against
oxidative stress. 77
Pancreatic β cells appear to be very sensitive to changes in NAD+ availability
likely because they have very low levels of intracellular NAMPT (iNAMPT). The
insulin-secreting function of β cells decreases over age due to decreased NMN/NAD+
availability.

31

Indeed, administration of NMN can improve glucose-stimulated insulin

secretion in aged mice. Furthermore, adding eNAMPT to human islets also increases
their insulin-secreting capability.

78

Therefore, intra- and extracellular NMN supply is

critical for pancreatic β cells to maintain their insulin-secreting function.
Hypothalamus. The hypothalamus has a very unique feature in terms of the connection
between sirtuin functions and systemic NAD+ biosynthesis. As described above, NAD+
biosynthesis, SIRT1 activity, and neural function in the hypothalamus are supported by
eNAMPT secreted from adipose tissue.

71

Although how exactly eNAMPT can support

hypothalamic NAD+ levels requires further investigation, this finding strongly suggests
that the NAD+/SIRT1-driven interplay between the hypothalamus and adipose tissue
significantly contributes to the systemic coordination of metabolic homeostasis in
response to environmental and nutritional stimuli.
One good example is the regulation of adaptive response to food deprivation.
During food deprivation, such as fasting and dietary restriction, mice increase their

12

physical activity levels and maintain body temperature as an adaptive response to
promote food-scavenging activity and survive through such a life-threatening condition.
This adaptive response is regulated by SIRT1 in the hypothalamus, particularly in
dorsomedial and lateral hypothalamic nuclei (DMH and LH, respectively).

79

Indeed,

whereas whole-body Sirt1 knockout mice show deficiencies in these adaptive responses
and neural activation in the DMH and LH, brain-specific SIRT1-overexpressing
(BRASTO) transgenic mice exhibit significant enhancement of these adaptive responses
and neural activities in the DMH and LH.

79

Furthermore, eNAMPT secretion from

adipose tissue is enhanced in response to fasting in a SIRT1-dependent manner, likely to
support NAD+ and SIRT1 activity levels in the hypothalamus under fasting.

71

Thus,

SIRT1 and NAMPT together play a critical role in coordinating such an adaptive
response to food deprivation.
Interestingly, BRASTO mice, both males and females, show significant delay in
aging and lifespan extension.

18

In the DMH and LH, SIRT1 binds to and deacetylates a

homeodomain transcription factor, NK2 homeobox 1 (Nkx2-1), promoting its
transcriptional activity and upregulating one of the key downstream genes, orexin type 2
receptor (Ox2r). Elevated expression of Ox2r increases neural activities in the DMH and
LH of BRASTO mice, mitigating age-associated decline in physical activity, body
temperature, oxygen consumption, and sleep quality (Figure 1.2).

18

Consistent with the

role of SIRT1 in the DMH and LH during food deprivation, OX2R is responsible for
maintaining these functions during the process of aging. Prdm13 is another downstream
gene in the SIRT1/NKX2-1 signaling in the DMH, which is necessary for the
maintenance of sleep quality and the control of adiposity.

13

80

Prdm13 expression is

significantly enhanced in the DMH of aged BRASTO mice. These findings indicate that
the interplay between the hypothalamus and adipose tissue is mediated by a novel
feedback loop regulated by SIRT1 and eNAMPT.
SIRT1 has also been reported to regulate energy homeostasis by modulating
neuronal functions related to feeding behavior and energy expenditure in the arcuate
nucleus (ARC) and ventromedial hypothalamus (VMH) (Figure 1.2).

In the ARC,

neurons that are positive for neuropeptide Y (NPY) and agouti-related protein (AgRP)
promote hunger, whereas neurons that are positive for proopiomelanocortin (POMC)
promote satiety.

81

NPY/AgRP neuron-specific Sirt1 knockout mice exhibit a marked

reduction in food intake and gain less body weight compared to control mice. 82 They do
not display any change in parameters related to energy expenditure. On the other hand,
in POMC neurons, SIRT1 promotes energy expenditure in the peripheral tissue through
sympathetic nerve stimulation.

83

SIRT1 deletion in POMC neurons causes leptin

resistance and defect in sympathetic nerve activity without altering in feeding behavior,
leading to reduced energy expenditure and excessive weight gain upon HFD. In the
VMH, SIRT1 in SF1 neurons is necessary for maintaining insulin sensitivity in the
skeletal muscle.

84

Loss of SIRT1 in SF1 neurons causes insulin resistance, making the

mice prone to HFD-induced obesity, while its overexpression protects mice against HFDinduced obesity and metabolic dysregulation.
SIRT1 also governs the function of the suprachiasmatic nucleus (SCN), the
central circadian pacemaker, by regulating the expression of circadian regulators (Figure
1.2).

45

The cooperative binding of SIRT1 with PGC1-α and the nuclear receptor RORα

enhances the expression of core clock regulators, Bmal1 and Clock. Expression of these
14

two core clock genes promotes the expression of circadian genes including Per1/2,
Cry1/2, and Nampt, maintaining the amplitude and rhythmicity of circadian machinery.
With age, SIRT1 protein levels decline in the SCN, resulting in the reduction of the core
clock machinery and circadian gene expression. These changes cause a longer circadian
period, contributing to age-associated decline in circadian functions.
Hippocampus. Hippocampus is a brain region primarily associated with memory,
learning, and emotion. It is also a unique site where neurogenesis is maintained in the
adult brain. With age, hippocampal NAMPT and NAD+ levels and the number of neural
stem cells significantly decline.

85

Loss of Nampt specifically in adult neural stem cells

results in impairment of their ability of self-renewal, proliferation, and differentiation.

85

Among neuronal and glial lineages, the differentiation into oligodendrocyte precursor
cells is specifically abrogated.

85

Gene expression profiles of lineage markers in Nampt-

deficient neural stem cells can be recapitulated in neural stem cells deficient for both
Sirt1 and Sirt2, indicating that SIRT1 and SIRT2 likely have redundant functions in the
downstream of NAMPT-mediated NAD+ biosynthesis. Importantly, long-term NMN
administration maintains the number of neural stem cells in the dentate gyrus of aged
mice.

85

Thus, it will be of great interest to examine whether NAMPT-mediated NAD+

biosynthesis plays an important role in the regulation of memory and learning.
Sensory neurons. Neurons are susceptible to damage and degeneration in a variety of
stress conditions. For examples, upon nerve transection and chemotoxic stress, sensory
neurons such as dorsal root ganglion (DRG) neurons undergo rapid axonal degeneration,
known as Wallerian degeneration.

86

It has been demonstrated that maintaining NAD+

levels by enhancing NAD+ biosynthesis or inhibiting NAD+ degradation leads to a
15

significant delay in axonal degeneration.

87,88

NAD+-mediated delay in axonal degeneration.

SIRT1 appears to be required for this
89

Recently, it has been reported that

SARM1, the key regulator that triggers axonal degeneration, possesses NADase activity.
52

This NADase activity of SARM1 is necessary for axonal NAD+ depletion and axonal

degeneration after injury.
Other studies have also demonstrated the neuroprotective role of NAD+ and
sirtuins on special sensory neurons. Intense noise exposure induces cochlear NAD+
decline and hair cell degeneration.

90

Increased NAD+ biosynthesis, NAD+ repletion by

NR, and overexpression of mitochondrial SIRT3 provide preventative effects against
noise-induced hearing loss. Post-exposure treatment by NR can also prevent hair cell
degeneration in a SIRT3-dependent manner.

Another type of sensory neurons,

photoreceptor cells in the visual system, is highly dependent on NAMPT-mediated NAD+
biosynthesis.

91

NAMPT deficiency specifically in rod or cone photoreceptor neurons

shows severe retinal dysfunction, which is dramatically ameliorated by NMN
administration. Photoreceptor neurons are susceptible to dysfunction and degeneration
by intensive light exposure, diabetes, and aging. Mitochondrial SIRT3 and SIRT5 play
important roles in the NAD+-dependent regulation of retinal function. Interestingly,
long-term NMN administration significantly improves photoreceptor functions in aged
mice.

38

Thus, sirtuin functions and NAMPT-mediated NAD+ biosynthesis tightly

cooperate to regulate retinal homeostasis.
Cardiovascular system. Cardiovascular disease is the leading cause of mortality
worldwide, and age is its greatest risk factor. The cardiovascular system is constantly
exposed to a variety of insults, such as mechanical, metabolic, and oxidative stresses.
16

Pressure overload and aging induce the expression of SIRT1, perhaps as a compensatory
mechanism to protect heart from such stresses.

92

Indeed, increased levels of NAD+ and

SIRT1 provide protection from the oxidative stress caused by ischemic/reperfusion
through the stimulation of autophagy (Figure 1.2).

93

Moderate overexpression of SIRT1

also attenuates age-dependent cardiac changes including hypertrophy, cellular senescence,
and apoptosis. Cardiac SIRT1 induces the expression of catalase, an antioxidant enzyme,
by modulating FOXO1 function. SIRT1 also deacetylates NKX2-5, which is protective
for cardiac function, and suppresses its transcriptional activity, suggesting that SIRT1 and
NKX2-5 form a negative feedback loop to maintain cardiac function within an optimal
range.

94,95

Consistently, an excessive overexpression of SIRT1 causes cardiomyopathy

by increasing apoptosis, hypertrophy, and cardiac dysfunction.

92

SIRT3 also plays an

important role in protecting heart from cardiac hypertrophy, myocardial infarction, and
heart failure. 96-99 These cardiac diseases cause mitochondrial dysfunction, and therefore,
enhancing SIRT3 function is beneficial to ameliorate these disease conditions. Indeed,
NMN administration improves cardiac function in these disease models, at least in part,
through SIRT3. 100
It has also been demonstrated that NAMPT-mediated NAD+ biosynthesis and
sirtuins together play a critical role in the regulation of endothelial cells, vascular smooth
muscle cells, and endothelial progenitor cells (Figure 1.2).

101

Age-dependent decline in

SIRT1 levels is correlated with increased production of reactive oxygen species and
increased levels of oxidative stress, leading to the impairment in endothelium-dependent
dilation. Enhanced SIRT1 activity by NMN treatment upregulates the expression of

17

manganese superoxide dismutase and mitochondrial antioxidant genes through the
activation of PGC-1α, thereby improving vascular elasticity.
Intestine. The intestinal epithelium is comprised of cells lining the luminal surface of the
gastrointestinal (GI) tract, functioning to absorb necessary nutrients and also form a
barrier against harmful agents.

Homeostasis of the GI tract is maintained by the

continuous replenishment of intestinal epithelial cells differentiated from intestinal stem
cells (ISCs). In response to dietary restriction, ISCs enhance their self-renewal capacity
and expand their pool while reducing the differentiation and the replenishment of
intestinal epithelial cells in villi. 102 Interestingly, coordinated activation of SIRT1 and the
mechanistic target of rapamycin complex 1 (mTORC1) is necessary for the ISC
expansion mediated by dietary restriction. Genetic and pharmacological manipulations
have demonstrated that deacetylation of S6 kinase 1 (S6K1) by SIRT1 promotes its
phosphorylation by mTORC1 and drives protein synthesis, cell growth, and metabolism.
Cyclic ADP-ribose (cADPR) secreted from neighboring Paneth cells upregulates Nampt
expression in ISCs, enhancing NAD+ biosynthesis and SIRT1 activity. These findings
provide further support for the intimate interplay between NAMPT-mediated NAD+
biosynthesis and sirtuin functions in different types of stem cells.

1.5

The concept of the NAD World: The NAMPT/NAD+/SIRT1-mediated systemic
regulatory network for aging and longevity control in mammals
As discussed in the previous sections, NAMPT-mediated NAD+ biosynthesis and sirtuins
cooperate tightly to regulate physiological resilience, particularly in life-threatening

18

conditions, and promote survival at a systemic level. This systemic, tight interplay
between NAMPT-mediated NAD+ biosynthesis and sirtuins, particularly SIRT1, forms a
firm foundation for the comprehensive concept for mammalian aging and longevity
control, named the “NAD World”.
proposed in 2009.

103

The original concept of the NAD World was

In the original concept, one of the key predictions was that the

decline in NAD+ biosynthesis at a systemic level triggers a variety of pathophysiological
changes, producing aging phenotypes through decreased activities of SIRT1 and other
sirtuins. As described above, this prediction has been demonstrated to be correct over the
past 6 years. Another important prediction was that when NAD+ biosynthesis decreases,
tissues and organs that have very low levels of iNAMPT and therefore rely on circulating
NMN to maintain adequate levels of NAD+ would become fragility points in the system.
Pancreatic β cells and central neurons, both of which have very low levels of iNAMPT,
have been predicted to be the most critical fragility points. This predicted susceptibility
of both cell types to NAD+ decline has also been confirmed, as described above.

18,31

Lastly, the concept proposed that the cascade of robustness breakdown triggered by a
decrease in systemic NAD+ biosynthesis is the central process of aging. Indeed, the
decline in NAD+ availability due to the decrease in its biosynthesis or the increase in its
consumption and degradation results in the reduction in activities of SIRT1 and other
sirtuins, leading to the acceleration of tissue dysfunctions and ultimately aging. 32,34
Over the past 8 years, it has been demonstrated that SIRT1 and NAMPT together
mediate critical inter-tissue communications, particularly among the hypothalamus,
skeletal muscle, and adipose tissue.

The hypothalamus functions as the high-order

control center of aging, sending a signal to skeletal muscle through the sympathetic

19

nervous system. Skeletal muscle appears to affect other tissue and organ functions by
secreting various myokines. Adipose tissue remotely modulates hypothalamic function
through eNAMPT, forming a NAD+/SIRT1-mediated feedback loop. With all these
developments, the concept has recently been reformulated as the NAD World 2.0, with an
emphasis on the importance of inter-tissue communications among three key tissues for
mammalian aging and longevity control (Figure 1.3).

104

An important prediction from

the concept of the NAD World 2.0 is that eNAMPT and NMN function as key systemic
regulatory molecules that maintain physiological resilience over time. Indeed, long-term
NMN administration shows remarkable anti-aging effects in mice. The role of eNAMPT
in mammalian aging and longevity is currently under investigation. This reformulated
concept will provide a new foundation to understand the system architecture and
dynamics for aging and longevity control in mammals and further promote the
development of an effective anti-aging intervention that is translatable to humans.
1.6

Concluding remarks
It is likely that NAMPT and sirtuins have coevolved together through different phyla.
For example, vibriophage KVP40 possesses three genes encoding NAMPT, NMNAT,
and a sirtuin family protein.

105

Furthermore, in bacterial species, the Nampt gene is

carried on a plasmid that seems to be passed from one bacterial species to another.

106

Interestingly, the DNA sequences franking the Nampt gene on the plasmid have
significant homology to the vibriophage genome.107 Given that bacterial and mammalian
NAMPT proteins show an unusually high homology, it might be possible that an
ancestral species of mammals inherited the Nampt gene from some symbiotic bacterial
species at some point of evolution, which might have immediately given enormous
20

benefits to activate sirtuins more efficiently and promote physiological resilience and
survival.

39

Although this is purely a speculation, it could provide a food of thoughts to

explain the tight connection between NAMPT-mediated NAD+ biosynthesis and sirtuins.
If this is indeed the case, some symbiotic relationship between mammalian hosts and
their microbiota could still be maintained through NAMPT/NMN/NAD+ and sirtuins in
mammals. More examples of this intimate connection will surely be discovered in
coming years, and our understanding of this dynamic relationship will further promote
the development of NAD+-based preventive and therapeutic interventions against ageassociated functional decline and diseases for humans.
1.7
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Table 1.1 Biochemical characteristics of sirtuins and subcellular NAD+ concentrations.
Localization, kinetics and dominant activity types of the sirtuin family members and the NAD+
concentration in subcellular compartments are listed. 35,108-116
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Figure 1.1 NAD+ biosynthetic pathways.
NAD+ can be synthesized through (1) De novo pathway, (2) Preiss-Handler pathway, (3) salvage
pathway, or (4) from NR. de novo, Preiss-Handler, and salvage pathways use tryptophan (Trp),
nicotinic acid (NA), and nicotinamide as starting substrates, respectively. NMN and NR are
NAD+ intermediates. In response to NAD+ availability, sirtuins remove acetyl group on the
specific lysine residue from the target protein. Deacetylation alters the protein functions,
initiating the downstream signaling cascade.
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Figure 1.2 Pleiotropic effects of sirtuins and NAD+ biosynthesis.
Increasing the levels of sirtuins or its activity through the enhancement of NAD+ biosynthesis
have beneficial effects on tissue homeostasis and functions in pancreas, hypothalamus, liver,
skeletal muscle, intestine, hippocampus, cardiovasculature, adipose tissue and others.
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Figure 1.3 The concept of NAD World 2.0.
Hypothalamus, skeletal muscle, and adipose tissue play as critical hubs for the systemic
regulatory network of aging/longevity control in mammals. Hypothalamus acts as a control
center, adipose tissue as a modulator, and skeletal muscle as a mediator. Each tissue
communicates with and regulates one another to maintain physiological resilience through
systemic NAD1 biosynthesis and sirtuins.
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Chapter 2:
SIRT1-mediated eNAMPT Secretion from Adipose
Tissue Regulates Hypothalamic NAD+ and Function
in Mice
This chapter is adapted from a manuscript published in Cell Metabolism:
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2.1 SUMMARY
Nicotinamide phosphoribosyltransferase (NAMPT), the key NAD+ biosynthetic enzyme,
has two different forms, intra- and extracellular (iNAMPT and eNAMPT), in mammals.
However, the significance of eNAMPT secretion remains unclear. Here we demonstrate that
deacetylation of iNAMPT by the mammalian NAD+-dependent deacetylase SIRT1 predisposes
the protein to secretion in adipocytes. NAMPT mutants reveal that SIRT1 deacetylates lysine 53
and enhances eNAMPT activity and secretion. Adipose tissue-specific Nampt knockout and
knockin (ANKO and ANKI) mice show reciprocal changes in circulating eNAMPT, affecting
hypothalamic NAD+/SIRT1 signaling and physical activity accordingly. The defect in physical
activity observed in ANKO mice is ameliorated by nicotinamide mononucleotide (NMN).
Furthermore, administration of a NAMPT-neutralizing antibody decreases hypothalamic NAD+
production, and treating ex vivo hypothalamic explants with purified eNAMPT enhances NAD+,
SIRT1 activity, and neural activation. Thus, our findings indicate a critical role of adipose tissue
as a modulator for the regulation of NAD+ biosynthesis at a systemic level.
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2.2

INTRODUCTION
The biosynthesis of nicotinamide adenine dinucleotide (NAD+), an essential
coenzyme and important currency for cellular energy metabolism, plays a critical role in
the regulation of diverse biological processes through key NAD+-consuming mediators,
including poly-ADP-ribose polymerases (PARPs), CD38/157 ectoenzymes, and sirtuins1.
NAD+ can be synthesized from four different substrates: nicotinamide, nicotinic acid,
tryptophan, and nicotinamide riboside (NR)2.

Among them, nicotinamide is

predominantly used to synthesize NAD+ in mammals1.
NAD+

biosynthesis

is

phosphoribosyltransferase

catalyzed
(NAMPT)

adenylyltransferase (NMNAT)3,4.

by

two
and

key

Starting from nicotinamide,
enzymes:

nicotinamide

nicotinamide
mononucleotide

NAMPT, the rate-limiting enzyme in this NAD+

biosynthetic pathway, catalyzes the conversion of nicotinamide and 5’-phosphoribosylpyrophosphate (PRPP) to nicotinamide mononucleotide (NMN), a key NAD+
intermediate. NMN, in turn, is adenylated by NMNAT to generate NAD+.
NAMPT is a unique enzyme that has an ancient origin and an interesting research
history3,4. NAMPT was originally identified as the product of the gene that confers the
capability of synthesizing NAD+ from nicotinamide, called NadV, in Haemophilus
ducreyi 5. Surprisingly, a set of genes encoding NAMPT and NMNAT homologues has
even been found in some bacteriophages 6. The biochemical and structural features of
NAMPT have been extensively studied by our and other groups, clearly demonstrating
that this protein belongs to a dimeric class of type II phosphoribosyltransferases7-10.
Interestingly, NAMPT has two different forms in mammals: intra- and extracellular
NAMPT (iNAMPT and eNAMPT, respectively)11. eNAMPT was previously identified
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as pre-B cell colony-enhancing factor (PBEF), a presumptive cytokine that enhanced the
maturation of B cell precursors, and as visfatin, a visceral fat-derived adipokine once
proposed to exert an insulin-mimetic function by binding to the insulin receptor3,4,12-14.
Neither function of PBEF nor visfatin has been reconfirmed to date. Our previous study
has clearly demonstrated that NAMPT functions as an intra- and extracellular NAD+
biosynthetic enzyme and that eNAMPT does not exert insulin-mimetic effects, either in
vitro or in vivo11. However, the physiological relevance and function of eNAMPT has
still been controversial, and whether eNAMPT secretion is actively regulated has been of
significant debate. Here we demonstrate that eNAMPT secretion is regulated by SIRT1mediated deacetylation in adipose tissue and also that eNAMPT secreted by adipose
tissue plays an important role in the maintenance of hypothalamic NAD+ production and
its function in vivo.
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2.3

RESULTS
Acetylation levels of iNAMPT affect the secretion of eNAMPT. Fully differentiated
brown and white adipocytes secrete eNAMPT, which has 2-4-fold higher enzymatic
activity than iNAMPT 11. We speculated that a post-translational modification was likely
responsible for this altered enzymatic activity and the secretion of eNAMPT. Analysis of
its post-translational modification, including acetylation and ADP-ribosylation, revealed
that iNAMPT was acetylated in brown and white adipose tissue (BAT and WAT,
respectively) (Figure 2.1A). Interestingly, acetylation levels of iNAMPT decreased by
~50% in response to 48-hr fasting (Figure 2.1A). To further assess the effect of NAMPT
acetylation on its function and secretion, we examined differentiated HIB-1B brown
adipocytes, which express a very high level of iNAMPT and secrete eNAMPT into
culture supernatants 11. In their cell extracts, relatively low levels of acetylated iNAMPT
were detected (Figure 2.1B, lane M). Acetylation levels significantly increased when
treating cells with trichostatin A (TSA) and nicotinamide, inhibitors of class I and II
deacetylases and class III NAD+-dependent deacetylases, respectively (Figure 1B, right
two T+N lanes).

In this condition, iNAMPT protein levels did not change in cell

extracts, whereas secreted eNAMPT protein levels in culture supernatants decreased by
~60% (Figure 2.1C), implicating that the acetylation status of iNAMPT might predispose
the protein to secretion. Because fasting decreased acetylation levels of iNAMPT in
adipose tissue, we examined the effects of low glucose in media on iNAMPT acetylation
and eNAMPT secretion in HIB-1B cells. Detection of changes in iNAMPT acetylation
turned out to be technically difficult due to low basal levels of acetylated iNAMPT in
HIB-1B cells. Nonetheless, lowering glucose dramatically enhanced eNAMPT secretion
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3.5-5.5-fold in differentiated HIB-1B cells and 3T3-L1 white adipocytes (Figure 2.1D).
Furthermore, nicotinamide completely inhibited the enhancement of eNAMPT secretion
by low glucose (Figure 2.1D), suggesting that nicotinamide-sensitive sirtuin family
members might be responsible for low glucose-induced enhancement of eNAMPT
secretion.
SIRT1 regulates eNAMPT secretion by physically interacting with and
deacetylating iNAMPT. SIRT1 enzymatic activity is effectively inhibited by
nicotinamide in culture conditions15. Therefore, we suspected that SIRT1 might regulate
eNAMPT secretion in adipose tissue. To address this possibility, we first examined
whole-body Sirt1 knockout (Sirt1-/-) mice on an FVB background. Different from other
Sirt1-/- mouse lines on the B6 or 129 backgrounds, these FVB Sirt1-/- mice do not die
postnatally and can grow into adulthood16. In Sirt1+/+ mice, plasma eNAMPT levels
showed moderate but significant increases in response to 48-hr fasting (Figure 2.2A).
However, these increases were completely abrogated in Sirt1-/- mice (Figure 2.2A).
Intriguingly, iNAMPT significantly accumulated in the WAT of Sirt1-/- mice compared to
Sirt1+/+ mice, whereas the iNAMPT protein levels did not differ in the liver between
Sirt1+/+ and Sirt1-/- mice (Figure 2.2B).

Given that Nampt mRNA levels were

indistinguishable in WAT between Sirt1+/+ and Sirt1-/- mice (Figure 2.2C), this abnormal
accumulation of iNAMPT in Sirt1-/- WAT is likely associated with a defect in eNAMPT
secretion in Sirt1-/- mice. To further demonstrate the importance of adipose SIRT1 for
the control of eNAMPT secretion, we generated adipose tissue-specific Sirt1 knockout
(AT-Sirt1-/-) mice. AT-Sirt1-/- mice showed a similar phenotype to the whole-body Sirt1-/mice (Figure 2.2D).

Indeed, AT-Sirt1-/- mice completely failed to increase plasma
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eNAMPT in response to 48-hr fasting, confirming the physiological relevance of this
SIRT1-mediated eNAMPT secretion from adipose tissue, particularly in response to
fasting.
To further examine the role of SIRT1 in eNAMPT secretion, we overexpressed
Sirt1 or Gfp in differentiated HIB-1B adipocytes by adenoviral transduction and
quantified eNAMPT secretion. Overexpression of SIRT1 enhanced eNAMPT secretion
2.3-fold compared to GFP controls in differentiated HIB-1B cells (Figure 2.3A). We
further confirmed this result by introducing both NAMPT and SIRT1 into HEK293 cells,
which shows negligible basal expression of both proteins. Again, overexpression of
SIRT1 enhanced eNAMPT secretion, and the enhancement was much more robust in the
HEK293 cells (~11-fold) compared to that in the differentiated HIB-1B cells (Figure
2.3B). We also assessed the acetylation status of iNAMPT in this condition. Acetylated
iNAMPT was detected only in the presence of TSA and nicotinamide, and iNAMPT
acetylation levels significantly decreased by SIRT1 overexpression (Figure 2.3C). These
results, in combination with the results from Sirt1-/- and AT-Sirt1-/- mice, suggest that
SIRT1-mediated deacetylation of iNAMPT predisposes the protein to secretion from
differentiated adipocytes.
Because SIRT1 typically interacts directly with its deacetylation targets, we also
examined whether SIRT1 and iNAMPT physically interact in differentiated adipocytes.
Indeed, SIRT1 and iNAMPT did interact in differentiated HIB-1B adipocytes (Figure
2.3D), and this interaction appeared to be enhanced by low glucose (Figure 2.3D, right
two lanes). Although SIRT1 is usually considered to be a nuclear sirtuin, we found that a
considerable amount of SIRT1 was localized in the cytoplasm of differentiated HIB-1B
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and 3T3-L1 cells (Figures 2.3E and S2.1). iNAMPT was primarily localized in the
cytoplasm of these adipocytes (Figures 2.3E and S2.1). Therefore, these results suggest
that SIRT1 physically interacts with and deacetylates iNAMPT in the cytoplasm of
differentiated adipocytes, promoting the secretion of eNAMPT.

Deacetylation of lysine 53 on iNAMPT enhances eNAMPT secretion. We next
attempted to determine which acetylated residues of iNAMPT are important for the
regulation of eNAMPT secretion. We established HEK293 and differentiated HIB-1B
cells expressing C-terminally FLAG-tagged iNAMPT, and then FLAG-tagged iNAMPT
and eNAMPT proteins were purified from those cell extracts and culture supernatants,
respectively.

These purified NAMPT proteins, as well as the bacterially produced

recombinant NAMPT protein, were subjected to a mass spectrometric analysis of protein
modification.

Five lysines, K53, K79, K107, K331, and K369, were found to be

acetylated on iNAMPT, whereas only K369 was acetylated on eNAMPT (Figures 2.4A
and S2.2). Surprisingly, four out of the five lysines were also acetylated on bacterially
produced recombinant NAMPT, although it had K339 acetylation instead of K107
(Figure 2.4A). This implies that regulation of NAMPT acetylation might be conserved
from bacteria to mammals. Among these acetylated lysines, the location of K53 on the
crystal structure of iNAMPT is particularly interesting. NAMPT is a dimeric type II
phosphoribosyltrasferase, and K53, which protrudes from each monomer, is aligned
along the “cleft” of the dimer and very close to the catalytic sites (Figure 2.4B)7,10.
Contrarily, K79 is located at the opposite side of the dimer to K53 (Figure 2.4B). Other
acetylated lysines are located on surrounding a-helices of the dimer. We introduced the
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deacetylation-mimicking K-to-R mutation into K53 and/or K79 and examined the
acetylation levels of each mutant iNAMPT in response to SIRT1. Whereas the wild-type
and K79R mutant iNAMPT proteins showed SIRT1-dependent deacetylation, the K53R
and K53/79R mutants displayed reduced acetylation levels and did not show further
reduction in acetylation levels by SIRT1 (Figure 2.4C), suggesting that K53 is the
SIRT1-dependent acetylation site on iNAMPT. We also assessed the enzymatic activity
and the secretion of this K53R mutant, as well as another mutant K53A, compared to the
wild-type NAMPT in differentiated HIB-1B adipocytes. The enzymatic activity of both
K53R and K53A mutants did not differ from that of the wild-type iNAMPT (Figure
2.4D). However, the secretion of these mutant proteins was 2.5-3-fold higher than that of
the wild-type protein (Figure 2.4E), strongly suggesting the importance of this particular
lysine and its deacetylation for the regulation of eNAMPT secretion.

Conversely,

introduction of the acetylation-mimicking K-to-Q mutation into K53 significantly
decreases the enzymatic activity and the secretion of the protein (Figures 2.4F and 2.4G),
suggesting that acetylation of lysine 53 suppresses NAMPT enzymatic activity and
secretion. Taken together, these results demonstrate that eNAMPT secretion is regulated
by SIRT1 through deacetylation of lysine 53 in differentiated adipocytes
Adipose tissue-specific Nampt knockout mice exhibit reduced plasma eNAMPT
levels and defects in NAD+ biosynthesis not only in adipose tissue but also in the
hypothalamus. Given that the secretion and enzymatic activity of eNAMPT are highly
regulated by SIRT1-dependent deacetylation in differentiated adipocytes, we suspected
that eNAMPT secreted by adipose tissue has a functional role as an extracellular NAD+
biosynthetic enzyme. To address this hypothesis, we generated adipose tissue-specific
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Nampt knockout (ANKO) mice by crossing floxed Nampt (Namptflox/flox) mice

17

and

adiponectin-Cre driver mice18. ANKO mice were born following the Mendelian ratio and
looked overtly normal. As expected, ANKO mice showed the complete lack of iNAMPT
expression in visceral WAT and BAT, although trace amounts of iNAMPT remained in
subcutaneous WAT (Figure 2.5A). Consistent with the lack of iNAMPT, NAD+ levels
were dramatically reduced to 7-28% of the control Namptflox/flox mice in ANKO WAT and
BAT (Figure 2.5B), demonstrating that NAMPT functions as a major NAD+ biosynthetic
enzyme in adipose tissue. This dramatic reduction in NAD+ levels did not seem to affect
the gross structure of white adipose tissue under an ad libitum-fed condition. Mean white
adipocyte diameter, body weight, and fat mass in ANKO mice were not significantly
different from those in the control Namptflox/flox mice (Figures S2.3A-C). We found that
plasma eNAMPT levels significantly decreased by 30-40% in both fed and fasted
conditions in ANKO females, compared to those in control Namptflox/flox mice (Figure
2.5C), demonstrating that adipose tissue significantly contributes to the production of
circulating eNAMPT in female mice. Contrarily, ANKO male mice did not show any
detectable decreases in plasma eNAMPT levels (Figure S2.3E). Surprisingly, while other
tissues such as the liver and skeletal muscle did not show any change in NAD+ levels
(Figure 2.5B), the hypothalamus, but not the hippocampus, showed significant decreases
in NAD+ levels in ANKO mice compared to controls (Figure 2.5D). mRNA expression
levels of Nampt and other NAD+ biosynthetic enzymes showed no decrease in ANKO
hypothalami (Figure S2.3D), indicating that the reduction in NAD+ levels detected in
ANKO hypothalami was not likely due to intrinsic defects in their NAD+ biosynthetic
machineries.

Consistently, mRNA expression of Ox2r, a SIRT1 target gene in the
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hypothalamus16,19, was also significantly decreased in the hypothalami of ANKO
females, but not in their hippocampi (Figure 2.5E), indicating that NAD+-dependent
SIRT1 activity is lower in female ANKO hypothalami. Consistent with their plasma
eNAMPT levels, ANKO males did not show any changes in hypothalamic NAD+ levels
(Figure S2.3F). These results suggest that adipose NAMPT significantly contributes to
plasma eNAMPT and is important to maintain normal NAD+ levels not only in adipose
tissue but also in the hypothalamus. Because the results from AT-Sirt1+/+ and AT-Sirt1-/mice indicate that the SIRT1-mediated secretion of eNAMPT from adipose tissue is more
important in response to fasting, we examined whether AT-Sirt1-/- mice show any defect
in maintaining hypothalamic NAD+ levels during fasting, compared to their ad libitumfed condition. We found that hypothalamic NAD+ levels decreased by 20% in response
to fasting in control AT-Sirt1+/+ mice, whereas AT-Sirt1-/- mice exhibited further
decreases (40%) in hypothalamic NAD+ levels in response to fasting (Figure S2.3G),
supporting the physiological role of eNAMPT secretion by adipose tissue in maintaining
hypothalamic NAD+ levels.
Physical activity is reciprocally altered in loss- and gain-of-function mouse models
of adipose NAMPT. In the hypothalamus, SIRT1 regulates Ox2r expression, and this
SIRT1-mediated signaling in the hypothalamus is critical to regulate physical activity of
mice during the dark time and in response to fasting16,19. Given that levels of NAD+ and
Ox2r expression were significantly reduced in female ANKO hypothalami, we examined
their physical activity during the dark time. Interestingly, we found that female ANKO
mice showed significantly reduced physical activity during the dark time (Figure 6A),
consistent with reduced hypothalamic NAD+ and Ox2r levels, all suggesting the
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impairment of SIRT1 activity in the hypothalamus.

Because we have previously

demonstrated that systemic administration of NMN can enhance NAD+ biosynthesis and
activate SIRT1 activity in multiple tissues11,20,21, we next asked whether NMN
administration could rescue the observed hypothalamic functional defect in ANKO
females. With the dose of NMN that our and other groups have previously used (500
mg/kg body weight)11,20-22, we confirmed that each hypothalamic nucleus showed 1.53.5-fold increases in NAD+, with a nicely grading distribution of NAD+ from the median
eminence23,24 towards the furthest nucleus (Figure S2.4A). We then injected NMN into
ANKO females at 5 pm, one hour before lights were turned off. Remarkably, NMNtreated ANKO females showed significantly higher physical activity compared to PBSinjected ANKO females for the first half of the 12-hr dark time (Figure 2.6B). Because
the enhancement of NAD+ biosynthesis by one NMN injection lasts for ~ 6 hrs in the
brain25, this result provides support to our notion that the hypothalamus of ANKO
females have defects in NAD+ biosynthesis and its function. Because adipose tissuedependent eNAMPT secretion is enhanced in response to fasting, we also examined the
physical activity levels of ANKO mice after 48-hr fasting. Their physical activity levels
in response to fasting were significantly reduced compared to those of control mice
(Figure 2.6C). Contrarily, adipose tissue-specific Nampt knockin (ANKI) mice, which
showed 2.2-2.5-fold increases in plasma eNAMPT levels under fasting in both males and
females (Figure S2.4B), exhibited increases in physical activity, compared to control
mice, in response to fasting (Figure 2.6D). Consistent with this phenotype, NAD+ levels
were significantly enhanced in ANKI hypothalami, but not in ANKI hippocampi,
compared to those in controls (Figure 2.6E). Ox2r expression levels, which reflects
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hypothalamic SIRT1 activity, were also enhanced in ANKI hypothalami (Figure 2.6F).
Therefore, these results provide significant support to our notion that eNAMPT plays an
important role in maintaining normal hypothalamic NAD+ levels, SIRT1 activity, and
physical activity, particularly in response to fasting.
A NAMPT-neutralizing antibody reduces hypothalamic NAD+ levels in vivo,
whereas eNAMPT increases hypothalamic NAD+ levels and neural activity ex vivo.
To further assess whether the NAD+ decrease observed in the ANKO hypothalamus is the
direct outcome of the decrease in eNAMPT-mediated NAD+ production, we systemically
injected a NAMPT-neutralizing polyclonal antibody and control rabbit IgG into wild-type
B6 male mice.

This particular polyclonal antibody was able to suppress NAMPT

enzymatic activity by 90% for recombinant NAMPT in vitro and by 40% for eNAMPT in
plasma (Figure S2.5). Interestingly, the injection of the NAMPT-neutralizing antibody
moderately but significantly reduced NAD+ levels in the hypothalamus, but not in the
hippocampus (Figure 2.7A), confirming the direct effect of eNAMPT on hypothalamic
NAD+ levels. To further confirm the biological relevance of eNAMPT in the regulation
of hypothalamic NAD+ levels, we established an ex vivo assay using hypothalamic
explants.

Using this assay, we examined the direct effect of eNAMPT-containing

conditioned media on NAD+ levels and neural activation measured by cFos expression in
hypothalamic explants. Interestingly, eNAMPT-containing conditioned media were able
to significantly increase NAD+ levels and cFos expression in hypothalamic explants,
compared to control conditioned media (Figure 2.7B). The extent of cFos activation by
eNAMPT-containing conditioned media was similar to that by ghrelin, an orexigenic gut
hormone known to stimulate hypothalamic neurons in rodents26.
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Consistently, the

addition of the purified eNAMPT protein to culture media was also able to significantly
increase NAD+, cFos, and Ox2r levels in hypothalamic explants (Figure 2.7C). These
results provide further support to our notion that eNAMPT is capable of directly
promoting hypothalamic NAD+ biosynthesis, SIRT1 activity, and neural activation.
Taken together, our findings indicate that NAD+/SIRT1-mediated eNAMPT secretion
from adipose tissue plays a critical role in the regulation of hypothalamic NAD+
biosynthesis and function.
2.4

DISCUSSION
Our present study has demonstrated that the secretion and enzymatic activity of eNAMPT
are regulated by SIRT1-dependent deacetylation in adipocytes.

Indeed, this highly

regulated process appears to be important particularly in adipose tissue in response to
changes in nutritional availability. Interestingly, SIRT1 and NAMPT comprise a novel
transcriptional-enzymatic feedback loop that produces a circadian oscillation of NAD+ in
peripheral tissues27,28. Our present study has revealed that SIRT1 and NAMPT comprise
another NAD+-regulatory feedback loop through the regulation of eNAMPT secretion
from adipose tissue.

In this new mechanism, SIRT1-dependent deacetylation of

iNAMPT at lysine 53 predisposes the protein to secretion. The deacetylation event seems
to occur in the cytoplasm of differentiated adipocytes, and approximately 0.5% of
iNAMPT per hour is estimated to be secreted as eNAMPT in differentiated HIB-1B
adipocytes (data not shown), suggesting that a very specific fraction of iNAMPT is
destined to enter this SIRT1-dependent secretory machinery. The experiments with K-toR and K-to-Q mutants of lysine 53 demonstrate that the acetylation status of lysine 53 is
critical to determine the fate of iNAMPT. Because the K53A mutation also significantly

45

increases eNAMPT secretion, lysine 53 per se appears to play an important role in
determining the fate of iNAMPT, possibly providing a docking site to an unidentified
factor that might interact with acetylated lysine 53 of iNAMPT and prevent it from
secretion (Figure 2.7D).
Acetylation is also important to regulate the enzymatic activity of NAMPT. We
identified five acetylation sites on iNAMPT, and four out of these five sites are found to
be deacetylated on eNAMPT. The enzymatic activity of iNAMPT is 2-4-fold lower than
that of eNAMPT

11

, and the K53Q mutant can recapitulate this acetylation-dependent

reduction in the enzymatic activity. Lysine 53 is distinguished from other lysine residues
because of its location at the “cleft” which contains the catalytic sites, although other
lysines might have other functions in different biological contexts. These results indicate
that acetylation/deacetylation might induce a conformational change in NAMPT structure
and regulate its enzymatic activity. It will be of great interest to examine what effects the
acetylation of lysine 53 makes on the structure of the catalytic sites and dimer formation
of NAMPT. Because NAD+ drives SIRT1 activity in a circadian oscillatory manner27,28,
it is also likely that deacetylation and secretion of eNAMPT follow circadian oscillation.
Indeed, plasma eNAMPT levels appear to show diurnal oscillation in mice, although it is
still unclear whether this oscillation is produced by an intrinsic clock mechanism
(unpublished observation). Therefore, our findings provide an interesting possibility that
the intimate interplay between SIRT1 and NAMPT contributes to multi-layered feedback
loops regulating the dynamics of NAD+ biosynthesis within and between tissues and
organs.
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Why does adipose tissue secrete a key NAD+ biosynthetic enzyme to blood
circulation? We have obtained important clues to this question from adipose tissuespecific Nampt knockout (ANKO) mice. Interestingly, ANKO females, but not males,
show significant decreases in plasma eNAMPT levels. A surprising finding is that the
adipose tissue-specific deficiency of NAMPT causes significant reduction in NAD+
levels not only in WAT and BAT, but also in some remote tissues, specifically the
hypothalamus. Because the hypothalami of ANKO females do not have any obvious
defects in their endogenous NAD+ biosynthetic machineries, the observed reduction in
NAD+ levels is likely attributed to the NAMPT deficiency in adipose tissue.
Furthermore, the defect appears to be specific at least to the hypothalamus because other
tissues and organs, including the liver, skeletal muscle, and the hippocampus, do not
show any reduction in NAD+ levels. Consistent with reduced NAD+ levels, ANKO
female mice also show significant reduction in the mRNA expression levels of Ox2r, a
critical hypothalamic SIRT1 target gene, and their physical activity during the dark time.
This hypothalamic functional defect can be ameliorated, at least partially, by a single
injection of NMN. Additionally, the results from the systemic injection of a NAMPTneutralizing antibody and ex vivo hypothalamic explant assays provide further support for
our conclusion that eNAMPT regulates hypothalamic NAD+ production and function.
This role of eNAMPT in maintaining normal hypothalamic NAD+ levels appears to be
more important in fasting because AT-Sirt1-/- mice had a defect in fasting-induced plasma
eNAMPT increase and also showed further decreases in hypothalamic NAD+ levels,
compared to controls, in response to fasting. Consistent with this notion, loss- and gainof-function mouse models of adipose NAMPT, namely, ANKO and ANKI mice,
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reciprocally change their plasma eNAMPT levels and physical activity, as well as their
hypothalamic NAD+ and Ox2r expression levels, in response to fasting.
Although how exactly eNAMPT regulates hypothalamic NAD+ levels and neuronal
activity is still under investigation, it is conceivable that eNAMPT secreted from adipose
tissue plays a critical role in supplying NMN to the hypothalamus. The hypothalamus
has a low level of NAMPT expression, implying that this tissue might require the
extracellular supply of NMN, possibly through the median eminence23,24, for the
maintenance of its optimal NAD+ biosynthesis. Our finding that adipose tissue actively
regulates the secretion and enzymatic activity of eNAMPT in an NAD+/SIRT1-dependent
manner provides strong support to the idea that adipose tissue functions as a critical
determinant for the spatial and temporal coordination of NAD+ biosynthesis throughout
the body. This systemic coordination of NAD+ biosynthesis might play an important role
in orchestrating metabolic responses in multiple tissues and maintaining metabolic
homeostasis against nutritional and environmental perturbations.

In this highly

coordinated systemic network, adipose tissue modulates the functions of remote tissues,
such as the hypothalamus, through the NAD+/SIRT1-dependent regulation of eNAMPT
secretion. This model also predicts that having an optimal amount of adipose tissue
might be beneficial to maximize the robustness of the physiological system through the
regulation of systemic NAD+ biosynthesis. Further investigation on the system dynamics
of this novel network will provide insight into the role of adipose tissue as a critical
modulator for the regulation of systemic NAD+ biosynthesis.
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2.5

Experimental Procedures
Detection of intracellular NAMPT and SIRT1 in tissues, and of extracellular
NAMPT in plasma. Mice fed ad libitum or fasted for 48 hr were euthanized by carbon
dioxide asphyxiation.

Organs were immediately collected, homogenized in 1X

Laemmli’s sample buffer using a Polytron (Kinematica, Switzerland), and boiled for 5
minutes. Samples were then centrifuged at 16000g, and protein concentrations were
measured by the Bradford assay (Bio-Rad, CA). Plasma samples from mice fed ad
libitum or fasted for 48 hr were collected by centrifuging blood at 3200g for 5 minutes at
4°C and immediately boiled for 5 minutes in 1X Laemmli’s sample buffer. Tissue
extracts and plasma samples were analyzed by Western blotting with anti-NAMPT
(Bethyl Laboratories, TX) or anti-SIRT1 (Sigma, MO) antibodies. For plasma samples,
equal loading was confirmed by Ponceau S staining of membranes.
Detection of acetylated NAMPT in adipose tissue and differentiated HIB-1B cells.
WAT and BAT collected from wild-type FVB mice were homogenized in 1X RIPA
buffer [50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Igepal CA630, 0.5% Sodium
deoxycholate, 0.1% SDS, 1 mM EDTA, 1 mM NaF, 10 mM Trichostatin A, 10 mM
nicotinamide, 0.5 mM DTT, protease inhibitor cocktail (Roche, Germany)]. Cell extracts
were

immunoprecipitated

with

anti-acetyl

lysine

antibody-conjugated

beads

(ImmuneChem, Canada) overnight. Immunoprecipitates were eluted with 1X Laemmli’s
sample buffer, boiled for 5 minutes, and analyzed by Western blotting with an antiNAMPT antibody (OMNI379, Enzo Life Science, NY). Fully differentiated HIB-1B
cells were homogenized in NAMPT-IP buffer [PBS (pH 7.4), 0.5% NP-40, 1 mM EDTA,
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1 mM NaF, 10 mM Trichostatin A, 10 mM nicotinamide, 0.5 mM DTT, protease
inhibitor cocktail (Roche, Germany)], and cell extracts were immunoprecipitated with an
anti-acetyl lysine antibody (Cell signaling, MA) and protein A agarose (Sigma, MO).
RNA isolation and analysis. Total RNA from WAT and BAT was isolated using the
RNeasy lipid tissue mini-kit (Qiagen, CA). Total RNA samples from all other tissues
were isolated using the RNeasy mini-kit (Qiagen, CA). cDNA was synthesized using the
High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, CA) with random
primers. Quantitative real-time RT-PCR was performed using the 7500 Fast Real-Time
PCR system (Applied Biosystems, CA). Relative expression levels were determined
based on Ct values and normalized to Gapdh.
Differentiation of 3T3L1 and HIB-1B preadipocyte cell lines. All cell lines were
cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine
serum and antibiotics.

Confluent cultures of HIB-1B brown pre-adipocytes were

differentiated by adding 0.5 mM isobutylmethylxanthine (IBMX), 1 mM dexamethasone,
5 mg/ml insulin, and 1 nM triiodothyronine (T3) for 2 days and then changing to the
media containing 5 mg/ml insulin and 1 nM T3 every other day for 6 more days. 3T3-L1
white pre-adipocytes were differentiated similarly, except that T3 was absent in the
media through the whole differentiation process. All chemicals were purchased from
Sigma.
Generation of HIB-1B cells stably expressing wild type or mutant NAMPT-FLAG.
A C-terminally FLAG-tagged NAMPT (NAMPT-FLAG) was created and cloned into the
mammalian expression vector pCXN2 as described previously

11

. Each lysine mutant

NAMPT-FLAG was generated using the QuikChange II Site-Directed Mutagenesis Kit
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(Stratagene, CA) according to the manufacturer’s protocol. To create HIB-1B cells
expressing NAMPT-FLAG or mutant NAMPT-FLAG, HIB-1B pre-adipocytes were
transfected (Superfect, QIAGEN, CA) with pCXN2-NAMPT-FLAG or pCXN2-mutant
NAMPT-FLAG. Transfected HIB-1B cells were selected by incubating with 500 mg/ml
of G418 (Invitrogen, CA) for 2 weeks. Before the secretion assay and the enzymatic
reactions, HIB-1B cells were fully differentiated as described above.
MS analysis of acetylated lysine sites on NAMPT. Recombinant mouse NAMPT was
expressed and prepared as described previously 8.

iNAMPT and eNAMPT were

immunoprecipitated from HEK293 cells and from media of differentiated HIB-1B cells
expressing NAMPT-FLAG, respectively, as described above. Each protein was resolved
by 10% SDS/PAGE and visualized by Coomassie blue staining. The bands of these
proteins were excised and subjected to MS analysis provided by the Taplin Biological
Mass Spectrometry Facility at Harvard Medical School.
eNAMPT secretion assay. 3T3-L1 or HIB-1B cells were differentiated as described
above. To detect endogenous iNAMPT or eNAMPT, cell extracts or culture supernatant
were collected, respectively, immunoprecipitated as described previously 11, and analyzed
by Western blotting with an anti-NAMPT polyclonal antibody (Bethyl Laboratories, TX).
HEK293 cells transfected with NAMPT-FLAG and HIB-1B cells stably expressing
NAMPT-FLAG were processed in the same way, except that anti-FLAG beads (M2,
Sigma, MO) were used for immunoprecipitation.

eNAMPT secretion levels were

calculated as (eNAMPT levels/iNAMPT levels)/the amount of total protein in cell lysates
or eNAMPT levels/(iNAMPT levels/ACTIN levels)/the amount of total protein in cell
lysates by quantifying Western blotting results.
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Enzymatic reactions. NAMPT enzymatic reactions were conducted as previously
described

11

. For immunoprecipitation of iNAMPT-FLAG, whole cell extracts were

prepared with NAMPT-IP buffer and mixed with anti-FLAG-M2 conjugated beads
(Sigma, MO) for 2-3 hours at 4°C. For immunoprecipitation of eNAMPT-FLAG, HIB1B culture supernatants were collected after incubating differentiated HIB-1B cells
overnight with DMEM without fetal bovine serum but supplemented with 5 mg/ml
insulin and 1 nM triiodothyronine, centrifuged at 3000 rpm for 2 min at 4°C,
concentrated 8 to 10 fold with Amicon Ultra-15 columns (Milipore, MA), and mixed
with anti-FLAG beads for 2-3 hr at 4°C. Immunoprecipitates were washed twice with IPbuffer and twice with PBS.
Immunoprecipitates on anti-FLAG beads were incubated in enzymatic reaction
buffer [50 mM Tris-HCl, pH 8.5, 100 mM NaCl, 0.25 mM nicotinamide, 10 mM MgSO4,
1.5% ethanol, 0.5 mM phosphoribosyl phyrophosphate (PRPP), 2 mM ATP] for 55 min
at 37°C.

After this reaction, mouse recombinant NMNAT and yeast alcohol

dehydrogenase were added at a final concentration of 10 mg/ml each, and the mixture
was incubated for 5 min at 37°C. Supernatants were collected by spinning down antiFLAG beads, and auto-fluorescence of NADH was measured in a PerkinElmer LS 50B
fluorometer (340 nm excitation, 460 nm emission). NADH auto-fluorescence values
were converted to the amount of NMN using a standard curve drawn with known
amounts of NMN. Immunoprecipitates bound on anti-FLAG beads were extracted with
1X Laemmli’s buffer, boiled for 5 min, and analyzed by Western blotting with an antiNAMPT antibody.

The amounts of NAMPT used for enzymatic reactions were

quantitated compared to the standards of mouse recombinant NAMPT. Kcat values were

52

calculated based on the molar amount of NMN generated per molar amount of
immunoprecipitated NAMPT-FLAG proteins per unit time.
Subcellular protein fractionation. Cytoplasmic and nuclear protein fractions were
separated and prepared using the Subcellular Protein Fractionation Kit (Thermo
Scientific, IL) according to the manufacturer’s protocol.
Generation of AT-Sirt1-/-, ANKO and ANKI mice and measurement of their physical
activity levels. Sirt1flox/flox mice were generated by flanking the exon 3 of the Sirt1 gene
by loxP sites (Takikawa et al, submitted). Namptflox/flox mice, Cre-inducible STOP-Nampt
mice, and Adiponectin-Cre mice were generously provided by Dr. Oberdan Leo at
Université de Léige, Belgium

17

, Dr. Joseph Baur at University of Pennsylvania
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, and

Dr. Evan Rosen at Beth Israel Deaconess Medical Center 18, respectively. All lines were
backcrossed to the C57BL/6J background.

Adiponectin-Cre mice were mated with

Sirt1flox/flox, Namptflox/flox, or STOP-Nampt mice, and cohorts were established by mating
F1 Sirt1flox/+;Cre or Namptflox/+;Cre to Sirt1flox/flox or Namptflox/flox mice, respectively.
Sirt1flox/flox;Cre and Namptflox/flox;Cre were considered as AT-Sirt1-/- and ANKO mice,
respectively. Sirt1flox/flox;+ and Namptflox/flox;+ were used as controls. For ANKI mice,
Cre-induced heterozygous mice were used, and Cre-minus littermates were used as
controls. When necessary, synchronized females were used. For synchronization of
female estrus cycle, female mice were exposed to bedding from male cages for 3 days.
Wheel-running activity of mice was recorded and evaluated as described previously

16

.

Physical activity after 48-hr fasting was measured by counting the numbers of quadrants
crossed during 10 min in recorded videos of each cage containing 5 mice 16. All animal
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procedures were approved by the Washington University Animal Studies Committee and
were in accordance with NIH guidelines.
NAD+ measurements. Frozen tissues were extracted in perchloric acid and neutralized in
K2CO3 on ice as described previously 28. NAD+ levels were determined using an HPLC
system (Shimadzu, Japan) with a Supelco LC-18-T column (15 cm x 4.6 cm; Sigma,
MO). The HPLC was run at a flow rate of 1 ml/min with 100% buffer A (50 mM
phosphate buffer, pH 7.4) from 0-5 min, a linear gradient to 95% buffer A /5% buffer B
(100% methanol) from 5-6 min, 95% buffer A /5% buffer B from 6-11 min, a linear
gradient to 85% buffer A /15% buffer B from 11-13 min, 85% buffer A /15% buffer B
from 13-23 min, and a linear gradient to 100% buffer A from 23-24 min. NAD+ is eluted
at 11 min. NAD+ levels were quantitated based on the peak area compared to a standard
curve and normalized to the weight of the frozen tissue.
In vivo eNAMPT neutralization. 20 mg of anti-NAMPT rabbit antibody (Bethyl
Laboratory, TX) or control rabbit IgG (Sigma, MO) were diluted in 100 ml PBS. 100 ml
of the solution were injected to 3-4 week-old age-matched male mice intravenously via
tail vein. One hour post injection, injected mice were sacrificed and hypothalamus was
collected. Hypothalamic samples were stored frozen until analysis.
Generation of eNAMPT-containing conditioned media. HEK293 cells were
transfected with pCXN2-Nampt-FLAG and selected by incubating with 500 mg/ml of
G418 (Invitrogen, CA) for 2 weeks. Subsequently selected cells were transduced with
FM1-SIRT1 lentivirus to promote eNAMPT secretion. NAMPT/SIRT1-overexpressing
or control HEK293 cells were plated and grown to confluency in 12-well plate.
Supernatants were collected after incubating cells for 72 hr with serum-free neurobasal
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media. Collected conditioned media were centrifuged at 3000 rpm for 2 min at 4°C,
concentrated 10-fold with Amicon Ultra-30 columns (Millipore, MA). The concentration
of eNAMPT was approximately 160 ng/ml in eNAMPT-containing conditioned media.
Ex vivo hypothalamic explant culture. Hypothalami were collected from 1-12 week-old
mice and cut into hemihypothalami along the sagittal plane.

Biologically-matched

hemihypothalami were incubated with either eNAMPT-containing or control conditioned
media for 1 hr at 37°C. In separate experiments, hemihypothalami were incubated with
serum-free media (50 ml) supplemented with 1mg of either the eNAMPT protein purified
from HEK293 culture supernatants (Adipogen) or BSA for 3 hr at 37°C. Hypothalamic
samples were stored frozen until analysis. Quantitative real-time RT-PCR was conducted
with the TaqMan Fast Universal PCR Master mix and TaqMan primers for cFos and
Gapdh in the GeneAmp 7500 fast sequence detection system (Applied Biosystems).
Relative gene expression levels were calculated by normalizing to Gapdh levels and then
to the mean of control hypothalamic explants.
Statistical Analysis. Differences between two groups were assessed using the Student’s t
test. Comparisons among several groups were performed using one-way ANOVA with
the Fisher’s LSD posthoc test. p values equal to or less than 0.05 were considered
statistically significant.
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Figure 2.1. iNAMPT acetylation levels decrease in response to fasting in adipose tissue and are
associated with eNAMPT secretion in differentiated adipocytes.
(A) iNAMPT acetylation levels in brown and white adipose tissues (BAT and WAT) of fed and fasted
wild-type female mice at 4-5 months of age. The right panel represents average values from two
independent experiments. Relative iNAMPT acetylation levels are normalized to fed values. (B)
iNAMPT acetylation levels in differentiated HIB-1B cells. Cells were treated with 5 mM Trichostatin A
(T) and 5 mM nicotinamide (N) for 3 hr. M; mock treatment. (C) Reduction of eNAMPT secretion after
Trichostatin A (T) and nicotinamide (N) treatment in differentiated HIB-1B cells. Levels of eNAMPT
secretion were calculated as described in Materials and Methods. (D) Enhancement of eNAMPT
secretion in response to low glucose in differentiated HIB-1B cells and 3T3-L1 cells. Cells were
incubated with high glucose (H, 25 mM) or low glucose (L, 5 mM) media in the presence or absence of
nicotinamide (N, 5 mM) for 3 hr. Bottom panels in C and D represent average values of three
independent experiments. Each value is normalized to values from the mock (C) or the high glucose
condition (D). Data were analyzed by the Student’s t test or one-way ANOVA with Fisher’s LSD
posthoc test. All values are presented as mean ± SEM. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001
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Figure 2.2. Plasma eNAMPT levels increase in response to fasting in a SIRT1-dependent
manner.
(A) Plasma eNAMPT levels from fed or 48 hr-fasted Sirt1+/+ and Sirt1-/- male mice at 4-5 months of age
(n= 7-12). The bottom panel shows average plasma eNAMPT levels normalized to the fed Sirt1+/+ level
in each condition. (B) iNAMPT and SIRT1 protein levels in white adipose tissue (WAT) and the liver of
Sirt1+/+ and Sirt1-/- male mice at 3-4 months of age. iNAMPT levels are normalized to TUBULIN levels.
The right panel shows average values normalized to the fed value in each tissue (n=3). (C) Nampt mRNA
expression levels in WAT of Sirt1+/+ and Sirt1-/- male mice at 3-4 months of age (n= 4). (D) Plasma
eNAMPT levels from fed or 48 hr-fasted AT-Sirt1+/+ and AT-Sirt1-/- female mice at 6 months of age
(n=5). Data were analyzed by the Student’s t test or one-way ANOVA with the Fisher’s LSD post-hoc
test. All values are presented as mean ± SEM. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
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Figure 2.3. SIRT1 promotes eNAMPT secretion by deacetylating iNAMPT.
(A and B) SIRT1 overexpression promotes eNAMPT secretion in differentiated HIB-1B cells (A) and
HEK293 cells (B). Levels of eNAMPT secretion were calculated as described in Materials and Methods.
The right panels represent average values from three independent experiments. Each value is normalized
to those of GFP- or NAMPT-expressing cells. (C) SIRT1 overexpression decreases iNAMPT acetylation
levels in HEK293 cells. Cells were incubated in the absence or presence of 5 mM Trichostatin A (T) and
5 mM nicotinamide (N) overnight prior to cell lysis. Acetylated iNAMPT levels are normalized to total
iNAMPT levels. The right panel represents iNAMPT acetylation levels normalized to total iNAMPT
levels in each condition (n=3). (D) Interaction between SIRT1 and iNAMPT in differentiated HIB-1B
cells. (E) Subcellular localization of SIRT1 and iNAMPT in differentiated HIB-1B cells. GAPDH and
TBP were examined as representative cytoplasmic and nuclear proteins, respectively. Cells were
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Figure 2.4. Deacetylation of lysine 53 on iNAMPT enhances eNAMPT secretion and enzymatic
activity.
(A) Acetyl-lysines detected on iNAMPT and eNAMPT prepared from cell lysate of HEK293 cells and
culture supernatant of differentiated HIB-1B cells, respectively. HEK293 cells overexpressing Cterminally FLAG-tagged mouse NAMPT were treated with 5 mM Trichostatin A and 5 mM nicotinamide
overnight prior to cell lysis. FLAG-tagged iNAMPT and eNAMPT were immunopurified and subjected
to mass spectrometric analysis. Recombinant mouse NAMPT was also prepared from bacteria. (B) The
location of K53 and K79 on the crystal structure of dimeric NAMPT (arrows). Each monomer is shown
in orange or green, and NMN molecules bound to the catalytic sites (arrows) are shown in blue. (C)
Changes in the acetylation status of wild-type (WT) or mutant (K53R, K79R, and K53/79R) iNAMPT by
SIRT1 in HEK293 cells. Cells were treated with 5 mM Trichostatin A and 5 mM nicotinamide overnight
prior to cell lysis. (D and F) The relative enzymatic activity of wild-type (WT) and mutant iNAMPT
from differentiated HIB-1B cells. The enzymatic activity was determined as described in Materials and
Methods. Each enzymatic activity is normalized to that of wild-type NAMPT (n=2-6). (E and G)
Secretion of wild-type (WT) and mutant eNAMPT. Levels of eNAMPT secretion were calculated as
described in Materials and Methods. Each value is normalized to the WT value. Each panel represents
averages from three independent experiments. Data were analyzed by the Student’s t test or one-way
ANOVA with the Fisher’s LSD posthoc test. All values are presented as mean ± SEM. *p ≤ 0.05; ***p
≤ 0.001.

62

Figure 2.5. ANKO mice exhibit reduced plasma eNAMPT levels and defects in NAD+
biosynthesis not only in adipose tissue but also in the hypothalamus.
(A) iNAMPT levels in visceral white adipose tissue (WAT), subcutaneous WAT, brown adipose tissue
(BAT), brain, liver, and muscle from 2-month-old female Namptflox/flox (f/f) and ANKO mice. (B) Tissue
NAD+ levels in visceral WAT, subcutaneous WAT, BAT, liver, and skeletal muscle from 3-4-month-old
female Namptflox/flox and ANKO mice (n=4-8). (C) Plasma eNAMPT levels in 5-6-month-old female
Namptflox/flox and ANKO mice. Plasma was collected from mice fed or fasted for 48 hr. Bottom panels
show average plasma eNAMPT levels normalized to those of Namptflox/flox mice (n=8-10). (D)
Hypothalamic and hippocampal NAD+ levels in 3-4-month-old female Namptflox/flox and ANKO mice.
(n=4-8) (E) Relative Ox2r mRNA expression levels in the hypothalami and the hippocampi from 3-4month-old female Namptflox/flox and ANKO mice (n=4). Data in B-E were analyzed by the Student’s t test.
All values are presented as mean ± SEM. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
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Figure 2.6. Physical activity is altered in loss- and gain-of-function mouse models of adipose
NAMPT.
(A) Wheel-running activity of ANKO and Namptflox/flox female mice at 5 months of age (n=3-6). (B)
Wheel-running activity of NMN-injected ANKO female mice and PBS-injected ANKO and Namptflox/flox
female mice at 5 months of age (n=3-6). NMN was injected at 500 mg/kg body weight at 5pm (indicated
by an arrow). Activity counts per minute at each time point are shown as mean values ± SEM. Data in A
and B were analyzed by Wilcoxon matched-pairs singled-ranks test. (C) Physical activity levels (total
numbers of quadrants crossed) measured after 48-hr fasting in ANKO and Namptflox/flox female mice at 4-5
months of age (n=4). (D) Physical activity levels (total numbers of quadrants crossed) measured after 48hr fasting in ANKI and control male and female mice at 4-6 months of age (n=4). (E) Hypothalamic and
hippocampal NAD+ levels in 8-10 month-old ANKI and control male mice after 48-hr fasting (n=5). (F)
Relative Ox2r mRNA expression levels in the hypothalami from 8-10 month-old ANKI and control male
mice after 48-hr fasting (n=5). Data in C-F were analyzed by the Student’s t test. All values are
presented as mean ± SEM. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
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Figure 2.7. eNAMPT regulates hypothalamic NAD+ levels, Ox2r expression, and neural
activation.
(A) NAD+ levels in the hypothalami and hippocampi isolated from B6 male mice after systemic injection
of a NAMPT-neutralizing antibody. 20 mg of anti-NAMPT antibody (NAMPT Ab) and rabbit IgG (IgG)
were injected into wild-type B6 male mice at 4-6 months of age. Hypothalamic NAD+ levels 1 hr after
injection were measured by HPLC (n=10-12). (B) NAD+ levels (left) and cFos mRNA expression (right)
in hypothalamic explants treated with eNAMPT-containing or control conditioned media. Hypothalamic
explants prepared from female mice at 1-12 weeks of age were cultured in each conditioned medium for
1hr. For neural activity, ghrelin (10 mg/ml) and PBS were also added to eNAMPT-containing (+) or
control- (-) conditioned media. NAD+ levels were measured by HPLC, and cFos expression levels were
quantitated by qRT-PCR (n=4-6). (C) NAD+ levels and cFos and Ox2r mRNA expression in adult
hypothalamic explants cultured in the media supplemented with the eNAMPT protein purified from
HEK293 culture supernatants or bovine serum albumin (BSA) as a control for 3 hr (n=4-6). 1 mg of each
protein was added to 50 ml of culture media containing a hypothalamic explant. Data were analyzed by
the Student’s t test or one-way ANOVA with Fisher’s LSD posthoc test. All values are presented as
mean ± SEM. *p ≤ 0.05; **p ≤ 0.01. (D) A model for the SIRT1-mediated regulation of eNAMPT
secretion in adipose tissue. iNAMPT (a dimer in blue) is acetylated at lysine 53 (Ac), and SIRT1
specifically deacetylates this lysine, predisposing the protein to secretion. Acetyl-lysine 53 might provide
a docking site to an unidentified factor (red) that prevents NAMPT from secretion. eNAMPT secreted
from adipose tissue promotes NAD+ biosynthesis and neural activity in the hypothalamus.
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Figure S2.1. Subcellular localization of SIRT1 and iNAMPT in differentiated 3T3-L1 cells.
GAPDH and TBP were examined as representative cytoplasmic and nuclear proteins,
respectively. Cells were incubated with media containing high glucose (H, 25mM) or low
glucose (L, 5 mM) for 3 hr.
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Figure S2.2. Detection of acetylated lysines 53 (K53, A) and 79 (K79, B) on mouse iNAMPT
by MS/MS analysis.
K* indicates acetylated lysine. Left panels display results from the search algorithm for N- and
C-terminal fragments produced by breakage at the peptide bond in the mass spectrometer (b and
y, respectively). The numbers represent N- or C-terminal residues present in the peptide
fragment. Right panels show the raw data of the spectra.
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Figure S2.3. Adipose, hypothalamic, and plasma eNAMPT features of ANKO and Namptflox/flox
(f/f) mice, and hypothalamic NAD+ ratio between fasted and fed conditions in AT-Sirt1+/+ and
AT-Sirt1-/- mice.
(A) Mean adipocyte diameter values from two independent 3-4-month-old females each for control (f/f)
and ANKO mice. (B) Body weights of 4-month-old control and ANKO female mice (n=9-11). (C) Body
composition analysis of 4-month-old control and ANKO female mice by Echo-MRI (n=2-4). (D)
Quantitative RT-PCR results for NAD+ biosynthetic genes in the hypothalami of 3-4-month-old control
and ANKO female mice (n=4). Nrk, nicotinamide ribose kinase; Qpt, quinolinic acid
phosphoribosyltransferase; Ido, Indoleamine 2, 3-dioxygenase; Tdo, Tryptophan 2, 3-dioxygenase. (E)
Plasma eNAMPT levels in 3-month-old control and ANKO male mice after 48-hr fasting (n=5).
Representative Western blot results are shown in the upper panel. (F) Hypothalamic NAD+ levels in 3month-old control and ANKO male mice. NAD+ levels were measured by HPLC (n=3). (G)
Hypothalamic NAD+ ratio between fasted and fed conditions in AT-Sirt1+/+ and AT-Sirt1-/- female mice at
6 months of age. Hypothalami were collected from ad libitum-fed and 48 hr-fasted AT-Sirt1+/+ and ATSirt1-/- mice, and hypothalamic NAD+ levels were measured by HPLC (n=5). Data were analyzed by the
Student’s t test. All values are presented as mean ± SEM. *p < 0.05.

68

Figure S2.4. NAD+ levels in individual hypothalamic nuclei 1 hr after systemic NMN
administration, and plasma eNAMPT levels in ANKI and control mice.
(A) The ARC, VMH, DMH, and LH were collected by laser-captured microdissection 1hr after NMN
(500 mg/kg) or PBS (equal volume) injection to 4 month-old female mice. NAD+ levels in each
hypothalamic nucleus were measured by HPLC, and the fold NAD+ increases were calculated (n=3). (B)
Plasma eNAMPT levels from 48 hr-fasted control and ANKI male and female mice at 4-6 months of age.
The right panels show relative plasma eNAMPT levels in ANKI mice normalized to those in control mice
(n=3-4). Data were analyzed by the Student’s t test. ***p ≤ 0.001.
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Figure S2.5. The NAMPT-neutralizing effects of an anti-NAMPT rabbit polyclonal antibody in
vitro and ex vivo.
(A) 2 mg of recombinant NAMPT produced in bacteria was incubated with 20mg of the anti-NAMPT
antibody (Bethyl Laboratory, TX) or control rabbit IgG (Sigma, MO) in enzymatic reaction buffer [50
mM Tris-HCl, pH 8.5, 100 mM NaCl, 0.25 mM nicotinamide, 10 mM MgSO4, 1.5% ethanol, 0.5 mM
phosphoribosyl phyrophosphate (PRPP), 2 mM ATP] for 1 hour at 37°C. (B) 103ml of plasma freshly
collected from 6 month-old mice was incubated with 5mg of the anti-NAMPT antibody or control rabbit
IgG in the enzymatic reaction buffer for 3 hours at 37°C. The amounts of NMN generated were measured
using HPLC (n=3 in each experiment). Data were analyzed by the Student’s t test. All values are
presented as mean ± SEM. ****p ≤ 0.0001.
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Chapter 3:
Nicotinamide phosphoribosyltransferase
(NAMPT)-mediated NAD+ biosynthesis is essential
for vision
This chapter is adapted from a manuscript published in Cell report:

Lin JB, Kubota S, Ban N, Yoshida M, Santeford A, Sene A, Nakamura R, Zapata N,
Kubota M, Tsubota K, Yoshino J, Imai SI, & Apte RS. Nicotinamide
phosphoribosyltransferase (NAMPT)-mediated NAD+ biosynthesis is essential
for vision. Cell Rep. 27;17(1):69-85. Sep 2016.

J.B.L. and S.K performed most of the experiments. M.Y performed experiments related
to NAD+ and ATP measurements.
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3.1 SUMMARY
Photoreceptor death is the endpoint of many blinding diseases. Identifying
unifying pathogenic mechanisms in these diseases may offer global approaches for
facilitating photoreceptor survival. We found that rod or cone photoreceptor-specific
deletion of nicotinamide phosphoribosyltransferase (Nampt), the rate-limiting enzyme in
the major NAD+ biosynthetic pathway beginning with nicotinamide, caused retinal
degeneration. In both cases, we could rescue vision with nicotinamide mononucleotide
(NMN). Significantly, retinal NAD+ deficiency was an early feature of multiple mouse
models of retinal dysfunction, including light-induced degeneration, streptozotocininduced diabetic retinopathy, and age-associated dysfunction. Mechanistically,
NAD+ deficiency caused metabolic dysfunction and consequent photoreceptor death. We
further demonstrate that the NAD+-dependent mitochondrial deacylases SIRT3/SIRT5
play important roles in retinal homeostasis and that NAD+ deficiency causes SIRT3
dysfunction. These findings demonstrate that NAD+ biosynthesis is essential for vision,
provide a foundation for future work to further clarify the mechanisms involved, and
identify a unifying therapeutic
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3.2 INTRODUCTION
Vision is a crucial sense that depends on photoreceptors for light
transduction. Photoreceptors are divided into two classes: rods and cones. Rod
photoreceptors mediate dim vision, while cone photoreceptors mediate precise
central vision in ambient light. Photoreceptors make up a significant portion of
the neurosensory retina, one of the most metabolically active tissues in the body
(Ames et al., 1992; Kooragayala et al., 2015; Okawa et al., 2008). Although
terminally differentiated and non-proliferative, photoreceptors have tremendous
metabolic demands throughout their lives and experience significant light-induced
oxidative stress due to their function of performing light transduction (Fu and Yau,
2007; Yau and Hardie, 2009).
Because of the critical role that photoreceptors play in light transduction,
photoreceptor death leads to blindness. Despite their differing etiologies, many
blinding diseases share this final pathway of photoreceptor death, which
inevitably causes vision loss. For example, age-related macular degeneration
(AMD) is one leading cause of blindness in older adults (Apte, 2010; Klein et al.,
2004; van Leeuwen et al., 2003). Although advanced AMD takes on two forms
(i.e., dry or wet AMD) (Sene and Apte, 2014), both pathways ultimately lead to
photoreceptor death. Similarly, inherited retinal degenerations, including retinitis
pigmentosa (RP), rod and cone dystrophies, and Leber congenital amaurosis
(LCA), are caused by genetic defects in over 100 different genes that lead to
photoreceptor death (Astuti et al., 2015; Hartong et al., 2006; Wright et al., 2010).
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Developing treatment strategies for this broad spectrum of retinal degenerative
diseases is challenging given these diverse pathogenic mechanisms.
Nicotinamide adenine dinucleotide (NAD+) is both an essential coenzyme,
functioning as an electron carrier in glycolysis and the Krebs cycle, and an
essential cosubstrate for NAD+-consuming enzymes, including sirtuins,
poly(ADP-ribose) polymerases (PARPs), mono-ADP ribosyltransferases, and
cyclic ADP-ribose hydrolase (CD38) (Ying, 2006). Given these numerous
functions, NAD+ has been shown to be important in many biological processes,
including metabolism (Garten et al., 2009; Mouchiroud et al., 2013), circadian
rhythms (Nakahata et al., 2009; Ramsey et al., 2009), and aging (Imai and
Guarente, 2014). Relevant to our studies, NAD+ has also been shown to be
important in neurodegeneration (Alano et al., 2010; Gerdts et al., 2015; Stein et al.,
2014; Zhou et al., 2015). However, the role of NAD+ in retinal degeneration has
been relatively unexplored to date.
We hypothesized that NAD+ biosynthesis plays an important role in
photoreceptor function and survival. This hypothesis is supported by past studies
demonstrating that LCA, the leading cause of childhood blindness from retinal
disease, can be caused by mutations in nicotinamide mononucleotide
adenylyltransferase

1

(NMNAT1)

(Chiang

et

al.,

2012; Falk

et

al.,

2012; Koenekoop et al., 2012; Perrault et al., 2012), an enzyme involved in
NAD+ biosynthesis. The various mutant forms of NMNAT1 associated with LCA
exhibit reduced NAD+ biosynthetic capacity and/or impaired protein folding (Falk
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et al., 2012; Koenekoop et al., 2012; Sasaki et al., 2015) with both factors
contributing to disease pathogenesis.
NAD+ can be synthesized in three ways: 1) de novo from tryptophan, 2) salvaged
from nicotinamide or nicotinic acid (NAM or NA, respectively), or 3) from
nicotinamide riboside (NR). In mammals, the salvage pathway beginning with
NAM is the predominant NAD+ biosynthetic pathway (Imai and Yoshino,
2013; Imai and Guarente, 2014). The first step of this biosynthetic pathway is
catalyzed by nicotinamide phosphoribosyltransferase (NAMPT), which combines
NAM with 5-phosphoribosyl pyrophosphate (PRPP) to form nicotinamide
mononucleotide (NMN). NMN is then adenylated by NMNAT1-3 to synthesize
NAD+.
In

this

study,

we

focus

on

the

role

of

NAMPT-mediated

NAD+ biosynthesis in photoreceptor survival and vision. Our results suggest that
NAD+ biosynthesis may be important not only in LCA but also in a broad
spectrum of retinal degenerations and age-associated retinal dysfunction, opening
up the possibility of using NAD+ intermediates to protect against retinal
degeneration. Although these studies provide a strong foundation for future
studies in this area, further work is needed to clarify the mechanisms involved. If
successful, this therapeutic strategy would be far-reaching since it could be used
for diverse retinal degenerations regardless of their etiology.
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3.3 RESULTS
Loss of NAMPT-mediated NAD+ biosynthesis impairs photoreceptor survival
and vision. Photoreceptors are one of the most metabolically active cells

of the body with demanding energy requirements (Ames et al.,
1992; Okawa et al., 2008) but limited mitochondrial reserve capacity
(Kooragayala

et

al.,

2015).

Therefore,

we

hypothesized

that

photoreceptors depend on NAMPT-mediated NAD+ biosynthesis to meet
their catalytic requirements. To test this hypothesis, we examined the
effect

of

disrupting

NAMPT-mediated

NAD+ biosynthesis,

the

predominant pathway in mammals, selectively in rod photoreceptors by
generating

conditional

knockout

mice

lacking Nampt in

rod

photoreceptors (Nampt−rod/−rod).
As expected, rod-enriched retinal isolates from Nampt−rod/−rod mice showed
significant

reduction

in Nampt gene

expression

(Fig

3.1A).

This

rod

photoreceptor-specific deletion of Nampt led to a ~26% reduction in retinal
NAD+ levels in Nampt−rod/−rod mice compared to NamptF/F littermates at 3 weeks
(Fig 3.1B). We also measured NAD+ levels in rod-enriched retinal isolates to
more specifically characterize the magnitude of NAD+ deficiency in rod
photoreceptors. We found that rod-enriched isolates from Nampt−rod/−rod mice had
a ~43% reduction in NAD+ levels compared to those from NamptF/F mice (Fig
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3.1C), suggesting that the NAD+ deficiency is predominantly specific to the rod
photoreceptors.
On biomicroscopy, we found that Nampt−rod/−rod mice had a degenerative
phenotype that, by 6 weeks, was characterized by massive atrophy of the
neurosensory retina, vascular attenuation with pigment mottling, and atrophy of
the underlying retinal pigment epithelium (RPE) cells, which was not observed in
NamptF/Flittermates (Fig 3.1D). This neurosensory retinal degeneration was also
associated with secondary atrophy and pallor of the optic nerve (Fig 3.1D). We
confirmed this degeneration with histological examination of eyes from
Nampt−rod/−rod mice. Although the histology was relatively normal at 2 weeks (Fig
3.S1A), there was progressive loss of the outer nuclear layer with associated
retinal degeneration, significant reduction of retinal thickness, and secondary
extension to multiple retinal layers in Nampt−rod/−rod eyes that was complete by 6
weeks (Fig 3.1E). Of note, the outer nuclear layer (arrows; Fig 3.1E) appeared to
be almost completely absent by 6 weeks, indicating substantial photoreceptor
death.
We performed electroretinography (ERG) to confirm the functional
deficits associated with this profound anatomic degeneration. By 6 weeks,
Nampt−rod/−rod mice demonstrated a dramatic reduction in the amplitudes of rodgenerated scotopic a-waves (Fig 3.1F), indicating significant impairment of rod
function. This impairment in rod photoreceptor function also led to declines in the
amplitudes of the scotopic b-waves (Fig 3.1G). Interestingly, Nampt−rod/−rod mice
also exhibited deficits in cone function, as manifested by a decline in the
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amplitudes of the photopic b-waves (Fig 3.1H). Although Nampt deletion was
specifically in rods, this cone dysfunction was not surprising; cone photoreceptor
degeneration is often observed as a secondary effect of rod photoreceptor
degeneration since rods are required for cone survival (Ait-Ali et al., 2015; Wong
and Kwok, 2016). Consistently, by 6 weeks, Nampt−rod/−rod mice had significantly
worse photopic visual acuity compared to age-matched NamptF/F controls (Fig
3.1I). As such, our findings replicate the progression of rod degeneration followed
by cone degeneration that is often observed in patients with inherited retinal
degenerations such as RP.
We also generated Nampt−rod/wt mice to determine the effect of partial
ablation of NAMPT-mediated NAD+ biosynthesis. As expected, rod-enriched
retinal

isolates

from

Nampt−rod/wt mice

exhibited

partial

reduction

in Nampt expression compared to NamptF/wt controls (Fig 3.S1B), which was
roughly half of the reduction in Nampt−rod/−rod versus NamptF/F mice. This singleallele Nampt deletion did not cause a statistically significant reduction in retinal
NAD+ levels (Fig 3.S1C) nor did it cause significant retinal degeneration by 6
weeks as measured on ERG (Figs S3.1D–F), suggesting that Nampt is
haplosufficient during this short time scale.
To confirm that this effect of Nampt deletion was cell autonomous, we
generated

mice

lacking Namptspecifically

from

cone

photoreceptors

(Nampt−cone/−cone). Although cones constitute only ~3% of the photoreceptors, they
are exclusively responsible for precise color and central vision. As expected,
immunohistochemistry revealed reduced intracellular NAMPT staining (red)
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within cone photoreceptors (green) in retinal sections from Nampt−cone/−cone mice,
while retinal sections from NamptF/F mice demonstrated robust cone NAMPT
expression (Fig 3.2A).
On biomicroscopy, Nampt−cone/−cone mice demonstrated changes consistent with
cone degeneration, including mottling of the RPE and pallor of the optic nerve
(Fig 3.2B). This structural degeneration also manifested in functional deficits on
ERG. By 6 weeks, Nampt−cone/−cone mice exhibited mild declines in their scotopic
a- and b-wave amplitudes (Figs 3.2C–D). More strikingly, Nampt−cone/−cone mice
exhibited dramatic declines in the amplitudes of their photopic b-waves (Fig 3.2E),
indicating predominant cone dysfunction. These structural and functional changes
in Nampt−cone/−cone mice were also associated with a significant decrease in
photopic visual acuity (Fig 3.2F). Cumulatively, these findings provide strong
support for the essential role of NAMPT-mediated NAD+ biosynthesis in
photoreceptor survival, as cell-specific deletion of this key enzyme led to rapid
photoreceptor degeneration and vision loss.
Exogenous NMN prevents photoreceptor degeneration and restores vision.

To confirm the importance of NAMPT-mediated biosynthesis in
photoreceptor survival, we tested whether exogenous supplementation
with NMN could rescue photoreceptor degeneration by bypassing the
NAMPT-catalyzed reaction. NAMPT catalyzes the conversion of NAM
to NMN and should reduce photoreceptor death by ameliorating the
NAD+ deficiency. We gave Nampt−rod/−rod mice daily intraperitoneal
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injections of NMN (150 mg/kg) or vehicle alone beginning at P5 and
ending at the time of ERG testing. Strikingly, ERG at 4 weeks in NMNtreated Nampt−rod/−rod mice revealed significant recovery of scotopic and
photopic retinal function compared to vehicle-treated Nampt−rod/−rod mice
(Figs 3.3A–C). There was no dramatic effect of NMN on the ERG of
NamptF/F controls (Figs S3.2A–C). Consistently, retinal sections from
NMN-treated Nampt−rod/−rod mice showed rescue of retinal degeneration
compared to vehicle-treated Nampt−rod/−rod mice, as manifested by
relative preservation of the outer nuclear layer (Fig 3.3D).
Correspondingly, daily intraperitonal NMN injections also significantly
improved retinal function by ERG in Nampt−cone/−cone mice compared to vehicletreated Nampt−cone/−cone mice (Figs 3.3E–G). These data clearly demonstrate that
NAMPT-mediated NAD+ biosynthesis is necessary for the survival and function
of both rod and cone photoreceptors, as promoting NAD+ biosynthesis in the
retina with NMN supplementation can compensate for Nampt deletion, thereby
reducing photoreceptor death and improving vision.
Early NAD+ deficiency is a feature of multiple mouse models of retinal
dysfunction. Next, we sought to determine whether NAD+ deficiency is

an early feature of other mouse models of retinal disease or dysfunction,
which would support the possibility that NAD+ intermediates may have
therapeutic potential against a broad spectrum of retinal degenerative
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diseases. Light-induced degeneration is a well-characterized model that
is widely used to study mechanisms of photoreceptor death (Grimm and
Reme, 2013) and is known to cause retinal dysfunction, which can be
observed on histology and ERG (Schimel et al., 2011). We found that
there was a significant reduction in retinal NAD+ levels as early as 24
hours following light exposure (Fig 3.3H). In addition, we tested
whether mice with streptozotocin (STZ)-induced diabetic retinopathy,
whose retinal dysfunction has been well characterized (Samuels et al.,
2015), exhibit retinal NAD+ deficiency. At 3 weeks after STZ induction,
hyperglycemic

mice

had

a

significant

reduction

in

retinal

NAD+ compared to non-hyperglycemic controls (Fig 3.3I). Finally, it is
well known that there are defects in retinal structure and function in old
mice, such as a decreased number of rod photoreceptors, a decreased
level of total opsin in the retina, and diminished rod ERG recordings
(Kolesnikov et al., 2010; Lin et al., 2016). Consistent with these past
reports, we found that 18-month-old wild-type mice (C57BL/6J) had
worse retinal function on ERG compared to strain-matched 6-month-old
mice from the same source (Figs S3.2D–F). As in light-induced
degeneration and STZ-induced diabetic retinopathy, this age-associated
retinal dysfunction was associated with a significant decline in retinal
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NAD+ levels (Fig 3.3J). These findings support the idea that
NAD+ deficiency may be a shared feature of retinal dysfunction.
NMN rescues retinal dysfunction in light-induced degeneration. Since we

showed that there is NAD+ deficiency associated with the retinal
dysfunction that follows light-induced degeneration, we sought to
determine whether exogenous NMN supplementation to rescue
NAD+deficiency would rescue retinal dysfunction. We gave wild-type
mice (129S1/SvImJ) daily intraperitoneal injections of NMN (300
mg/kg) or vehicle alone beginning 6 days prior to light exposure, on the
day of light exposure, and for 3 days following light exposure (total of
10 injections/mouse). Remarkably, NMN-treated wild-type mice were
more resilient against light exposure and retained improved retinal
function on ERG compared to vehicle-treated mice (Figs 3.4A–C).
These findings suggest that the NAD+ deficiency associated with retinal
disease can indeed be rescued by NAD+ intermediates such as NMN,
further supporting the possibility of using NAD+ intermediates to treat
retinal degenerative diseases.
Loss of NAMPT-mediated NAD+ biosynthesis leads to metabolic dysfunction.

To provide insight into how NAD+ deficiency leads to retinal
degeneration, we performed transmission electron microscopy on
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Nampt−rod/−rod retinas. Although there were no obvious differences in
mitochondrial ultrastructure at 3 weeks (Fig 3.S3A), we observed
profoundly dysmorphic changes in photoreceptor inner segments by 4
weeks along with disruption of the outer segments, which we did not
observe in NamptF/F littermates of the same age (Fig 3.S3B). Of interest,
by 4 weeks, the mitochondria of Nampt−rod/−rod retinas were rounded and
constricted with loss of cristae with a morphology that was distinctly
different from that observed in NamptF/F littermates (Fig 3.4D). In
addition, at this time point, we observed degenerative vacuoles in the
cytoplasm

of

Nampt−rod/−rod retinas,

which

appeared

to

contain

degenerated organelles including ruptured mitochondria (Fig 3.S3C).
These results suggest that loss of NAMPT-mediated NAD+ biosynthesis
in photoreceptors leads to mitochondrial structural irregularities that may
lead to or be associated with defects in mitochondrial function.
To characterize these possible mitochondrial defects, we performed nonbiased metabolomic analysis with liquid chromatography-mass spectrometry (LCMS) and gas chromatography-mass spectrometry (GC-MS), comparing retinas
isolated from 3-week old Nampt−rod/−rod mice from those isolated from gendermatched NamptF/F littermates. We chose this time point since it would allow us to
identify signs of mitochondrial dysfunction that precede gross retinal
degeneration. The LC-MS results revealed that although there were no
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statistically significant differences, there was a trend toward accumulation of
some acylcarnitine species in Nampt−rod/−rod retinas, suggesting a possible defect
in Krebs cycle efficiency (Fig 3.S3D). In addition, the GC-MS results revealed
that numerous mitochondrial metabolites were significantly elevated or reduced in
Nampt−rod/−rod retinas (Fig 3.S3E). To determine whether the identities of these
dysregulated metabolites were suggestive of defects in certain metabolic
pathways, we performed metabolite set enrichment analysis with MetaboAnalyst
3.0 (Xia et al., 2015) using the over representation analysis algorithm. This
analysis revealed that there are numerous metabolic pathways that are broadly
dysregulated in Nampt−rod/−rod retinas, including protein biosynthesis, propanoate
metabolism, and the citric acid cycle, among others (Fig 3.4E).
To confirm that these effects on mitochondrial function were indeed
related to loss of NAMPT function within photoreceptors, we treated 661W cone
photoreceptor-like cells with the pharmacological NAMPT inhibitor FK866 (20
µM) and measured reductive capacity to approximate metabolic activity. NAMPT
inhibition caused considerable reduction of photoreceptor cell reductive capacity.
By 24 hours, FK866-treated cells had roughly 40% of the reductive capacity of
vehicle-treated cells (Fig 3.5A). By 48 hours, there was an even more dramatic
effect with reductive capacity reduced down to ~20% (Fig 3.5B). Although there
was no cell death at 24 hours (Fig 3.5C), this loss of reductive capacity ultimately
led to cell death by 48 hours (Fig 3.5D). This finding highlights that metabolic
dysfunction, as represented by a decrease in reductive capacity, precedes cell
death.
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Since we observed that exogenous NMN supplementation rescued retinal
function in Nampt−rod/−rod and Nampt−cone/−cone mice, we tested whether NMN
supplementation could rescue the deleterious effects of NAMPT inhibition in
photoreceptor cells. Our results demonstrate that providing FK866-treated
photoreceptors with NMN (100 µM) could completely restore normal reductive
capacities at 24 hours (Fig 3.5A) and at 48 hours (Fig 3.5B), and prevent
subsequent cell death (Fig 3.5D). These results provide strong evidence for the
importance of NAMPT-mediated NAD+ biosynthesis in photoreceptors since we
demonstrate that bypassing the NAMPT-catalyzed reaction could restore normal
reductive capacity and prevent photoreceptor cell death.
To determine whether these dramatic effects of NAMPT inhibition were
unique to photoreceptors, we tested the effects of FK866 (20 µM) on the reductive
capacity and cell survival of ARPE-19 RPE cells. Of interest, an identical dose of
FK866 had no effect on the reductive capacity of RPE cells at 24 hours (Fig
3.S4A) and only a modest albeit statistically significant effect on reductive
capacity at 48 hours (Fig 3.S4B). Remarkably, FK866 did not reduce RPE cell
survival at either 24 hours (Fig 3.S4C) or 48 hours (Fig 3.S4D), demonstrating
that RPE cells are more resilient to metabolic dysfunction and thereby protected
from cell death. Ultimately, these results suggest that photoreceptors are uniquely
vulnerable to impairment of NAMPT-mediated NAD+ biosynthesis and implicate
this pathway as a master regulator of photoreceptor metabolism and survival.
NAMPT inhibition causes rapid NAD+ depletion, leading to an ATP crisis.

To further characterize the effects of NAMPT inhibition, we measured
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the NAD+ levels in photoreceptor cells after treatment with FK866 (20
µM). As expected, by 6 hours, FK866-treated photoreceptor cells
contained significantly less total NAD+ compared to vehicle-treated cells
plated at the same density (Fig 3.5E). Exogenous NMN supplementation
(100 µM) returned NAD+ back to near-normal levels (Fig 3.5E). After 24
hours, there were undetectable levels of NAD+ in FK866-treated cells
compared to vehicle-treated cells (Fig 3.5F). Similar to the 6-hour time
point, exogenous NMN supplementation for 24 hours prevented FK866associated NAD+ depletion, bringing NAD+ back to even higher levels
compared to vehicle-treated cells (Fig 3.5F). We interpret these results to
indicate that NAMPT inhibition causes rapid NAD+ deficiency, which
likely contributes to the metabolic dysfunction described above.
To further characterize the connection between NAD+ depletion and cell
death, we investigated the time course of NAD+ depletion and its effect on ATP
production by simultaneously measuring NAD+ and ATP content in photoreceptor
cells at various times after treatment with FK866 (20 µM). As above, we found
that FK866 caused rapid NAD+ deficiency. By 6 hours, NAD+ levels were down
to ~50% of their original levels (Fig 3.5G). NAD+ depletion continued rapidly,
dropping to ~15% by 12 hours and to undetectable levels by 24 hours (Fig 3.5G).
NAMPT inhibition also caused ATP depletion, but ATP levels did not decline
after 6 hours of FK866 treatment and dropped only modestly to ~70% of the
original levels by 12 hours (Fig 3.5G). By 24 hours however, ATP levels had
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dropped down to ~10% of the original levels (Fig 3.5G). The temporal
relationship between NAD+ and ATP depletion suggests that the ATP crisis is a
downstream effect of NAD+ deficiency-associated metabolic dysfunction.
To confirm the connection between NAD+ availability, ATP content,
metabolic function, and cell survival, we also measured the NAD+ and ATP levels
in RPE cells after NAMPT inhibition. Consistent with the mild effects on
metabolic function (Figs S3.4A–B) and the lack of effect on cell survival (Figs
S3.4C–D), 24 hours of FK866 treatment (20 µM) caused only a ~60% reduction
in total NAD+ levels (Fig 3.S4E), a smaller effect than that observed after 24
hours of FK866 treatment in photoreceptor cells. This intermediate decrease in
total NAD+ levels was accompanied by a concomitant increase in ATP levels (Fig
3.S4F), drastically different from the severe ATP depletion exhibited by
photoreceptor cells. These findings suggest that photoreceptor cells are more
vulnerable to perturbations in NAD+ biosynthesis compared to other nonphotoreceptor eye cells, such as RPE cells.
NAMPT inhibition impairs basal metabolism and the normal response to
metabolic stress. The rapid decline in ATP in photoreceptor cells within

24 hours of FK866 treatment suggests that NAMPT inhibition causes
significant metabolic dysfunction. To characterize what elements of
metabolic function were impaired, we treated photoreceptor cells with
FK866 (20 µM) and profiled various aspects of metabolism by
measuring oxygen consumption rate (OCR) as a measure of aerobic
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respiration and extracellular acidification rate (ECAR) as a measure of
glycolytic flux. We measured these parameters of metabolic function at
baseline and under various conditions of stress induced by sequential
treatments

with

oligomycin,

carbonyl

cyanide-4-

(trifluoromethoxy)phenylhydrazone (FCCP), and antimycin A/rotenone.
At baseline, FK866-treated photoreceptor cells exhibited reduced OCR
and ECAR (Figs 3.5H–I), indicating that NAMPT inhibition caused reduced basal
oxidative respiration and basal glycolytic flux. While vehicle-treated cells
responded appropriately to the ATP synthase inhibitor oligomycin by shifting
toward glycolytic metabolism (reduced OCR; increased ECAR), FK866-treated
photoreceptor cells were unable to shift toward glycolytic metabolism (Figs
3.5H–I). Moreover, while vehicle-treated cells responded appropriately to the
ionophore FCCP by elevating their oxidative respiration (increased OCR),
FK866-treated photoreceptor cells were unable to accelerate oxidative respiration
in response to metabolic stress (Fig 3.5H). NMN supplementation restored normal
baseline metabolism and the appropriate responses to stress (Figs 3.5H–I),
confirming that these phenotypes were specific to NAD+ deficiency.
To confirm that these effects on metabolic function were specific to
NAMPT inhibition, we performed Nampt knockdown in photoreceptor cells.
Partial

reduction

of

NAMPT-mediated

NAD+ biosynthesis

through Nampt knockdown in photoreceptor cells caused a reduction in
NAD+ levels (Fig 3.S5A) within 24 hours after knockdown. Although this
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intermediate reduction in NAD+ did not affect reductive capacity (Fig 3.S5B) or
cell survival at the early 48-hour time point (Fig 3.S5C), it did impair the ability
of photoreceptor cells to maximally accelerate oxidative respiration in response to
FCCP (Fig 3.S5D–E), further reinforcing the importance of NAMPT-mediated
NAD+ biosynthesis for maintaining mitochondrial homeostasis in photoreceptors.
Taken together, these data confirm the importance of NAMPT-mediated
NAD+ biosynthesis for maintaining photoreceptor glycolytic and mitochondrial
function – both at baseline and in response to metabolic stress – and highlight a
NAMPT-specific effect due to the ability of NMN to restore normal metabolic
responses. Importantly, we observed these signs of metabolic dysfunction after 24
hours of FK866 treatment prior to when we observed the effects on photoreceptor
cell viability. Once again, these results highlight that glycolytic and mitochondrial
dysfunction precede and therefore likely cause photoreceptor cell death.
NAD+ deficiency causes NAD-IDH dysfunction. Our in vitro and in vivo results
suggest that there are defects in oxidative metabolism in photoreceptors under
conditions of NAD+ deficiency. To more specifically characterize these defects in
oxidative metabolism, we tested the activity of three enzymes of the Krebs cycle
that require NAD+ as a coenzyme: NAD+-dependent isocitrate dehydrogenase
(NAD-IDH/IDH3), alpha-ketoglutarate dehydrogenase (AGDH), and malate
dehydrogenase (MDH). This fact that these enzymes require NAD+ as a
coenzyme provides the opportunity to determine whether their enzymatic
dysfunction is caused solely by loss of NAD+ as a coenzyme. If loss of NAD+ as a
coenzyme were solely responsible for enzymatic dysfunction, we would expect to
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be able to restore enzymatic function simply by providing sufficient NAD+ to the
reaction mixture.
We found that NAD-IDH activity was significantly lower in rods isolated
from Nampt−rod/−rod retinas compared to those isolated from NamptF/F retinas, even
when sufficient NAD+ was supplied in the reaction (Fig 3.5J) and despite similar
NAD-IDH expression levels (Fig 3.5K). These findings suggest that NAD-IDH
dysfunction cannot be explained by loss of NAD+ as a coenzyme alone. Of
significant interest, the rod AGDH and MDH activities were completely rescued
by NAD+ (Figs 3.5L–M), indicating selective enzymatic dysfunction. These
findings not only characterize one specific aspect of mitochondrial dysfunction
but also suggest that NAD+ plays important roles in regulating metabolism in
addition to its role as a coenzyme.
SIRT3 and SIRT5 play important roles in photoreceptor survival. In addition
to serving as a coenzyme for crucial steps of glycolysis and the Krebs cycle,
NAD+ also serves as a cosubstrate for NAD+-consuming enzymes, including the
sirtuins. Of the seven sirtuin family members, three of them, SIRT3, SIRT4, and
SIRT5, are known to regulate mitochondrial function (Laurent et al., 2013; Yang
et al., 2007; Zhang et al., 2015). Because other sirtuin family members have been
shown to play crucial roles in regulating the survival of retinal cells (Jaliffa et al.,
2009; Silberman et al., 2014) and because sirtuins depend on NAD+ availability
for optimal function (Satoh and Imai, 2014), we hypothesized that
NAD+ deficiency may also impair mitochondrial sirtuin activity, contributing to
mitochondrial dysfunction.
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To determine whether the mitochondrial sirtuins are essential for
photoreceptor survival, we performed individual and combined knockdown of
SIRT3, SIRT4, and SIRT5 in photoreceptor cells. Individual knockdown of
SIRT3 and SIRT5 caused significant reduction in reductive capacity compared to
knockdown by negative control (Fig 3.6A). Interestingly, individual knockdown
of SIRT4 did not diminish reductive capacity, highlighting the specificity of the
effect of SIRT3 and SIRT5 (Fig 3.6A). Combined SIRT3 and SIRT5 knockdown
had a synergistic effect, leading to significantly lower reductive capacity
compared to either single knockdown alone (Fig 3.6A). Of note, NMN was not
able to rescue the effect on reductive capacity in the SIRT3/SIRT5 double
knockdown (Fig 3.6A), suggesting that exogenous NMN cannot protect against
SIRT3/SIRT5 deletion.
This decline in reductive capacity secondary to SIRT3/SIRT5 knockdown
was also accompanied by progressive cell death. Individual knockdown of SIRT3
and SIRT5 caused significant reduction in cell survival compared to knockdown
by negative control (Fig 3.6B). Again, individual knockdown of SIRT4 had no
effect on cell viability (Fig 3.6B), highlighting the specificity of the SIRT3/SIRT5
effect. Once again, combined SIRT3 and SIRT5 knockdown had a more profound
effect on cell death compared to either individual knockdown alone (Fig 3.6B).
Consistently, NMN supplementation did not rescue the cell death caused by
combined SIRT3/SIRT5 double knockdown (Fig 3.6B).
To test whether loss of SIRT3 and SIRT5 causes mitochondrial
dysfunction that is similar to that caused by NAD+ deficiency, we performed
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individual and combined SIRT3 and SIRT5 knockdowns in photoreceptors and
measured the NAD-IDH activity 24 hours after transfection. We found that
knocking down SIRT3, SIRT5, or both SIRT3/SIRT5 in photoreceptor cells
recapitulated NAD-IDH dysfunction (Fig 3.6C). The fact that SIRT3 and SIRT5
knockdowns phenocopy the NAD-IDH dysfunction observed in rods isolated
from Nampt−rod/−rod retinas suggests that SIRT3 and SIRT5 may play a role in
governing the metabolic dysfunction associated with NAD+ deficiency.
To test the role of SIRT3 and SIRT5 in retinal function in vivo, we tested
mice lacking SIRT3 and SIRT5. Both SIRT3KO and SIRT5KO mice have normalappearing fundi on biomicroscopy (Figs S3.6A–B) and normal retinal function on
ERG compared to strain-matched controls (Figs S3.6C–H). However, since many
studies report that SIRT3 and SIRT5 regulate many of the same protein targets
and even the same lysine residues within the same protein (Hebert et al.,
2013; Park et al., 2013; Rardin et al., 2013a; Rardin et al., 2013b; Schwer et al.,
2009; Sol et al., 2012; Still et al., 2013), it is possible that SIRT3 and SIRT5 can
compensate for one another. To test this possibility, we also tested mice lacking
multiple mitochondrial sirtuins.
Although SIRT3KOSIRT5KO mice had normal retinal function at baseline (Figs
S3.6I–K), we could not yet conclude that SIRT3 and SIRT5 are inessential for
retinal function since previous studies have reported that mice lacking
mitochondrial sirtuins rarely show striking phenotypes (Lombard et al., 2007; Yu
et al., 2013) until they are challenged by specific stimuli such as fasting or a highfat

diet

(Hirschey

et

al.,

2011).
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To

this

end,

we

tested

whether

SIRT3KOSIRT5KO mice are more vulnerable to retinal degeneration after exposure
to light. We found that SIRT3KOSIRT5KO mice were strikingly more vulnerable to
retinal degeneration upon light stress compared to SIRT3hetSIRT5het controls as
manifested by retinal dysfunction on ERG (Figs 3.6D–F) when tested four days
after light treatment. Interestingly, SIRT3hetSIRT5KO and SIRT3KOSIRT5het mice
demonstrated an intermediate degenerative phenotype (Figs 3.6D–F), supporting
the notion that SIRT3 and SIRT5 synergistically regulate mitochondrial function
in photoreceptors. Together, these results provide strong evidence that SIRT3 and
SIRT5 not only are important for maintaining photoreceptor survival but also
have distinct, non-redundant roles in regulating retinal homeostasis.
NAMPT inhibition causes SIRT3 dysfunction. Since we found that SIRT3 and
SIRT5 are essential for photoreceptor survival, we sought to determine whether
NAD+ deficiency caused by NAMPT inhibition impairs SIRT3 and SIRT5
function in photoreceptor cells. Since SIRT3 regulates predominantly protein
acetylation (Parihar et al., 2015) and SIRT5 regulates predominantly protein
succinylation, malonylation, and glutarylation (Du et al., 2011; Nishida et al.,
2015; Papanicolaou et al., 2014; Tan et al., 2014), we tested whether NAMPT
inhibition modulates the acylation of mitochondrial proteins in photoreceptor cells.
We found that mitochondrial lysates generated from photoreceptor cells treated
with FK866 (20 µM) for 24 hours showed obvious hyperacetylation (Figs 3.7A–
B), indicating SIRT3 dysfunction. Normal acetylation patterns were restored with
NMN (Figs 3.7A–B), confirming that this hyperacetylation was specific to
NAMPT inhibition. Although there were clear acetylation changes, these
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mitochondrial lysates demonstrated only modest changes in succinylation (Figs
3.7C–D) and no obvious differences in malonylation (Fig 3.S7A) or glutarylation
(Fig 3.S7B), suggesting that NAD+ deficiency primarily impairs SIRT3 function.
To confirm that these effects were caused by NAMPT inhibition rather
than being secondary to metabolic dysfunction, we measured the activity of
SIRT3 and SIRT5 in the mitochondrial lysates generated from FK866-treated
photoreceptor cells. Consistent with our Western Blots, mitochondrial lysates
generated from FK866-treated photoreceptor cells had a significant reduction in
SIRT3 activity compared to mitochondrial lysates generated from vehicle-treated
cells (Fig 3.7E). There was, however, no difference in SIRT5 activity (Fig 3.7F).
Taken together, these results demonstrate that NAD+ deficiency leads to
dysregulation of the mitochondrial acylome primarily through impairment of
SIRT3 function. Since we show that SIRT3 is important for photoreceptor
survival, this NAD+ deficiency-associated impairment of SIRT3 activity likely
contributes to the mitochondrial dysfunction observed in photoreceptors
lacking Nampt, providing additional mechanistic evidence for why NAMPTmediated NAD+ biosynthesis is essential for mitochondrial homeostasis,
photoreceptor survival, and vision.
3.4

DISCUSSION
NAD+ has numerous functions in diverse biological processes including
metabolism, circadian rhythms, aging, and neurodegeneration (Alano et al.,
2010; Garten

et

al.,

2009; Gerdts

et

al.,

2015; Imai

and

Yoshino,

2013; Mouchiroud et al., 2013; Nakahata et al., 2009; Ramsey et al., 2009; Stein
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et al., 2014; Zhou et al., 2015). In the current study, we demonstrate that
NAMPT-mediated NAD+ biosynthesis is indispensable for photoreceptor survival
and vision. Using loss of function approaches, we show that disrupting NAMPTmediated NAD+ biosynthesis in rod and cone photoreceptors leads to
photoreceptor death, retinal degeneration, and blindness. By testing the effects of
NAMPT inhibition on non-photoreceptor cells, we confirm that photoreceptors
are uniquely susceptible to perturbations in NAD+biosynthesis.
Moreover, we demonstrate that, in photoreceptors, loss of NAMPTmediated NAD+ biosynthesis leads to NAD+ deficiency, significant glycolytic and
mitochondrial dysfunction under basal conditions, and the inability to respond
appropriately to metabolic stress, which ultimately lead to photoreceptor death
and retinal degeneration. Corresponding with this energetic failure, metabolic
profiling of retinas from Nampt−rod/−rod mice revealed dysregulation of numerous
metabolic pathways. Of interest, there was a trend (p = .0704) toward
dysregulation of the citric acid cycle, a key pathway in oxidative metabolism. The
trends toward accumulation of various acylcarnitine species also support a failure
of Krebs cycle efficiency. These hallmarks of metabolic dysfunction can be
identified prior to cell death and vision loss, supporting the possibility of probing
mitochondrial function to predict subsequent photoreceptor death (Perron et al.,
2013). These findings are interesting, especially considering recent studies that
show that photoreceptors have limited mitochondrial reserve capacity, which may
make them susceptible to defects in energy homeostasis (Kooragayala et al.,
2015). We speculate that defects in the Krebs cycle cause broad energetic failure,
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which contributes to downstream defects in numerous metabolic pathways, such
as protein biosynthesis and propanoate metabolism. Further studies are necessary
to explore the precise connection between these phenomena.
Our results also identify that NAD+ deficiency leads to selective
enzymatic dysfunction and that cell death is unlikely to be caused by loss of
NAD+ as a coenzyme alone. When we tested the activity of the three NAD+dependent enzymes of the Krebs cycle in rods isolated from Nampt−rod/−rod retinas,
the activity of only one of the three, NAD-IDH, could not be rescued by providing
sufficient NAD+ as a coenzyme, while the activity of the other NAD+-dependent
Krebs cycle enzymes AGDH and MDH were restored by providing exogenous
NAD+. This result stresses the importance of NAD-IDH in maintaining metabolic
homeostasis in photoreceptors. In support, the retina has been shown to be highly
dependent on NAD-IDH and exquisitely sensitive to defects in NAD-IDH
function, such that mutations in NAD-IDH that impair its catalytic activity cause
RP (Hartong et al., 2008). Of significant interest, these RP patients have normal
NADP+-dependent IDH (i.e., NADP-IDH or IDH1/IDH2) activity and no other
manifestations of disease despite the fact that they carry this mutation in all cells
of their body (Hartong et al., 2008). This finding suggests that in contrast with
most organ systems, the retina uniquely relies on the NAD+-dependent form of
IDH (Hartong et al., 2008).
We further demonstrate that SIRT3 and SIRT5 both play important roles
in photoreceptor survival and that NAD+ deficiency leads to predominately SIRT3
dysfunction. Our results agree with past studies reporting that other sirtuin family
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members, including SIRT1 (Jaliffa et al., 2009) and SIRT6 (Silberman et al.,
2014), play roles in photoreceptor survival and survival of other retinal cells.
Interestingly, we demonstrate that the deleterious effects of SIRT3 and SIRT5
deletion are synergistic. These findings strongly suggest that SIRT3 and SIRT5
are not redundant even though they may regulate the acylation status of the same
mitochondrial proteins and even the same lysine residues within the same proteins
(Hebert et al., 2013; Park et al., 2013; Rardin et al., 2013a; Rardin et al.,
2013b; Schwer et al., 2009; Sol et al., 2012; Still et al., 2013).
Based on our results, we hypothesize that SIRT3 dysfunction caused by
NAD+ deficiency may contribute to mitochondrial dysfunction by causing
aberrant hyperacetylation of key mitochondrial proteins, such as NAD-IDH. This
possibility that SIRT3 dysfunction is linked to decreased NAD-IDH activity is
supported not only by our ability to recapitulate NAD-IDH dysfunction with
SIRT3 knockdown but also by the fact that NAD-IDH has been identified as a
target of SIRT3 (Hebert et al., 2013; Rardin et al., 2013b; Schwer et al., 2009; Sol
et al., 2012; Still et al., 2013). Further studies are needed to explore this
possibility and to extend these findings in vivo, perhaps using new technologies
such as CRISPR/Cas9 to delete Namptselectively from photoreceptors.
Cumulatively, these findings provide unique insights that point to the dominant
mammalian NAD+biosynthesis pathway as a master regulator of photoreceptor
metabolism. Human retinal degenerations encompass a broad spectrum of
diseases that include seemingly unrelated disorders such as LCA and RP, which
have been associated with mutations in enzymes involved in NAD+ biosynthesis
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(Chiang et al., 2012; Falk et al., 2012; Koenekoop et al., 2012; Perrault et al.,
2012) and the Krebs cycle (Hartong et al., 2008). Despite these genetic insights,
the mechanisms underlying these conditions and what ultimately causes
photoreceptor degeneration in these genotypically diverse disorders are poorly
understood. We propose a model linking NAD+ biosynthesis, SIRT3/SIRT5, and
metabolism in photoreceptors, which may connect these diverse retinal
neurodegenerations at the molecular level.
Remarkably,

our

studies

also

demonstrate

exogenous

NMN

supplementation to bypass the NAMPT-catalyzed reaction can restore normal
NAD+ levels in photoreceptor cells despite NAMPT inhibition and reduce
photoreceptor death in Nampt−rod/−rod mice. In photoreceptor cells subjected to
NAMPT inhibition, NMN supplementation prevented metabolic dysfunction and
cell death by restoring normal basal glycolytic and mitochondrial function and the
ability to respond appropriately to metabolic stress. This therapeutic effect is
likely explained by the importance of NAD+ not only to perform its coenzyme
role in various steps of the Krebs cycle and glycolysis but also to maintain
optimal SIRT3 activity. We show that multiple mouse models of retinal
dysfunction,

including

light-induced

degeneration,

STZ-induced

diabetic

retinopathy, and age-associated retinal dysfunction all exhibit early retinal
NAD+ deficiency. Moreover, the retinal dysfunction associated with light-induced
degeneration can be partially rescued with NMN. These findings offer powerful
therapeutic avenues for degenerative diseases of the eye and are supported by past
studies exploring the therapeutic applications of NAD+ supplementation in light-

98

induced degeneration (Bai and Sheline, 2013), noise-induced hearing loss (Brown
et al., 2014), and high-fat diet- and age-induced metabolic complications (Canto
et al., 2012; Ramsey et al., 2008; Stein and Imai, 2014; Yoshino et al., 2011).
Once successfully implemented, this treatment strategy would be far-reaching
since it could be implemented for multiple diseases with diverse pathogenic
mechanisms, including not only inherited forms of retinal degenerations but also
other blinding diseases characterized by a final pathway of photoreceptor death
such as age-related macular degeneration and diabetic retinopathy. Given the
global importance of NAD+ biosynthesis and mitochondrial dysfunction in
neurons, our findings may also be broadly relevant to other systemic
neurodegenerative

diseases

such

as

Alzheimer’s

disease

where

NAD+ intermediate supplementation may be neuroprotective.

3.5

Experimental Procedures
Mice. All animal experiments were approved by the Animal Studies Committee
and performed in accordance with the Washington University School of Medicine
Animal Care and Use guidelines. Namptflox/flox(NamptF/F) mice were previously
characterized (Rongvaux et al., 2008) and were provided by Dr. Shin-ichiro Imai.
To generate mice lacking Nampt specifically from rod photoreceptors, we crossed
NamptF/Fmice with mice carrying one copy of the Rhodopsin-iCre75 transgene,
which were provided by Dr. Ching-Kang Jason Chen and have been previously
characterized (Li et al., 2005). To generate mice lacking Namptspecifically from
cone photoreceptors, we crossed NamptF/F mice with mice carrying one copy of
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the human red/green pigment-Cre (HRGP-Cre) transgene, which were provided
by Dr. Yun Le and have been previously characterized (Le et al., 2004). We
received 6-month-old and 18-month-old wild-type C57BL/6J mice from the
National Institutes on Aging (Bethesda MD) and purchased streptozotocin (STZ)induced hyperglycemic mice (C57BL/6J) from Jackson Laboratories (Bar Harbor
ME). We also purchased SIRT3−/−, SIRT5−/−, and the appropriate strain-matched
wild-type mice (129S1/SvImJ for SIRT3−/− and B6129SF2/J for SIRT5−/−) from
Jackson Laboratories.
Cells and reagents. We routinely cultured 661W cone photoreceptor-like cells,
provided by Dr. Muayyad Al Ubaidi (Tan et al., 2004), in Dulbecco’s Modified
Eagle Medium with 1 g/L glucose and 110 mg/L sodium pyruvate (DMEM;
Thermo Fisher, Carlsbad CA) supplemented with 10% Fetal Bovine Serum (FBS;
Sigma, St. Louis MO) and 1% penicillin-streptomycin (Thermo Fisher, Carlsbad
CA). We prepared stock solutions of FK866 (Santa Cruz Biotechnology, Dallas
TX) at 200 mM in DMSO. We purchased nicotinamide mononucleotide (NMN)
from Sigma (St. Louis MO) and dissolved it directly in cell culture media,
prepared as described above.
Real-time PCR in rod-enriched samples. We generated rod-enriched samples
by vortexing dissected whole retinas for 60 seconds at medium speed and
centrifuging the resulting supernatant at 12,800 g for 10 minutes. We extracted
total RNA from the resulting pellet with the RNeasy Mini Kit (Qiagen, Valencia
CA), prepared cDNA with the High Capacity cDNA Reverse Transcription Kit
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(Life Technologies, Grand Island NY), and performed PCR amplification of
cDNA using Taqman probe-based gene expression assays (Life Technologies,
Grand Island NY) as described previously (Kelly et al., 2007). We used probes
for Nampt (Mm01293560_m1)

and Idh3a(Mm00499674_m1)

normalized

to ActB (Mm00607939_s1) or Rho (Mm01184405_m1) with the ΔΔCT method.
Retinal imaging. We performed digital color fundus photography using the
Micron III™ animal fundus camera (Phoenix Research Laboratories, Pleasanton
CA). Prior to fundus imaging, we anesthetized mice with an intraperitoneal
injection of 86.9 mg/kg ketamine and 13.4 mg/kg xylazine, and administered
1.0% tropicamide eye drops (Bausch & Lomb, Tampa FL) to dilate the pupils.
Histology and immunohistochemistry. After euthanizing the mice, we
enucleated the eyes and fixed them overnight in 10% formalin. Next, we
embedded the eyes in methacrylate and prepared eight to ten sections of 6–8 µm
thickness cut at different planes for each eye. We stained slides with hematoxylin
and eosin, rabbit anti-NAMPT(161–173) (B5812-200UL; Sigma, St. Louis MO),
and rabbit anti-cone arrestin (AB15282; Millipore, Billerica MA). We acquired
images with an Olympus FV1000™ upright confocal microscope with UVsensitive (405), multi-Argon (458, 488 & 513) & Helium-Neon (543 & 633)
lasers, and a Plan Apo N 60x oil objective (N.A.=1.42).
Electroretinography. We performed electroretinography (ERG) as previously
described

(Hennig

et

al.,

2013)

by

using

the

UTAS-E3000

Visual

Electrodiagnostic System running EM for Windows (LKC Technologies,
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Gaithersburg MD). We extracted quantitative measurements from the ERG
waveforms using an existing Microsoft Excel macro that defines the a-wave
amplitude as the difference between the average pre-trial baseline and the most
negative point of the average trace and defines the b-wave amplitude as the
difference between this most negative point to the highest positive point, without
subtracting oscillatory potentials.
Photopic visual acuity. We measured mouse photopic visual acuity under
standard photopic conditions (1.85 log cd m−2) by testing the optokinetic reflex
with the OptoMotry™ System (CerebralMechanics) as described previously
(Kolesnikov et al., 2011; Umino et al., 2008).
Transmission

electron

microscopy.

To

perform

transmission

electron

microscopy, we dissected enucleated eyes to remove the cornea and lens, and
fixed eye cups for 4 hours at room temperature in 2% paraformaldehyde/2.5%
glutaraldehyde (Polysciences, Warrington PA) diluted in 100 mM sodium
cacodylate (pH 7.2). We then washed the fixed eye cups in cacodylate buffer and
post-fixed them in 1% osmium tetroxide (Polysciences) for 1 hour. We then
rinsed the postfixed eye cups extensively in deionized H2O prior to en
bloc staining with 1% aqueous uranyl acetate (Ted Pella, Redding CA) for 1 hour.
Following several rinses, we dehydrated the stained eye cups with a graded series
of ethanol solutions and embedded them in Eponate 12 resin (Ted Pella). We cut
95 nm sections with a Leica Ultracut UCT ultramicrotome (Leica Microsystems,
Bannockburn IL), stained the sections with uranyl acetate and lead citrate, and
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imaged them on a JEOL 1200 EX transmission electron microscope (JEOL USA,
Peabody MA) equipped with an AMT 8 megapixel digital camera (Advanced
Microscopy Techniques, Woburn MA).
Metabolomic analysis. We isolated retinas at the same time of day after
restricting oral nutrient intake for 4 hours. We pooled 6 retinas per group and
snap-froze them in liquid nitrogen. We then added ammonium bicarbonatebuffered solution to the tissue pellets and transferred these tissue suspensions to
tubes for subsequent metabolite extraction. We extracted intracellular metabolites
and culture media samples into cold methanol:acetonitrile (ACN):water (H2O),
dried them, derivatized them to their tert-butyldimethylsilyl esters (tBDMS), and
then analyzed them on an Agilent 7200 GC-quadrupole-time of flight (QTOF)MS operating in electron impact ionization mode. We dried an aliquot of each
extract and dissolved it in ACN:H2O for subsequent LC-QTOF-MS analysis. We
performed metabolite set enrichment analysis with MetaboAnalyst 3.0 (Xia et al.,
2015) by inputting the list of dysregulated metabolites with a statistically
significant difference (corrected p-value < .05) and a fold-change > 1.10. These
data were processed with the over representation algorithm and the metabolic
pathway-associated metabolite set library.
Reductive capacity assay. To quantify reductive capacity, we used the Cell
Proliferation Reagent WST-1 (Roche Applied Science, Indianapolis IN)
according to manufacturer’s instructions. In short, we washed cells once with PBS
after the desired treatment and replaced the media with fresh media containing the
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WST-1 assay solution at a 1:10 dilution. After 2 hours of incubation at 37°C, we
measured absorbance at 450 nm with the SpectraMax 190 Absorbance Microplate
Reader (Molecular Devices, Sunnyvale CA).
Cell survival assay. To determine cell survival, we used the cell-permeant dye
calcein AM (Thermo Fisher, Carlsbad CA) according to manufacturer’s
instructions. In short, we washed cells once with PBS after the desired treatment
and replaced the media with calcein AM diluted in PBS (working concentration of
2 µM). After 30 minutes at 37°C, we measured fluorescence at 485 nm
excitation/520 nm emission with the Infinite 200 PRO (Tecan, Männedorf
Switzerland).
Quantification of NAD+ & ATP levels with HPLC. To quantify the NAD+ and
ATP levels of mouse retina, pooled rod-enriched isolates, or 661W cells, we
performed reverse-phase high-performance liquid chromatography (HPLC) as
described previously (Yoshino and Imai, 2013). We quantified NAD+ and ATP
levels based on the peak area on the HPLC spectrogram relative to a standard
curve, and normalized these values to tissue weights for retinas, number of retinas
for rod-enriched isolates, or based on cell number.
OCR

and

ECAR

measurements.

We

performed

detailed

metabolic

characterization of 661W cells after NAMPT inhibition using an XF96
Extracellular Flux Analyzer (Seahorse Bioscience, Billerica MA). After the
desired treatment, we washed the cells three times and left them in 180 µL of
prewarmed bicarbonate-free DMEM (pH 7.4). After 30–60 minutes in a non-
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CO2 incubator, we simultaneously measured oxygen consumption rate (OCR) and
extracellular acidification rate (ECAR) to quantify oxidative respiration and
glycolytic flux, respectively, both at baseline and after sequential treatments of
1.5

µM

oligomycin,

1.0

µM

carbonyl

cyanide

4-(trifluoromethoxy)

phenylhydrazone (FCCP), and a combination of 1.0 µM antimycin A and 1.0 µM
rotenone. Each 5-minute measurement period was preceded by 2 minutes of
mixing and a 1-minute pause; we made 3 sequential measurements per treatment
condition.
SIRT3-5 and Nampt knockdown in 661W cells. We transfected 661W cells

with custom LNA longRNA GapmeRs reagents (Exiqon, Woburn MA)
targeting SIRT3, SIRT4, or SIRT5 at a final concentration of 100 nM, and
commercially available siRNA targeting Nampt (Mm_Pbef1_5; Qiagen,
Valencia CA) at a final concentration of 50 nM. In short, we seeded
661W cells and allowed them to adhere for 30 minutes. We prepared the
transfection complexes by incubating the appropriate GapmeR/siRNA
with Lipofectamine RNAiMAX transfection reagent (Invitrogen, Grand
Island NY) for 5 minutes at room temperature (1.0 µl or 2.4 µl of
RNAiMAX per well for the 96-well and 24-well plate formats,
respectively). We confirmed knockdown efficiency with real-time PCR.
Light-induced

degeneration

(LID).

We

performed

light-induced

degeneration as described previously (Grimm and Reme, 2013). In short,
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we dilated pupils with two sequential drops of 1.0% atropine sulfate and
1.0% tropicamide (Bausch & Lomb, Tampa FL), and then exposed the
mice to 13,000 lux from fluorescent lights suspended directly over the
mice. We placed the mice in clear plastic cages that were surrounded on
all sides with reflective aluminum foil and re-dilated pupils with two
additional drops every 2 hours. We assessed retinal function 4 days
following light-induced degeneration with ERG as described above. All
the mice we tested carried the RPE65Leu/Leu variant, making them equally
vulnerable to light-induced degeneration (Wenzel et al., 2001).
Krebs cycle enzymatic activity assays. We performed retinal dissociation

by incubating dissected retinas in 12 U/ml papain (Sigma, St. Louis MO)
and 5 mM L-cysteine in DMEM for 30 minutes on a small vibrating
aquarium pump at room temperature. After washing away residual
papain with 5 exchanges to fresh DMEM, we triturated the samples with
fire-polished Pasteur pipets. We then separated rod photoreceptors with
the EasySEP Mouse PE Positive Selection Kit (Stem Cell Technologies,
Vancouver Canada) and PE-conjugated anti-CD73 antibodies (Miltenyi
Biotec, Bergisch Gladback Germany). We measured the enzymatic
activity of NAD+-dependent isocitrate dehydrogenase (NAD-IDH/IDH3),
alpha-ketoglutarate dehydrogenase (AGDH), and malate dehydrogenase
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(MDH) in these rods with assay kits from Sigma (St. Louis MO)
according to the manufacturer’s instructions. We normalized enzymatic
activity to total protein and/or viable rod cell number.
Western Blotting for mitochondrial protein acylation. We isolated

mitochondria from 661W cells as described previously (Frezza et al.,
2007). We denatured mitochondrial lysates in NuPAGE LDS Sample
Buffer and NuPAGE Sample Reducing Agent (Thermo Fisher, Carlsbad
CA) for 10 minutes at 70°C, loaded them into 4–12% Novex Bis-Tris
Protein Gels, and then ran them at 50 V for 15 minutes followed by 150
V for 60 minutes. We transferred the gel to a 0.2 µm nitrocellulose
membrane (Bio-Rad, Hercules CA) in transfer buffer (192 mM glycine,
25 nM Tris-base, 10% methanol) for 60 minutes at a constant current of
400 mA. We blocked the membranes for 60 minutes at room temperature
with 5% (w/v) bovine serum albumin (BSA; Sigma) in TBS with 0.05%
Tween-20 (0.05% TBST). We then stained the membranes overnight at
4°C with 1:1,000 anti-acetyllysine (#9441; Cell Signaling Technology,
Danvers MA), 1:1,000 anti-succinyllysine (PTM-401; PTM BioLabs,
Chicago IL), 1:1,000 anti-malonyllysine (PTM-901; PTM BioLabs), or
1:1,000 anti-glutaryllysine (PTM-1151; PTM BioLabs) diluted in
blocking buffer. We then washed the membranes and incubated them for
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60 minutes at room temperature with the appropriate secondary antibody
conjugated to either IRDye 800CW or IRDye 680LT (LI-COR, Lincoln
NE) diluted 1:5,000 in blocking buffer. We detected proteins and
analyzed the band densities with the Odyssey Infrared Imaging System
(LI-COR). We normalized protein loading per lane with the Pierce BCA
Protein Assay Kit (Thermo Fisher, Carlsbad CA) and used anti-COX IV
(4D11-B3-E8) antibody (#11967; Cell Signaling Technology) as the
loading control.
SIRT3 and SIRT5 activity assays. We measured the SIRT3 activity and

SIRT5 activity of mitochondrial isolates from 661W cells with
commercially available kits (Abcam, Milton Cambridge; Enzo Life
Sciences, Farmingdale NY; respectively) according to manufacturer’s
instructions. We did not add exogenous SIRT3/5 or NAD+ to the
reaction mixture to allow us to accurately quantify native deacylase
activity.
Statistics. We performed statistical testing with GraphPad Prism (Version

6.0), using the appropriate test for each data set. Prior to all data analysis,
we assessed the normality of the data graphically and with the
Kolmogorov-Smirnov test and, when necessary, used appropriate non-
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parametric alternatives. We defined statistical significance as a p-value <
0.05.
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Figure 3.1. Nampt−rod/−rod mice exhibit severe retinal degeneration.
(A) Rod-specific deletion of Nampt caused significant reduction in Nampt mRNA expression
from rod-enriched retinal isolates (n=7 isolates/group; Mann-Whitney U test). (B) Nampt−rod/−rod
retinas had lower NAD+ levels than those from NamptF/F mice (n=5–8 retinas/group; 2-tailed,
unpaired t-test). (C) Rod-enriched retinal isolates from Nampt−rod/−rod mice had lower NAD+ levels
than those from NamptF/F retinas (n=9–10 pooled samples/group; 1-tailed, unpaired t-test). (D)
Representative fundus images from Nampt−rod/−rod mice demonstrated severe signs of retinal
degeneration including vascular attenuation and optic nerve atrophy. (E) Representative retinal
sections from Nampt−rod/−rod mice at 6 weeks stained with hematoxylin & eosin showed
significantly reduced outer nuclear layer thickness (see arrows) with secondary retinal
degeneration. (F–H) Nampt−rod/−rod mice exhibited impaired retinal function on ERG (n=5
NamptF/F mice/10 Nampt−rod/−rod mice; 2-way mixed ANOVA with Bonferroni post-hoc test), and
reduced photopic visual acuity (I; n=5–6 mice/group; 2-tailed, unpaired t-test). Graphs depict
mean + S.E.M. (A–C, I) or mean ± S.E.M. (F–H) (* p < .05; ** p < .01; *** p < .001; # p <
.0001).
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Figure 3.2. Nampt−cone/−cone mice exhibit cone-specific degeneration.
(A) Cone-specific deletion of Nampt caused reduced intracellular NAMPT staining (red) in cone
photoreceptors stained with cone-arrestin (green) and the nuclear DAPI stain (blue). (B)
Representative fundus images from Nampt−cone/−cone mice demonstrated retinal pigment epithelial
cell mottling (arrows) and optic nerve atrophy (arrowhead) consistent with mild retinal
degeneration. (C–E) Nampt−cone/−cone mice also exhibited impaired retinal function on ERG (n=8–
10 mice/group; 2-way mixed ANOVA with Bonferroni post-hoc test) and reduced photopic visual
acuity (F; n=4 mice/group; Mann-Whitney U test). Graphs depict mean + S.E.M. (F) or mean ±
S.E.M. (C–E) (* p < .05; ** p < .01; # p < .0001).
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Figure 3.3. Exogenous NMN protects against retinal degeneration in mice lacking Nampt
and may have efficacy against diverse retinal degenerative diseases.
(A–C) Nampt−rod/−rod mice receiving daily intraperitoneal injections of 150 mg/kg NMN beginning
at P5 had improved retinal function on ERG (n=12 vehicle/5 NMN; 2-way mixed ANOVA with
Bonferroni post-hoc test) compared to vehicle-treated mice, consistent with relative preservation
of the outer nuclear layer on histology (D; see arrows). (E–G) Nampt−cone/−cone mice receiving
daily intraperitoneal injections of 150 mg/kg NMN beginning at P5 also had improved retinal
function on ERG (n=9 vehicle/5 NMN; 2-way mixed ANOVA with Bonferroni post-hoc test).
Retinal NAD+ deficiency is a feature of multiple mouse models of retinal dysfunction, including
light-induced degeneration (H; n=10–12/group; 2-tailed, unpaired t-test), streptozotocin-induced
diabetic retinopathy (I; n=5/group; 2-tailed, unpaired t-test), and age-associated retinal
dysfunction (J; n=5/group; 2-tailed, unpaired t-test). Graphs depict mean + S.E.M. (H–J) or mean
± S.E.M. (A–C, E–G) (* p < .05; ** p < .01; *** p < .001; # p < .0001).
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Figure 3.4. NAD+ deficiency disrupts retinal energy homeostasis and can be rescued with
exogenous NMN.
(A–C) Wild-type mice (129S1/SvImJ) receiving intraperitoneal injections of 300 mg/kg NMN
were more resilient against light exposure (n=8/group; 2-way mixed ANOVA with Bonferroni
post-hoc test) compared to vehicle-treated mice. (D) Representative electron microscopy images
of retinas from 4-week old Nampt−rod/−rod mice revealed mitochondria that are rounded,
disorganized, and with loss of cristae compared to NamptF/F mice. (E) Nampt−rod/−rod retinas also
exhibited significant disruption of numerous metabolic pathways on metabolite set enrichment
analysis. Graphs depict mean ± S.E.M. (A–C) (* p < .05).
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Figure 3.5. NAMPT inhibition causes metabolic dysfunction and photoreceptor death.
(A–B) NAMPT inhibition with 20 µM FK866 caused loss of reductive capacity in 661W cone
photoreceptor-like cells by 24 hours and 48 hours (n=15/group from three independent
experiments; 1-way ANOVA with Tukey post-hoc test). (C–D) This metabolic dysfunction
caused cell death by 48 hours (n=14/group from three independent experiments; 1-way ANOVA
with Tukey post-hoc test). The effects of NAMPT inhibition were rescued with 100 µM NMN
(A–B, D). (E) NAMPT inhibition with 20 µM FK866 led to a significant reduction in total NAD+
in photoreceptor cells by 6 hours, which was restored to near-normal levels with 100 µM NMN
(n=3/group; 1-way ANOVA with Tukey post-hoc test). (F) 24 hours of 20 µM FK866 treatment
led to undetectable levels of NAD+ (N.D. = not detected), which once again was restored with
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100 µM NMN (n=5–7/group). (G) NAMPT inhibition also caused ATP depletion but in a delayed
time frame relative to NAD+ depletion (n=4/group). (H–I) FK866-treated photoreceptor cells had
reduced oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) at baseline,
impaired ECAR acceleration after oligomycin treatment, and impaired OCR acceleration after
FCCP treatment (n=15–16/group from representative experiment; 2-way mixed ANOVA with
Bonferroni post-hoc test). 100 µM NMN restored normal metabolic responses (H–I). (J) NAD+dependent isocitrate dehydrogenase (NAD-IDH/IDH3) activity was reduced in rods isolated from
Nampt−rod/−rod mice compared to those isolated from NamptF/F mice, even when sufficient NAD+
was added to the reaction mixture (n=6/group from three independent experiments; 2-tailed,
unpaired t-test) and despite similar Idh3a expression levels (K; n=11–13/group from three
independent experiments; 2-tailed, unpaired t-test). (L–M) The activities of other NAD+dependent enzymes alpha-ketoglutarate dehydrogenase (AGDH; n=5/group from three
independent experiments; Mann-Whitney U test) and malate dehydrogenase (MDH; n=7/group
from three independent experiments; 2-tailed, unpaired t-test) in rods from Nampt−rod/−rod mice
were restored with exogenous NAD+. Graphs depict mean + S.E.M. (A–F, J–M) or mean ±
S.E.M. (G–I) (* p < .05; ** p < .01; *** p < .001; # p < .0001; red: vehicle versus FK; blue: FK
versus FK+NMN).
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Figure 3.6. SIRT3 and SIRT5 are essential for photoreceptor survival.
(A) Individual SIRT3 and SIRT5 knockdown but not SIRT4 knockdown caused significant loss
of reductive capacity relative to negative control (NC); combined SIRT3/SIRT5 knockdown
caused significantly more loss of reductive capacity than individual knockdowns, which could not
be rescued with NMN (n=6/group from representative experiment; 1-way ANOVA with Tukey
post-hoc test). (B) Individual SIRT3 and SIRT5 knockdown but not SIRT4 knockdown caused
significant cell death relative to negative control (NC); combined SIRT3/SIRT5 knockdown
caused significantly more cell death than individual knockdowns, which could not be rescued
with NMN (n=18/group from three independent experiments; 1-way ANOVA with Tukey posthoc test). (C) Individual and combined SIRT3/SIRT5 knockdowns recapitulated NAD-IDH
dysfunction compared to negative control (NC; n=3/group from three independent experiments;
1-way ANOVA with Tukey post- hoc test). (D–F) Mice lacking SIRT3 and SIRT5
(SIRT3KOSIRT5KO) were significantly more vulnerable to light-induced degeneration (LID)
compared to SIRT3hetSIRT5het mice, while SIRT3KOSIRT5het and SIRT3hetSIRT5KO mice
exhibited intermediate vulnerability to LID (n=5–7 mice/group; 2-way mixed ANOVA with
Bonferroni post-hoc test). Graphs depict mean + S.E.M. (A–C) or mean ± S.E.M. (D–F) (* p <
.05; ** p < .01; *** p < .001; # p < .0001; ^ p < .05 relative to both SIRT3KD and SIRT5KD; red:
SIRT3hetSIRT5het versus SIRT3KOSIRT5KO; brown: SIRT3KOSIRT5het versus SIRT3KOSIRT5KO;
grey: SIRT3hetSIRT5KO versus SIRT3KOSIRT5KO).
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Figure 3.7. NAD+ deficiency impairs mitochondrial sirtuin function.
(A–B) NAMPT inhibition caused selective mitochondrial protein hyperacetylation (n=4
biological replicates from two independent blots; 1-way ANOVA with Tukey post-hoc test). (C–
D) NAMPT inhibition caused only modest changes in mitochondrial protein succinylation (n=6
biological replicates from three independent blots; 1-way ANOVA with Tukey post-hoc test). (E)
NAD+ deficiency impaired SIRT3 activity (n=6/group; 2-tailed, unpaired t-test) but not SIRT5
activity (F; n=15–16/group; 2-tailed, unpaired t-test). Graphs depict mean + S.E.M. (B, D–F) (**
p < .01; *** p < .001).
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Figure S3.1. Nampt expression is essential for rod photoreceptor survival.
(A) Representative retinal sections at 2 weeks stained with hematoxylin & eosin showed
-rod/-rod
F/F
qualitatively normal retinal appearance in Nampt
mice compared to Nampt
mice.
Although single-allele, rod-specific deletion of Nampt caused significant reduction in Nampt
expression in rod-enriched retinal isolates (B; n=5-6 isolates/group; 2-tailed, unpaired t-test), this
+
decrease in Nampt expression did not cause a statistically significant decrease in retinal NAD
(C; n=6 retinas/group; 2-tailed, unpaired t-test) or retinal dysfunction as measured by ERG (D-F;
F/wt
- rod/wt
n=4 Nampt
/7 Nampt
mice; 2-way mixed ANOVA). Graphs depict mean + S.E.M.
(B-C) or mean ± S.E.M. (D-F) (*** p < .001).
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Figure S3.2. Exogenous NMN supplementation has no effect on the retinal function of
F/F
Nampt
mice; old mice have retinal dysfunction compared to young mice.
(A-C) Although daily intraperitoneal injections of 150 mg/kg NMN beginning at P5 rescued
-rod/-rod
-cone/-cone
vision in Nampt
and Nampt
mice, they had no effect on the retinal function
F/F
of Nampt
mice by ERG (n=8 vehicle/6 NMN; 2-way mixed ANOVA). (D-F) 18-month-old
wild- type mice had retinal dysfunction by ERG compared to 6-month-old controls (n=8 6mo/10
18mo; 2-way mixed ANOVA with Bonferroni post-hoc test). Graphs depict mean ± S.E.M. (A-F)
(* p < .05; ** p < .01; *** p < .001).
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-rod/-rod
Figure S3.3. Nampt
mice have progressive metabolic dysfunction.
-rod/-rod
(A) Representative electron microscopy images of retinas from 3-week-old Nampt
mice
exhibited qualitatively normal mitochondrial ultrastructure compared to images of retinas from 3F/F
- rod/-rod
F/F
week-old Nampt
mice. (B) By 4 weeks, Nampt
retinas but not Nampt
retinas had
profoundly dysmorphic photoreceptor inner segments with disruption of outer segments and (C)
contained an abundance of degenerative vacuoles, which appeared to contain degenerated
organelles including mitochondria with ruptured cristae. (D) Although not statistically significant,
-rod/-rod
LC-MS analysis revealed trends toward accumulation of some acylcarnitines in Nampt
retinas, which are suggestive of a defect in Krebs cycle efficiency. (E) GC-MS revealed
-rod/-rod
dysregulation of numerous metabolites with >1.10 fold-change between Nampt
retinas
F/F
and Nampt
retinas (corrected p-values < .05).
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Figure S3.4.. Retinal pigment epithelium (RPE) cells are more resilient to NAMPT
inhibition than photoreceptor cells.
(A-B) The reductive capacity of RPE cells was unaffected by NAMPT inhibition (FK866 at 20
µM) at 24 hours with a modest effect at 48 hours, which was rescued with 100 µM NMN
(n=10/group from two independent experiments; 1-way ANOVA with Tukey post-hoc test). (CD) NAMPT inhibition had no effect on RPE cell survival (n=10/group from two independent
+
experiments; 1-way ANOVA), although it did cause a reduction in total NAD levels (E;
n=5/group; 2-tailed, unpaired t-test) and a concomitant increase in total ATP levels (F;
n=5/group; 2-tailed, unpaired t-test). Graphs depict mean + S.E.M. (A-F) (** p < .01; *** p <
.001).
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Figure S3.5. Nampt knockdown (KD) in photoreceptor cells causes intermediate
metabolic dysfunction.
+
(A) Nampt knockdown caused significant reduction in total NAD levels (n=6/group; 2-tailed,
unpaired t-test) compared to transfection with negative control (NC) but did not affect reductive
capacity (B; n=12/group from two independent experiments; Mann-Whitney U test) or cell
survival (C; n=6/group; 2-tailed, unpaired t-test). (D-E) Although Nampt KD did not affect basal
oxygen consumption rate (OCR) or basal extracellular acidification rate (ECAR), it reduced the
maximal oxidative respiratory capacity, as manifested by the lower maximal OCR after FCCP
treatment (n=10/group from representative experiment; 2-way mixed ANOVA with Bonferroni
post-hoc test). Graphs depict mean + S.E.M. (A-C) or mean ± S.E.M. (D-E) (** p < .01; # p <
.0001).
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KO
KO
KO
KO
Figure S3.6.. SIRT3 , SIRT5 , and SIRT3 SIRT5
mice have normal retinal
function at baseline.
KO
(A) At 2-3 months, SIRT3
mice had a normal-appearing fundus compared to strain-matched
controls and normal retinal function by ERG (C-E; n=5 mice/group; 2-way mixed ANOVA). (B)
KO
At 2-3 months, SIRT5
mice also had a normal-appearing fundus compared to strain-matched
controls and normal retinal function by ERG (F-H; n=9-10 mice/group; 2-way mixed ANOVA).
KO
KO
(I-K) At 2-3 months, SIRT3 SIRT5
mice had normal retinal function by ERG compared to
KO
het
het
KO
het
het
SIRT3 SIRT5 , SIRT3 SIRT5 , and SIRT3 SIRT5
mice (n=3-6 mice/group; 2way mixed ANOVA). Graphs depict mean ± S.E.M. (C-K).
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Figure S3.7. NAMPT inhibition does not affect the malonylation and glutarylation
profile of mitochondrial proteins in photoreceptor cells. Malonylation
(A) and glutarylation (B) of mitochondrial proteins was unchanged in photoreceptor cells after
NAMPT inhibition (representative blots showing 2 biological replicates).
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Chapter 4:
Extracellular vesicle-mediated delivery of eNAMPT
delays aging and extends healthspan
This chapter is adapted from a manuscript submitted in Cell Metabolism:

Yoshida M, Satoh A, Lin JB, Mills KF, Rensing N, Wong M, Apte RS and Imai SI. Exosomemediated systemic delivery of eNAMPT delays aging and extends healthspan.

S.I. conceived and supervised the entire study. M.Y designed, performed, and supervised the
experiments and analyzed the data. A.S. and N.R performed sleep analysis. L.J.B. performed
electroretinography. M.Y. and S.I. wrote the manuscript.
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4.1 SUMMARY
Aging is a significant risk factor for impaired tissue functions and chronic diseases. Ageassociated decline in systemic NAD+ availability plays a critical role in regulating the aging
process across many species. Here we show that the circulating levels of extracellular
nicotinamide phosphoribosyltransferase (eNAMPT) significantly decline with age in mice and
humans. Increasing circulating eNAMPT levels in aged mice by adipose-tissue specific
overexpression of NAMPT increases NAD+ levels in multiple tissues including the
hypothalamus, pancreas, and retina, thereby enhancing their functions and extending healthspan
in females. Interestingly, eNAMPT is carried in exosomes through systemic circulation in both
mice and humans. Exosomal eNAMPT is internalized into cells and enhances NAD+
biosynthesis. Supplementing eNAMPT-containing exosomes isolated from young mice
improves wheel-running activity in aged mice. Our findings have revealed a novel exosomemediated delivery mechanism for eNAMPT, which promotes systemic NAD+ biosynthesis and
counteracts aging, suggesting a potential avenue for anti-aging intervention in humans.
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4.2

INTRODUCTION
In recent years, nicotinamide adenine dinucleotide (NAD+) metabolism has emerged as a
central topic in the field of aging and longevity research 1-4. It has now been established
that NAD+ availability declines over age at a systemic level, triggering a variety of ageassociated pathophysiological changes in diverse model organisms. In mammals, the
age-associated decline in NAD+ availability appears to be caused by two major events:
decreased NAD+ biosynthesis and increased NAD+ consumption 5,6. The former could be
caused by chronic inflammation with enhanced oxidative stress and/or increased
inflammatory cytokines, whereas the latter could be caused by increased DNA damages.
As a consequence, NAD+ levels decrease with age in multiple tissues, including adipose
tissue, skeletal muscle, liver, pancreas, skin, neurosensory retina, and brain 1-4,7. The
realization of such systemic NAD+ decline as a fundamental event for age-associated
pathophysiology has now provided a strong rationale to develop effective anti-aging
interventions using key NAD+ intermediates, such as nicotinamide mononucleotide
(NMN) and nicotinamide riboside (NR) 2,4. Indeed, many studies have already proven
the efficacy of NMN and NR to mitigate age-associated functional decline and treat ageassociated disease conditions in various mouse models 2,4.
In mammals, nicotinamide phosphoribosyltransferase (NAMPT) is the rate limiting
enzyme in a major NAD+ biosynthetic pathway, converting nicotinamide and 5’phosphoribosyl-pyrophosphate (PRPP) to NMN 8,9. Interestingly, there are two distinct
forms of NAMPT in mammals: intra- and extracellular NAMPT (iNAMPT and
eNAMPT, respectively) 10. Whereas the function of iNAMPT as a critical NAD+
biosynthetic enzyme has been fully established, the physiological relevance and function
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of eNAMPT has long been controversial. eNAMPT was previously identified as pre-B
cell colony-enhancing factor (PBEF) and insulin-mimetic visfatin, neither of which has
been reconfirmed to date 8,9,11-13. Additionally, eNAMPT was also reported to function as
a proinflammatory cytokine, although this particular function has not yet been confirmed
in loss- or gain-of-function Nampt mutants 14. We have previously demonstrated the
physiological relevance of eNAMPT in vivo by adipose tissue-specific genetic
manipulation of Nampt 15. Adipose tissue-specific Nampt knockout (ANKO) mice,
particularly females, show significant decreases in circulating eNAMPT levels.
Surprisingly, ANKO mice exhibit a significant reduction in NAD+ levels not only in
adipose tissue, but also in other remote tissues such as the hypothalamus 15. Subsequent
intensive investigations have revealed a novel function of eNAMPT that enhances NAD+,
SIRT1 activity, and neural activation in the hypothalamus in response to fasting. These
findings suggest the existence of a novel inter-tissue communication system between
adipose tissue and the hypothalamus, mediated by eNAMPT 5. However, how exactly
eNAMPT regulates hypothalamic NAD+ levels has remained elusive.
Because the hypothalamus has been suggested to function as a high-order control center
of aging in mammals 16-18, we hypothesized that eNAMPT secreted from adipose tissue
plays a critical role in affecting the process of aging and eventually lifespan. To address
this hypothesis, we generated adipose tissue-specific Nampt knock-in (ANKI) mice 15 and
characterized their aging phenotypes. Interestingly, aged ANKI mice maintained
youthful levels of circulating eNAMPT and increased NAD+ levels in multiple tissues
including the hypothalamus, pancreas, and retina, exhibiting significant improvement in
physical activity, sleep quality, glucose metabolism, and photoreceptor functions. With

135

these beneficial phenotypes against aging, ANKI mice, particularly females, showed a
significant extension of healthspan. Surprisingly, we found that eNAMPT was carried in
exosomes through blood circulation in mice and humans. Exosomal eNAMPT was
internalized into primary hypothalamic neurons and enhanced NAD+ biosynthesis
intracellularly. Injecting eNAMPT-containing exosomes purified from young mice was
able to enhance wheel-running activity in aged mice. There findings demonstrated a
novel inter-tissue communication mechanism driven by an exosome-mediated delivery of
eNAMPT. This exosomal eNAMPT-medited physiological system plays a critical role in
maintaining systemic NAD+ biosynthesis and counteracting age-associated physiological
decline, implying exosomal eNAMPT as a potential anti-aging biologic in humans.
4.3

RESULTS
Plasma eNAMPT levels decline with age in both mice and humans. Our previous
study has demonstrated that adipose NAMPT expression decreases with age 19.
Consistently, we found that the protein expression levels of iNAMPT in isolated
adipocytes decreased from 6 months to 18 months of age (Figure S4.1A). Given that
adipose tissue is a major source of circulating eNAMPT 15, we examined whether
circulating eNAMPT levels changed during aging in mice. As expected, plasma
eNAMPT levels significantly declined from 6 months to 18 months of age by 33% and
74% in both female and male mice, respectively (Figure 4.1A). Interestingly, plasma
eNAMPT levels appeared to show a trend of oscillatory patterns throughout a day in 6
month-old young mice (Figures 4.1B and S4.1B). Calculated plasma eNAMPT levels
were higher in young females (55-123 ng/µl) compared to those in males (29-52 ng/µl).
However, such a trend of oscillatory patterns became blunted in aged (18 month-old)
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mice, particularly in males (Figure 4.1B). The age-associated reduction in plasma
eNAMPT raised a possibility that plasma eNAMPT levels could be a valuable surrogate
biomarker for aging. Thus, we measured plasma eNAMPT levels across several different
age groups in mice and humans. We found that plasma eNAMPT levels linearly declined
with age in both mice and humans (Figure 4.1C), suggesting that the process underlying
eNAMPT secretion and its potential significance during aging might be conserved in both
species. To further evaluate the potential association between plasma eNAMPT levels
and aging, we asked whether the reduced levels of plasma eNAMPT could predict higher
mortality risks and remaining lifespans of mice in a small prospective study.
Intriguingly, the number of days for which an individual mouse lived since the day of
eNAMPT measurement was highly correlated with their plasma eNAMPT levels (Figure
4.1D). The higher the level of plasma eNAMPT went, the longer the remaining lifespan
became. These results led us to the interesting hypothesis that circulating eNAMPT
might play a critical role in regulating not only the process of aging and but also lifespan
in mammals.
Adipose-tissue specific overexpression of Nampt maintains plasma eNAMPT levels
and NAD+ biosynthesis in multiple tissues during aging. To investigate the role of
eNAMPT in aging and longevity control, we examined aging cohorts of adipose tissuespecific Nampt knock-in (ANKI) mice 15. At 4 months of age, plasma eNAMPT levels
did not differ between ANKI and control mice under an ad libitum-fed condition (Figure
4.2A). Young ANKI mice showed significantly higher levels of plasma eNAMPT only
in response to fasting 15. When they reached 24 months of age, plasma eNAMPT levels
were maintained at 3.3- and 3.6-fold higher levels in ANKI female and male mice,
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respectively, compared to those in the age-matched control mice (Figure 4.2B). Plasma
eNAMPT levels in 18 month-old ANKI mice were comparable to those in 6 month-old
control mice (Figure S4.2A). Adipose tissue Nampt overexpression was maintained
~1.5-fold higher in aged ANKI mice, compared to that in control mice, confirming that
Nampt overexpression was in the physiological range and suggesting that the ANKI
model is physiologically valid (data not shown).
Our previous study has demonstrated that eNAMPT enhances hypothalamic NAD+
biosynthesis in response to fasting 15. We also found that NAD+ levels increased in the
pancreas and retina, but not in liver, kidney, lung and skeletal muscle, in fasted 8-10
month-old ANKI mice (Figure S4.2B), indicating that in addition to the hypothalamus,
there are additional target tissues for eNAMPT. In ad libitum-fed 20 month-old ANKI
mice, increased NAD+ levels were also observed in the hypothalamus, hippocampus,
pancreas, and retina in females, whereas only pancreas and retina showed increased
NAD+ levels in males (Figures 4.2C and S4.2C). It should be noted that those tissues that
showed increased NAD+ levels in aged ANKI mice are the ones that have relatively very
low levels of iNAMPT 10,15,20. These results suggest that adipose tissue-specific
overexpression of Nampt mitigates age-dependent decline in circulating eNAMPT levels
and tissue NAD+ levels in multiple tissues including the hypothalamus, pancreas, and
retina.
Aged ANKI mice display significant enhancement in physical activity and sleep
quality. Given that hypothalamic NAD+ levels increased in aged ANKI female mice and
also that hypothalamic SIRT1 activity is critical to regulate physical activity and sleep
quality during aging 16,21, we examined these age-associated physiological traits in aged
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ANKI mice. Consistent with the reduction in circulating eNAMPT levels with age,
wheel-running activity during the dark time was significantly reduced in 18 month-old
wild-type mice, compared to that in 6 month-old wild-type mice (Figure S4.3A). ANKI
female mice at 4 months of age exhibited equivalent levels of wheel-running activity
during the dark time to those of age-matched control mice, whereas ANKI female mice at
18 months of age showed significantly enhanced wheel-running activity compared to that
in the age-matched control mice, similar to the activity levels in 6 month-old wild-type
mice (Figures 4.3A and S4.3A). Additionally, we evaluated locomotor activity in the
open field in these mice. Consistent with wheel-running activity during the dark time,
aged ANKI female mice showed significantly higher total ambulatory and rearing
activities, compared to the age-matched control mice (Figure 4.3B). However, aged
ANKI male mice failed to show any significant differences in total ambulatory and
rearing activities, compared to the age-matched control mice (Figure S4.3B), consistent
with the lack of NAD+ increase in the hypothalamus (Figure 4.2C).
In humans, it has been well documented that the number of sleep-wake transitions
increases over age, a phenomenon called sleep fragmentation 22. Consistent with such
changes in the older humans, 20 month-old wild-type mice also showed increased
numbers of transitions between non-REM (NREM) sleep and wake cycles, compared to
those in 4 month-old wild-type mice (Figure 4.3C, left panel), indicating that sleep
fragmentation significantly increases with age in mice. There were no differences in the
numbers of transitions between REM sleep and wake or NREM sleep cycles (data not
shown). Interestingly, compared to the age-matched control mice, aged ANKI mice
showed a significant reduction in the numbers of transitions between NREM sleep and
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wake cycles, which maintained levels similar to those seen in 4 month-old wild-type mice
(Figure 3C, right panel), implying that aged ANKI mice maintain a better quality of
sleep.
These age-associated activity and sleep traits are regulated by hypothalamic
SIRT1 through the regulation of its downstream target genes, Orexin type-2 receptor
(Ox2r) and PR domain 13 (Prdm13) 16,21. Ox2r expression is important for the control of
wheel-running activity during the dark time 16, whereas Prdm13 expression is critical for
the maintenance of sleep quality 21. Thus, we examined mRNA expression levels of
Ox2r and Prdm13 in the hypothalami of age-matched control and ANKI female mice.
Consistent with the observed enhancement of physical activity and sleep quality,
hypothalamic Ox2r and Prdm13 expression levels were significantly increased in aged
ANKI female mice, compared to those in age-matched control mice (Figure 4.3D).
These results indicate that an age-associated decline in circulating eNAMPT levels
contributes to the reduction in hypothalamic NAD+ levels and SIRT1 activity, resulting in
the age-associated decline in physical activity and sleep quality, and that these functional
reductions can be ameliorated by increasing circulating eNAMPT.
Aged ANKI mice show significant improvement in glucose tolerance, insulin
secretion, and photoreceptor function. Because pancreatic and retinal NAD+ levels
were increased in aged ANKI mice (Figure 4.2C), we suspected that aged ANKI mice
might also exhibit improvements in glucose metabolism and retinal function. We first
performed intraperitoneal glucose tolerance tests (IPGTTs) in aged ANKI and control
mice. We observed a moderate but significant improvement in glucose tolerance in aged
ANKI male mice (Figure 4.4A). During IPGTTs, we also detected a significant increase
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in glucose-stimulated insulin secretion at the 30-min time point (Figure 4.4B). The
results from insulin tolerance tests did not differ between aged ANKI and control mice,
both showing severe insulin resistance (Figure S4.4A), suggesting that improved glucose
tolerance in aged ANKI mice is mainly due to increased insulin secretion. These results
are consistent with the role of NAD+ biosynthesis and SIRT1 in promoting glucosestimulated insulin secretion in pancreatic β cells 10,23,24 and further support the notion that
eNAMPT plays an important role in the maintenance of tissue functions through the
enhancement of NAD+ biosynthesis at a systemic level. Aged ANKI female mice did not
show any improvement in glucose tolerance (data not shown), consistent with a much
larger variability in pancreatic NAD+ levels (Figure 4.2C). Aged ANKI female mice
showed moderate increases in body weight and fat mass, whereas aged ANKI male mice
showed no difference (Figures 4.4C and S4.4B), suggesting that the observed phenotypes
in glucose metabolism are unrelated to body weight or adiposity.
We next conducted electroretinography to examine retinal function under rod- and
cone-dominated testing conditions. We found that, compared to age-matched control
mice, aged ANKI mice showed significantly higher scotopic a-wave amplitudes at 5 db
and a trend toward higher scotopic a-wave amplitude at -4 and 0 db. (Figure 4.4D, upper
left panel), indicating improved rod photoreceptor function. Similarly, improvement in
rod photoreceptor function also led to trends towards enhanced scotopic b-waves (Figure
4.4D, upper right). We also observed trends toward enhanced photopic b-waves
amplitudes in aged ANKI mice, which suggest enhanced cone function (Figure 4.4D
lower left panels). Of interest, these changes are remarkably similar to those observed in
the long-term NMN administration 25. These findings provide further support to the
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physiological significance of eNAMPT in the maintenance of tissue functions, such as
the hypothalamus, pancreas, and retina, during aging by enhancing systemic NAD+
biosynthesis.
ANKI female mice exhibit significant extension of median lifespan and delay in
aging. Because maintaining higher eNAMPT levels significantly mitigates ageassociated functional decline in aged ANKI mice, we set up cohorts of ANKI and control
mice to examine their lifespan. When fed regular chow ad libitum, ANKI female mice
showed statistically significant extension (14.3%) for median lifespan (control 693 days
versus ANKI 792 days, Wilcoxon test, χ2=7.94, df=1, p=0.0052) (Figures 4.5A and
4.5B). Their maximal lifespan did not differ from that of control mice (Figure 4.5B).
Interestingly, ANKI female mice exhibited significant delays in age-associated mortality
up to ~2 years of age (Figure 4.5C). However, towards the end of their lifespan, the
difference in age-associated mortality was no longer present, which could explain the
lack of maximal lifespan extension. Although neoplasms are a major cause of death, the
incidence and the type of neoplasms did not differ between ANKI and control mice
(Figure 4.5D). In contrast to females, ANKI male mice exhibited no lifespan extension
(Figures 4.5A and 4.5B) and no difference in age-associated mortality rate throughout the
majority of their lifespan (Figure 4.5C). These results demonstrate that maintaining
youthful levels of circulating eNAMPT is critical to delay aging and extend healthspan in
mice, although there is a significant sex difference.
Plasma eNAMPT is localized exclusively to exosomes. How circulating eNAMPT
enhances tissue NAD+ biosynthesis has so far remained elusive. Our finding that
eNAMPT enhances NAD+ biosynthesis in a tissue-specific manner suggested a
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possibility that circulating eNAMPT could directly contribute to NAD+ biosynthesis in its
target tissues. In recent years, a transport mechanism of mircoRNA by exosomes from
one tissue to another has drawn much attention as an important mechanism of inter-tissue
communications 18,26,27. Thus, we asked whether eNAMPT could also be transported by
exosomes in systemic circulation. Surprisingly, eNAMPT was highly enriched in the
exosome fraction, compared to whole plasma or the remaining non-exosomal fraction,
when the same amounts of proteins were loaded (Figure 4.6A). The exosomal
localization of eNAMPT was also confirmed by the enrichment of exosomal markers
CD63 and TSG101. When the whole plasma, exosome fraction, and the remaining nonexosomal fraction were loaded after adjusting them to an equal volume, nearly 100% of
circulating eNAMPT was detected in the exosome fraction, indicating that, under a
normal physiological condition, eNAMPT exist almost exclusively as an exosomeassociated form (Figure 4.6B). We also examined whether eNAMPT in human plasma
was contained in exosomes. Consistent with mouse plasma eNAMPT, human plasma
eNAMPT was also mainly contained in the exosomal fraction (Figure 4.6B). The
localization of eNAMPT in the exosome fraction was further confirmed with an
independent method using ultracetrifugation (Figure 4.6C). The enrichment of exosomes
from mouse and human plasma was also confirmed by electron microscopy (Figures
S4.6A and B). We found that the eNAMPT content in exosomes dramatically decreased
from 6 month- to 22 month-old mice (Figure 4.6D). We also confirmed that the
exosomal eNAMPT content in 24 month-old ANKI mice was significantly higher than
that in age-matched control mice (Figure 4.6E). Because our attempt at immunogold
labeling for exosomal eNAMPT failed due to the unavailability of an appropriate
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antibody for this purpose, we examined whether eNAMPT in the plasma is protected
from the protease treatment due to its localization within the exosome. Whereas the
treatment of plasma with proteinase K nearly completely digested circulating plasma
proteins such as transferrin, the levels of eNAMPT remained unchanged (Figure 4.6F).
Furthermore, upon adding a detergent (Triton-X) to dissolve the exosomal lipid bilayer,
the proteinase K treatment was able to eliminate eNAMPT. These findings confirmed
that eNAMPT secreted into blood circulation was encapsulated into the exosome. Taken
together, our results provide compelling evidence that eNAMPT in mouse and human
circulation is carried by exosomes and also that changes in plasma eNAMPT levels
observed during aging or in ANKI mice are due to the changes in the levels of exosomal
eNAMPT.
Exosomal eNAMPT is internalized into cells and directly enhances NAD+
biosynthesis. Having demonstrated eNAMPT localization within exosomes, we next
examined whether exosomal eNAMPT could be internalized into cells and enhance
NAD+ biosynthesis intracellularly. We first labeled isolated exosomes with the BODIPY
TR Ceramide, a red-fluorescent dye that can label lipid bilayers of exosomes, and then
incubated primary hypothalamic neurons with these BODIPY-labeled exosomes.
Primary hypothalamic neurons were labeled only when adding BODIPY-labeled
exosomes, but not when adding control BODYPI-treated media, suggesting that
exosomes were incorporated into primary hypothalamic neurons (Figure 4.7A). Next, we
added bacterially produced FLAG-tagged recombinant NAMPT alone or FLAG-tagged
recombinant NAMPT encapsulated into exosomes to primary hypothalamic neurons.
Interestingly, only exosomal FLAG-tagged NAMPT was internalized into the
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cytoplasmic fraction of primary hypothalamic neurons (Figure 4.7B). We also confirmed
the very high efficiency of the exosome-mediated eNAMPT delivery, compared to
recombinant NAMPT alone (50 µg added to the culture), in HEK293 cells (Figure
S4.7A). When incorporating FLAG-tagged recombinant NAMPT into purified
exosomes, these exosomes with an additional amount of NAMPT were able to increase
intracellular NAD+ levels in primary hypothalamic neurons (Figure 4.7B, right panel).
The internalization of exosomal eNAMPT into the cytoplasm of primary hypothalamic
neurons was also examined by using mouse plasma and isolated exosomes from 6 monthand 18 month-old mice (Figures 4.7C and D). The amounts of internalized NAMPT in
the cytoplasm mirrored the amounts of eNAMPT contained in original plasma or isolated
exosomes, indicating that exosomes from young mice can deliver higher amounts of
eNAMPT into cells, compared to those from old mice.
We next asked whether this internalized eNAMPT protein can enhance NAD+
biosynthesis in primary hypothalamic neurons. Intracellular NAD+ levels in primary
hypothalamic neurons were higher when incubated with exosomes purified from 6
month-old mice, compared to those purified from 20-22 month-old mice (Figure 4.7E,
left panel). Increments in intracellular NAD+ levels caused by exosomal eNAMPT were
significantly higher with exosomes from 6 month-old mice compared to those from 20-22
month-old mice (Figure 4.7E, right panel). Exosomes from ANKI male and female mice
were also able to increase intracellular NAD+ levels in primary hypothalamic neurons,
compared to those from age-matched control mice (Figure 4.7F). These results suggest
that exosomal eNAMPT, which is internalized into target cells, can contribute to the
enhancement of NAD+ biosynthesis within its target cells.
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Supplementation with exosomal eNAMPT enhances physical activity in aged mice.
Given that exosomal eNAMPT from ANKI mice was able to enhance intracellular NAD+
levels in primary hypothalamic neurons (Figure 4.7F), we reasoned that supplementation
with eNAMPT-containing exosomes could convey similar anti-aging effects on aged
wild-type mice, as observed in ANKI mice. To test this possibility, we injected
exosomes isolated from 4-6 month-old mice intraperitoneally into 20 month-old wildtype female mice for 4 consecutive days. Remarkably, supplementation with exosomal
eNAMPT significantly enhanced wheel-running activity levels during the dark time,
compared to PBS-injected control mice (Figure 4.7G). Importantly, a mild enhancement
of wheel-running activity was also observed in aged male mice (Figure S4.7B),
suggesting that male mice can also respond to high levels of exosomal eNAMPT
supplementation. Taken together, these findings indicate that supplementation with
exosomal eNAMPT is an effective anti-aging intervention to mitigate age-associated
functional decline in mice.
4.4

DISCUSSION
Our present study has demonstrated that exosome-mediated systemic delivery of
eNAMPT mitigates age-associated functional decline in specific target tissues including
the hypothalamus, pancreas, and retina, delays age-associated mortality rate, and extends
healthspan in mice. The surprising finding in this study is that exosomal eNAMPT is
internalized into target cells and enhances NAD+ biosynthesis intracellularly, whereas the
NAMPT protein alone cannot be internalized by itself. This provides a critical resolution
for a long-standing debate on the physiological importance and function of eNAMPT in
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mammals. Whereas eNAMPT can function as a systemic NAD+ biosynthetic enzyme
and enhance NAD+, SIRT1 activity, and neural activation in the hypothalamus 10,15,
eNAMPT has also been reported to function as a proinflammatory cytokine 14. Given
that eNAMPT in circulation is almost exclusively contained in exosomes under
physiological conditions and also that only exsosomal eNAMPT is properly internalized
into the cytoplasmic fraction of cells, we conclude that the physiological relevance and
function of eNAMPT is to maintain NAD+ biosynthesis systemically, particularly in the
tissues that have relatively low levels of iNAMPT, such as the hypothalamus, pancreas,
and retina. Although the precise mechanism by which eNAMPT-containing exosomes
are targeted specifically to those tissues needs to be elucidated, this exosome-mediated
systemic delivery of eNAMPT is a novel inter-tissue communication mechanism that
maintains NAD+ homeostasis throughout the body and modulates the process of aging
and healthspan in mammals.
Systemic decline in NAMPT-mediated NAD+ biosynthesis limits tissue functions
during aging. In mammals, NAMPT is the rate-limiting enzyme in a major NAD+
biosynthetic pathway starting from nicotinamide, a form of vitamin B3. It has now been
well established that systemic NAD+ availability declines dramatically over age, and that
age-associated reduction in iNAMPT levels contributes to limiting NAD+ availability in
many tissues 4. We now show that circulating eNAMPT levels also decline with age in
mice and humans, limiting NAD+ availability in specific tissues that rely on exosomal
eNAMPT-mediated NAD+ biosynthesis. Adipose tissue-specific overexpression of
Nampt maintains circulating eNAMPT levels, resulting in significant enhancement in
physical activity, sleep quality, glucose-stimulated insulin secretion, and retinal
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photoreceptor function. These remarkable anti-aging effects of eNAMPT also contribute
to the extension of median lifespan in mice. In aged ANKI mice, we did not observe any
significant adverse effects of eNAMPT, arguing against the proposed primary function of
eNAMPT as a proinflammatory cytokine.
Because circulating eNAMPT levels decline with age, an individual’s capacity to
sustain high levels of circulating eNAMPT must be important to maintain functional
homeostasis of tissues over time, which likely determines a healthspan of each individual.
The results from our small prospective study provides compelling support for this notion,
showing a significant correlation between circulating eNAMPT levels and the remaining
lifespan. Given that eNAMPT secretion from adipose tissue is regulated in a
NAD+/SIRT1-dependent manner 15, the reservoir and/or the turnover of adipose NAD+
could be a critical determinant for circulating eNAMPT levels and thereby lifespan.
Interestingly, it has been reported that the effect of lifespan extension by diet restriction
correlates inversely with fat reduction measured at mid-life and later ages, suggesting that
certain factors associated with fat are important for survival and lifespan extension under
diet restriction 28. Based on our results, it would be of great interest to examine whether
eNAMPT secreted from adipose tissue is a significant contributor to the delayed aging
and lifespan-extending effects of diet restriction.
Genetic supplementation of eNAMPT delays aging and extends healthspan in mice.
Aged ANKI mice show remarkable enhancement of NAD+ levels and tissue functions in
the hypothalamus, pancreas, and retina. We have previously demonstrated that NAD+
and NAD+-dependent sirtuins play important roles in regulating these tissue functions. In
the hypothalamus, particularly in the dorsomedial and lateral hypothalamic nuclei (DMH
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and LH, respectively), NAD+/SIRT1 signaling is critical in controlling the process of
aging and determining lifespan 16. In pancreatic β cells, NAD+ and SIRT1 are critical to
regulate glucose-stimulated insulin secretion 10,23. In the retina, NAD+ and mitochondrial
sirtuins SIRT3/5 are essential for the survival and function of rod and cone photoreceptor
neurons 25,29. These three tissues most likely represent a group of tissues that are the
most vulnerable to NAD+ decline. There may be other tissues to which eNAMPT are
also targeted to maintain adequate NAD+ biosynthesis. Considering that adipose tissue is
a major source of circulating eNAMPT 15, it will be important to further elucidate intertissue communications between adipose tissue and other tissues through exosomemediated eNAMPT delivery.
Interestingly, phenotypes of aged ANKI mice overlap with those of aged
BRASTO mice 16. Particularly, the enhancement of physical activity and sleep quality
are observed in both aged ANKI and BRASTO mice. Consistent with these phenotypes,
the hypothalamic expression levels of Ox2r and Prdm13, two SIRT1 target genes
responsible for those phenotypes 16,21, are significantly increased in both mouse models.
Nonetheless, whereas BRASTO mice exhibit both median and maximal lifespan
extension, ANKI mice show only median lifespan extension. This discrepancy between
BRASTO and ANKI mice suggests an interesting possibility that the level of SIRT1 in
hypothalamic neurons determines a maximal level of their function and thereby limits
maximal lifespan, whereas the level of circulating eNAMPT modulates the range of
hypothalamic neuronal function and thereby changes median lifespan or healthspan
accordingly.
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One important remaining question is about sex-dependent differences in
circulating eNAMPT levels and the effects of eNAMPT on tissue NAD+ levels and
functions. For example, whereas ANKI female mice show significant median lifespan
extension compared to control mice, ANKI male mice show equivalent lifespan curves to
control male mice. Such phenotypic preferences to females have also been observed in
Nampt+/- heterozygous mice 10, BRASTO mice 16, and adipose tissue-specific Nampt
knockout (ANKO) mice 15. Therefore, female mice might have higher sensitivity to
changes in eNAMPT and/or NAD+ levels. Further investigation will be necessary to
elucidate the molecular mechanisms of these sex-specific phenotypes.
Exosome-mediated systemic delivery of eNAMPT is a novel inter-tissue
communication mechanism that controls aging and healthspan in mice. In recent
years, many studies have reported an important role of exosomes as a new inter-cellular
or inter-tissue communication tool for transporting proteins and microRNAs 18,26,27.
Indeed, it has recently been demonstrated that adipose tissue is a major source of
circulating exosomal microRNAs that regulate gene expression in distant tissues 30. In
this regard, it is intriguing that eNAMPT in blood circulation is contained almost
exclusively in exosomes. In adipose tissue, SIRT1-dependent deacetylation of lysine 53
on iNAMPT predisposes the protein to secretion 15, implicating that this deacetylation
might be involved in the process of incorporating the NAMPT protein into exosomes.
However, how eNAMPT-containing exosomes are targeted specifically to certain tissues,
such as the hypothalamus, pancreas, and retina, remains unknown. This exosomemediated delivery is critical for eNAMPT to be properly internalized into cells and
enhance NAD+ biosynthesis intracellularly. When giving the eNAMPT protein alone, the
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protein is not internalized properly. Thus, it will be of great importance to understand the
mechanism by which eNAMPT-containing exosomes are delivered and internalized to
specific tissues.
Interestingly, eNAMPT-containing exosomes are transferable from one individual
to another. In particular, our finding that supplementing eNAMPT-containing exosomes
purified from young mice significantly enhances the wheel-running activity of aged mice
opens a new possibility that exosomal eNAMPT could be used as an anti-aging biologic.
Given that significant amounts of eNAMPT are contained in circulating exosomes, it
would be of great interest to further investigate the importance of exosomal eNAMPT in
other biological models, such as heterochronic parabiosis and plasma transfusion. In
human blood, eNAMPT is also contained exclusively in exosomes. Thus, it will be of
great importance to evaluate a possible connection between exosomal eNAMPT levels
and the vulnerability to age-associated diseases and also whether exosomal eNAMPT
supplementation could convey anti-aging effects in humans.
4.5

Conclusion
Our present study demonstrates the importance of a novel exosome-mediated inter-tissue
communication mechanism that delivers eNAMPT, a key NAD+ biosynthetic enzyme, to
specific tissues in controlling the process of aging and determining healthspan in mice.
Age-associated decline in the levels of circulating exosomal eNAMPT limits NAD+
availability and tissue functions in these target tissues, including the hypothalamus,
pancreas, and retina. Supplementing exosomal eNAMPT to aged mice genetically or
pharmacologically mitigates age-associated physiological decline during aging. These
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findings open a new possibility to use the exosome-mediated systemic delivery of
eNAMPT as a biologic for an effective anti-aging intervention.
4.6

Experimental Model and Subject Details
Animal Models. All mouse experiments and procedures were approved by the
Institutional Animal Care and Use Committee (IACUC) at Washington University in
St.Louis were in accordance with NIH guidelines. C57BL/6 mice were obtained from
NIH aged rodent colony or bred in our laboratory with mice purchased from Jackson
Laboratories. Young (4-6 months old) and aged (18-26 months old) mice used in each
experiments were age- and source-matched. Cre-inducible STOP-Nampt mice and
adiponectin-Cre mice were generously provided by Joseph Baur at University of
Pennsylvania and Evan Rosen at Beth Israel Deaconess Medical Center, respectively. All
lines were backcrossed to the C57BL/6J background. For the entire study, heterozygous
ANKI mice were generated by crossing heterozygous Adiponectin-Cre mice and
homozygous STOP-Nampt mice. All mice were fed ad libitum and housed in a group of
4-5 unless noted otherwise.
Human subjects. Human plasma samples used for eNAMPT quantification was obtained
from male subjects at Washington University in St. Louis. The protocol for obtaining
plasma and its use in research was reviewed and approved by the Human Research
Protection Office of Washington University in St. Louis. Signed informed consent were
obtained from all human subjects prior to blood collection.
Cell Culture. HEK293 cell lines were obtained from ATCC (Manassas, VA) and were
maintained in DMEM from Sigma Aldrich (St. Louis, MO) supplemented with 10% FBS
and antibiotics. All cells were maintained at 37C° and 5% CO2.
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Method Details
Lifespan analysis. All animals were kept in our animal facility with unlimited access to
standard laboratory diet and water. Mice set aside for longevity study were not used for
any other biochemical, physiological, or metabolic tests. All mice in the aging cohort
were carefully inspected daily. The endpoint of life was determined when each mouse
was either found dead or euthanized according to our IACUC guidelines. Necropsy was
conducted immediately following the death or euthanasia by Washington University
Mouse Pathology Core. Age associated mortality rate (qx) was estimated by the number
of animals alive at the end of each interval over the number of animals at the beginning
of the interval. The hazard rate (hz) was estimated by hz = 2qx/(2-qx) and natural
logarithm of hz was plotted against time.
Physical activity. Assessment of locomotor activity was performed at the Washington
University Animal Behavior Core. Briefly, individual mice were placed into a transparent
polystyrene container surrounded by pairs of 4x8 matrix of photocells which quantified
total number of ambulation. Another sets of photocells were located 7cm above the floor
to quantify vertical rearing motion. Assessment of wheel running activity was performed
by placing mice in individual cages with a running wheel and housed in circadian
cabinetry under 12:12 light-dark cycle. Mice were habituated for 2 weeks before wheel
running activity was recorded and analyzed.
Sleep analysis. Mice are anesthetized with isofluorane and surgically implanted with
screw electrodes in the skull for electroencephalography (EEG) and platinum wire
electrodes in the nuchal muscle for electromyography (EMG). Mice recovered from
surgery for 3 days and were subsequently habituated in the recording cage for 2 weeks.
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EEG/EMG recording was performed continuously for 2 consecutive days. 10 second
epochs of EEG/EMG signals were visually scored as wake [low amplitude delta (1-4Hz)
and theta (4-8Hz) frequency with high EMG activity], NREM sleep [high amplitude delta
in the absence of EMG activity], and REM sleep [low amplitude rhythmic theta activity
in the absence of EMG activity]. Scorer was blinded for genotypes during quantification.
Metabolic assessment (IPGTT, ITT, echoMRI). For glucose tolerance tests, mice were
intraperitoneally injected with one dose of dextrose (1g/kg body weight) after overnight
fasting in aspen bedding. Blood was collected from the tail vein at each time point for the
measurement of blood glucose and insulin levels. For insulin tolerance tests, mice were
intraperitoneally injected with insulin (0.70 units/kg body weight) and blood was
collected from tail vein for the measurement of blood glucose. Quantification of plasma
insulin levels was performed using Singulex assay at the Core Laboratory for Clinical
Studies at Washington University. EchoMRI was performed at the Diabetes Models
Phenotyping Core of Diabetes Research Center at Washington University.
Electroretinography. Mice anesthetized by ketamine-xylazine mix were subjected to
ERG using UTAS-E3000 Visual Electrodiagnostic System. Quantitation of ERG
waveforms were performed using an existing Microsoft Excel macro that defines a-wave
amplitude as the difference between the average baseline and the most negative point of
the average trace and defines b-wave amplitude as the difference between the most
negative point to the highest positive point of the wave peak.
Small cohort prospective lifespan analysis. Female C57BL/6 mice at 26-28 months old
were obtained from the NIA aging colony. Plasma was collected from the tail vein blood
to quantify eNAMPT levels. Subsequently the mice were housed in groups of 4 mice per
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cage and untouched except for daily inspection. Number of days from the blood
collection to the death was calculated as a remaining lifespan.
Western blot analysis of eNAMPT. Plasma was collected from the tail vein by capillary
or cardiac puncture with syringe pre-treated with heparin sulfate under ketamine-xylazine
anesthetization. Blood was span down at 3000g. 0.5ul of freshly collected plasma was
incubated with 50ul of 1x sample buffer at 95C for 10min before being stored at -30C
until its use. Right before the analysis, 5ul of the samples were added to 45ul of 1x
sample buffer and further incubated at 95C for 30min. 10ul of final mixture was
separated on 4-15% SDS-PAGE and analyzed by western blotting with anti-NAMPT
polyclonal antibody (Bethyl) for mice and anti-NAMPT monoclonal antibody
(Adipogen) for human.
Gene expression analysis. RNA was extracted by RNeasy Mini Kit (QIAGEN) and
converted to cDNA by High-Capacity cDNA Reverse Transcription Kit (Thermo).
Quantitative real-time RT-PCR was conducted and relative expression levels were
calculated for each gene by normalizing to Gapdh levels and then to the average of the
control mice.
Exosome purification and characterization. Exosomes used in this study were isolated
using the Total Exosome Isolation Kit From Plasma (Thermo Fisher) according to the
manufacturer’s instruction unless noted otherwise. Exosomes were resuspended in the
same volume of PBS as the volume of plasma used to isolate exosomes unless noted
otherwise. The supernatant was collected as the soluble protein fraction. The proper
isolation of exosomes was confirmed by measuring the levels of exosome-specific
markers using antibody against TSG101 (Santa Cruz Biotechnology) and CD63 (Santa
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Cruz Biotechnology). 40ug of protein from total plasma, isolated exosome fraction and
remaining soluble protein were loaded to a SDS-PAGE gel and evaluated by western blot
for detectign TSG101 and CD63. For the isolation of exosomes by ultracentrifugation,
plasma was diluted in PBS and ultracentrifuged at 110,000xg for 3 hours at 4C. The
pettelet was washed with cold PBS and resuspended in the same volume of PBS as the
volume of the plasma used in the beginning. The supernatant was collected as the soluble
protein fraction.
Proteinase K digestion assay. Proteinase K was added to 50ul of Plasma at the final
concentration of 1µg/µl and incubated at 37C for 10min. Subsequently, 25ul of PBS and
15ul of Exosome Precipitation Agent were added and the mixture was incubated on ice
for 30min. The mixture was centrifuged at 1000xg and the precipitated exosomes were
analyzed by western blot.
Isolation of primary hypothalamic neurons. Hypothalami from E16-E18 embryo were
dissected and placed on ice in HibernateE medium. Hypothalami were digested in 0.25%
trypsin-EDTA (Sigma) supplemented with DNaseI (Sigma) at 37C for 15min. After equal
volume of DMEM supplemented with 10% FBS was added, cells were gently dissociated
by pipetting until no clumps remains. Cells were collected by centrifuging at 450xg for
5min at room temperature. Cells were washed and resuspended in Neurobasal media
containing 10% FBS, 2% B27, 2M L-glutamine, and antibiotics. Cells were plated onto
wells directly or onto coveslips pre-coated with poly-l-lysine (Sigma). Two days after
the isolation, cells were treated with 10uM Ara-C (Sigma) for at least 4 days or until nonneural cells are eliminated.
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Exosome internalization assay. Isolated exosomes were resuspended in Opti-MEM.
BODIPY TR ceramide in DMSO was added to exosome or pure Opti-MEM at the final
concentration of 100uM and incubated at 37C for 1 hour. Excess unicorporated dye from
the labeled exosomes was removed by Exosome Spin Column following manufacturer’s
instructions. Purified exosome or Opti-MEM solution was added directly to primary
hypothalamic neurons growing on coverslips and incubated for 30 minutes. Following
incubation, cells were washed in PBS and fixed in 4% performaldehyde
Generation of exosomal recombinant NAMPT and internalization assay. Isolated
exosomes were resuspended in 1µg/ul His and 3xFlag-tagged recombinant NAMPTs and
incubated overnight at 37C. Exosomal recombinant NAMPT was isolated from the
solution by the addition of 0.2 volume of Exosome Precipitation Reagent. Exosomal
recombinant NAMPT was reconstituted into the same volume of PBS as the starting
plasma
In vivo rescue by exosome injection. For exosome injection experiment, 20 months old
male and female mice were habituated by 6 days of mock injection. For pre-treatment
measurement of physical activity, mice were intraperitoneally injected with 100ul of PBS
for 4 days. Subsequently, the same mice were injected with 100µl of resuspended
exosomes collected from 200µl and resuspended in PBS. Every injection was performed
approximately at 5:30PM.
Quantification and statistical analysis
Data analysis. Results are presented as mean ± SEM. All statistical tests were performed
using GraphPad prism 5. Significance between two groups was measured by Student’s ttest. The comparisons between two groups or more were carried out using one-way
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ANOVA with Tukey post-hoc test. Analysis of plasma eNAMPT levels over 24 hours
between 6 and 18 month old mice was performed using two-way ANOVA. Linear
regression analysis was used to analyze plasma eNAMPT level of mice and humans
across different age groups. Comparison of locomotor and wheel running activity was
analyzed by Wilcoxon matched-pairs singled-ranked test was used. ERG signal was
analyzed by two-way ANOVA with Bonferroni post-hoc test. Cehan-Breslow-Wilcoxon
test was used for the statistical analysis of lifespan. Fisher’s exact test was used to
compare the proportion of the cause of death. Statistical comparison of physical activity
at pre-treatment and post-treatment in exosome injection experiment was performed by a
paired t test. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. Significance was
concluded at p < 0.05.
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Figure 4.1. Plasma eNAMPT levels are reduced with age in both mice and humans and predicts
remaining lifespans of individual mice.
(A) Plasma eNAMPT levels of female and male mice at 6 and 18 months of age (n=5).
(B) Plasma eNAMPT concentrations of female and male mice at 6 and 18 months of age over a 24-hr
period (n=5 per time point per age).
(C) Plasma eNAMPT levels of mice and humans across different age groups (n=9 for mice; n=13 for
humans).
(D) Relationship of plasma eNAMPT levels and the remaining lifespans of individual mice (n=8).
eNAMPT levels were measured at 26-28 months of age.
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Figure 4.2. Adipose tissue-specific overexpression of Nampt maintains higher plasma eNAMPT
levels and NAD+ biosynthesis in multiple tissues during aging.
(A) Plasma eNAMPT levels of control (CTRL) and ANKI mice at 4 months of age (n=3-4 per
group).
(B) Plasma eNAMPT levels of control and ANKI mice at 24 months of age (n=3-4 per group).
(C) Tissue NAD+ levels of control and ANKI mice at 20 months of age (n=3 per group).

163

A

18M

4M

B

D

C

Figure 4.3. Aged ANKI mice display significant enhancement of physical activity and sleep
quality.
(A) Wheel-running activity of control (CTRL) and ANKI female mice at 4 and 18 months of age (4month old, n=3; 18-month old, n=10-13 per group).
(B) Total ambulatory (upper panel) and rearing (lower panel) activities of control and ANKI female mice
at 18 months of age (n=4-5 per group).
(C) The levels of sleep fragmentation in 4- and 20-month old mice (n=6 per group) and control and ANKI
mice at 20 months of age (n=5-6 per group). The numbers of transitions between NREM sleep (NR) and
wake (W) cycles are shown.
(D) mRNA expression levels of Ox2r and Prdm13 in the hypothalamic of control and ANKI female mice
at 20 months of age (n=3-6).
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Figure 4.4. Aged ANKI mice show significant improvement in glucose tolerance, insulin
secretion, and photoreceptor function.
(A, B) Blood glucose (n=8-13) (A) and insulin concentration (n=8-9) (B) during the IPGTTs in control
(CTRL) and ANKI male mice at 17-20 months of age.
(C) Body weights of control and ANKI female and male mice at the age of 18-20 months of age (male,
n=20-36; female, n=19-23).
(D) Scotopic a, scotopic b, and photopic b waves from ERG analysis of ANKI and control mice at 18-20
months of age (n=6-7).
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Figure 4.5. Female ANKI mice exhibit significant extension of median lifespan and delay in
aging.
(A) Kaplan-Meier curves of female and male ANKI mice (females, control 40, ANKI 39; males, control
39, ANKI 39).
(B) Lifespan parameters of control and ANKI mice. Mean and maximal lifespans of the oldest 10% and
20% of each cohort are shown as mean values ± SEM.
(C) Age-associated mortality rates of control and ANKI female and male mice.
(D) Identified causes of death in aged control and ANKI mice (n=37). Sarcoma subtypes includes histio-,
hemangio-, lipo-, and fibrosarcoma, and carcinoma subtypes includes hepatocellular, bronchiolo-alveolar,
and chlangiocarcinoma.
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Figure 4.6. Plasma eNAMPT is exclusively localized to exosomes in both mice and humans.
(A) Levels of eNAMPT and exosome markers, CD63 and TSG101, in whole plasma (P), exosome
fraction (E) and soluble protein fraction (S) isolated from three independent mice. 40 µg of protein from
each fraction was loaded.
(B) Levels of eNAMPT in each fraction isolated from mice and humans. Each fraction was loaded after
adjusting them to an equal volume.
(C) Levels of eNAMPT in plasma, exosome fraction and soluble protein fraction isolated using
ultracentrifugation.
(D) Levels of exosomal eNAMPT in the plasma from 6- and 22-month old mice (n=4).
(E) Levels of exosomal eNAMPT in the plasma of control (CTRL) and ANKI mice at 24 month of age
(n=4).
(F) Levels of exosomal eNAMPT following the treatment with proteinase K and/or Trion X-100.
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Figure 4.7. Exosomal eNAMPT directly enhances NAD+ biosynthesis in primary hypothalamic
neurons and ameliorates age-associated decline in physical activity in mice.
(A) Fluorescent images of primary hypothalamic neurons following the incubation with BODIPY-labeled
exosomes. Exosomes purified from 200 µl (1X) or 400 µl (2X) of plasma were added to the same volume
of culture media.
(B) Cytoplasmic levels of FLAG-tagged recombinant NAMPT (recNAMPT) and cellular NAD+ levels in
the primary hypothalamic neurons after incubated with recNAMPT alone or exosomal recNAMPT (n=3).
(C, D) Levels of cytoplasmic NAMPT and NAD+ levels in primary hypothalamic neurons after incubated
with plasma (C) or exosomes (D) isolated from 6- and 18-month old mice.
(E) Levels of total cellular NAD+ (left panel) and increments in NAD+ levels (right panel) after incubated
with exosomes isolated from 6- and 20-22-month old mice.
(F) NAD+ levels in primary hypothalamic neurons after incubating with exosomes isolated from control
(CTRL) and ANKI mice at 20 months of age.
(G) Wheel-running activity over 24 hrs and total activity counts of 20-month old female mice before and
after 4 consecutive daily injections of exosomes purified from 4-6-month old mice.
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Figure S4.1. Adipocyte and plasma NAMPT levels significantly declines with age.
(A) NAMPT levels in the isolated adipocyte from 6 and 18 month old male mice. (n=5) (B) Western blot
for plasma eNAMPT levels over the course of 24 hours in male and female mice at the age of 6 and 18
months. (n=5 per group per time point)
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Figure S4.2. Adipose-tissue specific overexpression of Nampt increases plasma eNAMPT levels
and NAD+ biosynthesis.
(A) Plasma eNAMPT levels of 6-month-old control, 18-month-old ANKI, and 18-month-old control
mice. (n=3) (B) Tissue NAD+ levels of control and ANKI male mice under 48 hour fasting. (n=3-5) (C)
Quantitative relationship of plasma eNAMPT levels to hypothalamic NAD+ levels in control and ANKI
female mice. (n=5)
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Figure S4.3. ANKI male mice do not show any locomotor activity phenotype.
(A) Locomotor (top) and rearing (bottom) activity of male ANKI male mice. (n=4-7) (B) Wheel running
activity of 6 and 18 month old mice. (n=3-9)
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Figure S4.4. ANKI male mice do not show significant difference in insulin tolerance or body
composition.
(A) Plasma glucose levels of 17-20 month old control and ANKI male mice during insulin tolerance test.
(B) Body composition of 17-20 month-old control and ANKI mice.
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Figure S4.6. Characteristics of exosome isolated from mouse and human plasma.
(A) Electron microscopic image and particle size quantification of exosome isolated from mouse plasma.
(n=100) (B) Electron microscopic image and particle size quantification of exosome isolated from human
plasma. (n=100)
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Figure S4.7. Exosomal eNAMPT is internalized by cells and rescues age-associated decline in
physical activity.
(A) Quantitative relationship of plasma eNAMPT levels and internalized NAMPT by hypothalamic
neurons. (B) Levels of Flag-tagged recNAMPT in cytoplasm of HEK293 following the incubation with
pure recNAMPT or exosomal recNAMPT. (top) Levels of recNAMPT in media supplemented with pure
recNAMPT or exosomal recNAMPT prepared with different levels of recNAMPT incorporation.
(bottom) Levels of recNAMPT detected in the cytoplasmic extract of HEK293. (C) The total activity
counts of 20month old male mice before and after 4 consecutive daily injections of exosome.

174

Chapter 5:
Ongoing studies, Future Directions, and Conclusions
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5.1

Summary
We demonstrated that the rate-limiting NAD+ biosynthetic enzyme, NAMPT, is
secreted from adipose tissue and systemically circulates in the blood in a form we termed
eNAMPT. 1As an adaptive response to food scarcity such as fasting, eNAMPT secretion
is enhanced through the activation of adipose-tissue SIRT1 and its deacetylation activity
on Lysine 53 of NAMPT. In turn, secreted eNAMPT modulates hypothalamic NAD+
biosynthesis, SIRT1 activity, and neural activity, thereby regulating physical activity as a
hypothalamus-regulated behavioral output. Loss of adipose-tissue NAMPT expression
diminishes the physical activity, while injection of NAMPT product, NMN, rescues it.
eNAMPT is a critical inter-tissue regulatory mechanism to regulate systemic NAD+
biosynthesis in adaptive response.
In contrast, eNAMPT declines significantly in a linear fashion with age in both
mice and humans. A reduced level of eNAMPT is strongly associated with higher
mortality risks in aged mice. Genetically increasing the levels of eNAMPT in ANKI mice
enhanced NAD+ biosynthesis in several vital tissues such as the hypothalamus,
hippocampus, pancreas, and retina, thereby delaying age-associated decline in their
related functions. Aged female ANKI mice showed improved hypothalamic function,
such as enhanced physical activity and reduced sleep fragmentation. Furthermore, aged
male ANKI mice showed improved glucose metabolism with enhanced glucosestimulated insulin secretion, suggesting improved beta cell function. Aged ANKI mice
also showed preserved retinal functions, particularly in rod photoreceptors. Lastly, in
female ANKI mice, increased levels of eNAMPT lead to significant median lifespan
extension.
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Detailed characterization of plasma-derived eNAMPT revealed its exclusive
localization to exosomes. In vitro study showed exosomal eNAMPT is directly uptaken
and enhances NAD+ biosynthesis in hypothalamic neurons. Administration of exosomal
eNAMPT isolated from the plasma of young mice rescued age-related decline in physical
activity, demonstrating that eNAMPT repletion is a potential strategy against ageassociated functional decline.
5.2

Ongoing Studies and Future Directions
To further understand the role of exosomal eNAMPT in aging, we are carrying
out several key experiments to 1) characterize other function that may be affected by
eNAMPT-mediated NAD+ biosynthesis, 2) demonstrate the impact of exosome repletion
on lifespan in aged mice, 3) demonstrate that eNAMPT is the critical component of
exosome that directly enhances NAD+ biosynthesis in the target cells and ameliorates
age-associated behavior.
In aged female ANKI mice, we observed that hippocampal NAD+ levels are
increased; however, we did not follow up for our initial study because its NAD+ levels
were not affected in fasting-induced conditions. (Figure 5.1) However, exosome tracing
experiment in which we administered fluorescently labeled plasma exosomes using
BODYPI-TR into mice by intravenous injection, we detected significant fluorescence
signals in the hippocampus and hypothalamus, raising a possibility that the hippocampus
may also be another target of eNAMPT-mediated NAD+ biosynthesis. (Figure 5.2)
Additionally, given that NAMPT expressions and NAD+ levels significantly decline with
age, we suspected that the effect of eNAMPT might become more substantial with aging
than in response to fasting conditions2,3. Therefore we evaluated the cognitive function of
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20-month-old female ANKI mice using a contextual fear conditioning test. Consistent
with our hypothesis, aged female ANKI mice showed significantly more freezing time
than control mice, indicating that the ANKI mice have improved hippocampal function.
(Figure 5.3B) ANKI mice and control shows equivalent freezing time during the toneshock training phase and auditory cue, indicating that the effect of eNAMPT is
specifically on hippocampal cognitive function. (Figure 5.3 A, C)
Given that eNAMPT is enriched in plasma exosome and its level declines with
age, we hypothesized that eNAMPT supplementation by the injection of plasma exosome
isolated from young mice might be an effective anti-aging therapy. In support of this
idea, injections of exosomes isolated from young mice dramatically improved the
physical activity of aged mice. (Figure 4.7G) To further investigate the impact of
eNAMPT repletion by exosome injection on aging, we evaluated its impact on the
lifespan. We have weekly administered 28-months-old female mice with exosomes
isolated from 500ul of plasma collected from 4-12-months old mice by intraperitoneal
injection. While the study is still ongoing, exosome-injected mice have shown significant
median lifespan extension compared to vehicle-injected mice and are highly likely to
show significant maximum lifespan extension. (Figure 5.4) This data, together with the
physical activity enhancement by exosome injection, demonstrate that eNAMPT
repletion by exosome injection is an effective anti-aging strategy that can ameliorate both
age-associated functional morbidity and lifespan.
Furthermore, to demonstrate that eNAMPT is the key component of exosome that
directly enhances NAD+ biosynthesis, we generated exosomes with NAMPT
overexpression (NAMPT-OE) and knockdown (NAMPT-KD) using differentiated OP9
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adipocytes. Consistent with the enrichment of plasma eNAMPT in exosome fraction,
OP9-derived eNAMPT is also exclusively localized in exosome fraction. (Figure 5.5) We
have confirmed that exosomes derived from NAMPT-OE OP9 cells show higher levels of
eNAMPT, while exosomes derived from NAMPT-KD OP9 cells show a loss of
eNAMPT. (Figure 5.6) Furthermore, Enhancement of NMN biosynthesis in hypothalamic
neurons was exclusively observed in the exosome fraction but not in the media or the
supernatant after the exosome removal. (Figure 5.7) While NAMPT-OE exosomes and
wildtype exosomes significantly enhanced NMN biosynthesis, NAMPT-KD exosomes
failed to do so, demonstrating that, indeed, eNAMPT is the key component of exosomes
that directly enhance cellular NAD+ biosynthesis. (Figure 5.8) We are currently
evaluating the effect of NAMPT-OE and NAMPT-KD exosome on the physical activities
of aged mice to demonstrate the direct contribution of eNAMPT on a behavioral
phenotype observed in exosome repletion experiments. Given the significant extension of
lifespan by eNAMPT repletion through plasma exosome injection, it would be interesting
to assess the effect of OP9-derived exosome on the lifespan. In case that OP9 derived
exosomes exert the same lifespan extending effect as the plasma exosomes, this will
provide a convenient platform to generate exosomal eNAMPT for clinical applications.
5.3

Conclusions
The worldwide rise in the aging population and associated inflation in the
prevalence of chronic diseases calls for increasing demand to develop an intervention to
delay the aging process. The emerging role of NAD+ homeostasis has shed light on its
potential as such interventions against aging and associated morbidity. The work
presented in this dissertation provides new insight into how systemic NAD+ biosynthesis
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is maintained systemically by eNAMPT through a newly identified mechanism and the
potential for its repletion as a therapeutic approach against aging.
5.4
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Figure 5.1. NAD+ levels in a subset of tissues are increased in fasted ANKI mice.
Tissue NAD+ levels measured by HPLC in male ANKI and control (CTRL) mice after 48 hour fasting.
(n=3-6)
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tail vein injection. Tissues were collected after 2 hours of injection.

Baseline

B

shock

60
40
20
0

0

1

2
3
4
Time (minutes)

ANKI
CTRL
5
6

60

ANKI
CTRL

40

**

C
*

20
0

0

1
2
Time (minutes)

Freezing (%)

80

Freezing (%)

Freezing (%)

A

80

Baseline

Tone

60
40
20
0

ANKI CTRL
1 2 3 4 5 6 7 8 9 10
Time (minutes)

Figure 5.3. Aged female ANKI mice exhibit higher hippocampal cognitive function in
contextual fear conditioning test.
(A) Percent time freezing of 20 months-old female ANKI and CTRL mice at the baseline and during the
training with tone-shock (shock) on Day1. (B) Percent time freezing in response to contextual fear on
Day2. (3) Percent time freezing at the baseline and auditory cue (tone) on Day3. (n=4-5)

182

Treatment started at 28-month-old

Survival probability (%)

100

50

P = 0.0009
0
750

Exosome
Vehicle
800

850

900

950

Age (days)
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Figure 5.5. eNAMPT derived from OP9 adipocyte is exclusively localized in exosome fraction.
Levels of eNAMPT and exosome markers, CD9, CD81, Hsp70, and TSG101 in OP9 conditioned
media, exosome fraction, and supernatant after exosome removal. 10ug of protein was equally
loaded for every fraction.
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Figure 5.6. NAMPT levels in exosomes derived from NAMPT-OE and –KD OP9 adipocytes.
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Figure 5.7. Exosome fraction containing eNAMPT exclusively enhances NMN biosynthesis in
hypothalamic neurons.
Relative rate of NMN biosynthesis in hypothalamic neurons treated with media, exosome
fraction, and supernatant after exosome removal from OP9 conditioned media.
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Figure 5.8. eNAMPT is necessary for the enhancement of NMN biosynthesis by exosome.
Relative rate of NMN biosynthesis in hypothalamic neurons treated with CTRL, NAMPT-OE,
NAMPT-KD exosome.
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